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Resonance Imaging
Abstract
This project’s main objective was to develop and implement a molecular imaging tool based on
hyperpolarized 13C magnetic resonance imaging (MRI) to quantitatively interrogate lung metabolism. The
pulmonary system plays a major role in performing a variety of biochemical functions that maintain body
homeostasis, but that undergo significant detrimental alteration in the setting of lung injury and/or
inflammation. Such changes cause lactic acid to be released from the lungs and are associated with
increased patient mortality. The ability to directly measure both changes in lung metabolism and its
spatial heterogeneity can provide insight into the relationship between abnormal mechanics and
cellularity in diseased lung tissue. This work primarily focuses on small and large mammalian species as
a stepping stone toward translation to human subjects. The key deliverables of this project are acquisition
and quantification tools for the regional assessment of hyperpolarized pyruvate’s conversion to lactate in
lung tissue.
To demonstrate the utility of our method, we used a two-hit animal model of acid aspiration and
ventilator-induced lung injury that mimics a variety of inflammatory pulmonary diseases including acute
lung injury (ALI) and acute respiratory distress syndrome (ARDS). We measure the conversion of pyruvate
to lactate using hyperpolarized lactate-to-pyruvate ratio, and show that this ratio is significantly correlated
with inflammatory activity in the lung tissue as well as the degree of systemic hypoxemia. To further
investigate hypoxia’s contribution to increased pulmonary lactate production, we assessed overall lung
metabolism in non-injured hypoxic animals: while pulmonary pyruvate metabolism is resilient to moderate
levels of hypoxemia, it changes significantly as a result of severe hypoxemia. Our data suggest that the
increased lactate-to-pyruvate ratio in injured lungs is predominantly caused by inflammation.
Next, we used our techniques to image both healthy and injured pigs on a clinical scanner in order to
demonstrate the potential clinical translatability of hyperpolarized 13C imaging. Finally, we explored the
possibility of using other imaging pulse sequences to achieve higher spatial and temporal resolution in
both small and large animals, concluding that our method can serve as a future basis for rapid, highresolution metabolic imaging of the lungs.
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ABSTRACT

METABOLIC IMAGING OF ACUTE LUNG INJURY USING HYPERPOLARIZED 13C
MAGNETIC RESONANCE IMAGING

Mehrdad Pourfathi
Rahim R. Rizi, Ph.D.

This project’s main objective was to develop and implement a molecular imaging tool based on
hyperpolarized 13C magnetic resonance imaging (MRI) to quantitatively interrogate lung metabolism. The
pulmonary system plays a major role in performing a variety of biochemical functions that maintain body
homeostasis, but that undergo significant detrimental alteration in the setting of lung injury and/or
inflammation. Such changes cause lactic acid to be released from the lungs and are associated with increased
patient mortality. The ability to directly measure both changes in lung metabolism and its spatial
heterogeneity can provide insight into the relationship between abnormal mechanics and cellularity in
diseased lung tissue. This work primarily focuses on small and large mammalian species as a stepping stone
toward translation to human subjects. The key deliverables of this project are acquisition and quantification
tools for the regional assessment of hyperpolarized pyruvate’s conversion to lactate in lung tissue.
To demonstrate the utility of our method, we used a two-hit animal model of acid aspiration and
ventilator-induced lung injury that mimics a variety of inflammatory pulmonary diseases including acute
lung injury (ALI) and acute respiratory distress syndrome (ARDS). We measure the conversion of pyruvate
to lactate using hyperpolarized lactate-to-pyruvate ratio, and show that this ratio is significantly correlated
with inflammatory activity in the lung tissue as well as the degree of systemic hypoxemia. To further
investigate hypoxia’s contribution to increased pulmonary lactate production, we assessed overall lung
metabolism in non-injured hypoxic animals: while pulmonary pyruvate metabolism is resilient to moderate
levels of hypoxemia, it changes significantly as a result of severe hypoxemia. Our data suggest that the
increased lactate-to-pyruvate ratio in injured lungs is predominantly caused by inflammation.
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Next, we used our techniques to image both healthy and injured pigs on a clinical scanner in order
to demonstrate the potential clinical translatability of hyperpolarized 13C imaging. Finally, we explored the
possibility of using other imaging pulse sequences to achieve higher spatial and temporal resolution in both
small and large animals, concluding that our method can serve as a future basis for rapid, high-resolution
metabolic imaging of the lungs.

vi

TABLE OF CONTENTS

ACKNOWLEDGMENT ................................................................................................ IV
ABSTRACT ...................................................................................................................... V
LIST OF TABLES ....................................................................................................... XIII
LIST OF ILLUSTRATIONS ........................................................................................XV
LIST OF ABBREVIATIONS .................................................................................... XXX
CHAPTER 1: INTRODUCTION.................................................................................... 1
1.1. Background and Significance .................................................................................................................1
1.2. Objective and Specific Aims ...................................................................................................................4
1.3. Thesis Organization.................................................................................................................................5
1.4. References ................................................................................................................................................9

CHAPTER

2:

MAGNETIC

RESONANCE

IMAGING

AND

HYPERPOLARIZATION ............................................................................................. 12
2.1. Introduction ...........................................................................................................................................12
2.2. A Brief History .......................................................................................................................................13
2.3. Fundamentals of Nuclear Magnetic Resonance..................................................................................14
2.3.1. T1 and T2 Relaxation Mechanisms ...................................................................................................17
2.3.2. Radio-frequency Excitation and Signal Detection ...........................................................................19
2.3.3. Chemical Shift..................................................................................................................................21
2.4. Hyperpolarization..................................................................................................................................23
2.4.1. Methods of Hyperpolarization .........................................................................................................24

vii

2.4.2. Optical Pumping ..............................................................................................................................25
2.4.3. Parahydrogen Induced Polarization .................................................................................................26
2.4.4. Dynamic Nuclear Polarization .........................................................................................................26
2.5. DNP: Practical Aspects for Medical Imaging .....................................................................................29
2.6. Molecular Imaging Using Hyperpolarized 13C MRI ..........................................................................31
2.6.1. Hyperpolarized [1-13C] Pyruvate: Probing Glycolysis ....................................................................32
2.7. Spatial Encoding, K-Space and Image Formation .............................................................................35
2.7.1. Acquisition Methods and MRI Pulse Sequences .............................................................................37
2.8. Chemical Shift Imaging ........................................................................................................................40
2.8.1. Spectroscopic Imaging Approaches .................................................................................................41
2.8.2. Iterative Decomposition Using Echo Asymmetry and Least Square Estimation ............................43
2.8.3. Spatial-Spectral Excitation for Chemical Shift Imaging..................................................................45
2.9. Imaging Considerations ........................................................................................................................46
2.9.1. General Considerations ....................................................................................................................47
2.9.2. Special Considerations for Hyperpolarized MRI .............................................................................48
2.10. References ............................................................................................................................................50

CHAPTER 3: LUNGS AND ACUTE RESPIRATORY DISTRESS SYNDROME 54
3.1. Introduction ...........................................................................................................................................54
3.2. Healthy Lungs ........................................................................................................................................55
3.2.1. Anatomy and Physiology ...................................................................................................................55
3.2.2. Respiratory Mechanics ......................................................................................................................57
3.3. Acute Respiratory Distress Syndrome and Acute Lung Injury ........................................................58
3.3.1. Characterization and Clinical Definition .........................................................................................58
3.3.2. Mechanical Ventilation ....................................................................................................................60
3.3.3. Pathogenesis .....................................................................................................................................61
3.3.4. Pulmonary Lactate Production .........................................................................................................64
3.3.5. Animal Models of ALI and ARDS ..................................................................................................65

viii

3.3.6. Emerging Treatments .......................................................................................................................67
3.4. Current Lung Imaging Tools ...............................................................................................................68
3.4.1. Radiography .....................................................................................................................................68
3.4.2. Computed Tomography (CT)...........................................................................................................70
3.4.3. Positron Emission Tomography (PET) ............................................................................................71
3.4.4. Magnetic Resonance Imaging (MRI) ...............................................................................................73
3.4.5. Ultrasound Imaging and Electrical Impedance Tomography (EIT) ................................................75
3.5. References ..............................................................................................................................................77

CHAPTER 4: METABOLIC IMAGING OF ACUTE LUNG INJURY USING
HYPERPOLARIZED 13C MRI ..................................................................................... 80
4.1. Introduction ...........................................................................................................................................80
4.2. Development and Optimization of a Lung Imaging Protocol ...........................................................81
4.3. Study Design and Methodology ............................................................................................................86
4.3.1. Animal Preparation and Injury Protocol ..........................................................................................86
4.3.2. Hyperpolarization Protocol ..............................................................................................................88
4.3.3. MRI/MR Spectroscopic Imaging Protocol ......................................................................................89
4.3.4. MRI Data Processing and Statistical Analysis .................................................................................90
4.4. Results .....................................................................................................................................................91
4.5. Discussion ...............................................................................................................................................98
4.6. Application for Lung Cancer Imaging ..............................................................................................103
4.6.1. Cancer Induction, 1H and 13C Imaging Protocols ..........................................................................103
4.6.2. Cancer Imaging Results and Discussion ........................................................................................105
4.7. Conclusion ............................................................................................................................................108
4.8. References ............................................................................................................................................110

CHAPTER 5: IMPACT OF POSITIVE-END EXPIRATORY PRESSURE ON
LUNG METABOLISM ................................................................................................ 113
ix

5.1. Introduction .........................................................................................................................................113
5.2. Study Design and Methodology ..........................................................................................................114
5.2.1. Animal preparation, Injury and Imaging Protocols .......................................................................114
5.2.2. Immunohistochemistry...................................................................................................................117
5.2.3. Statistical Analysis .........................................................................................................................118
5.3. Results ...................................................................................................................................................119
5.3.1. Global Assessment of Lung Metabolism and Function .................................................................121
5.3.2. Correlation Between Imaging Markers and Biology .....................................................................124
5.3.3. Regional Analysis of Lung Metabolism ........................................................................................128
5.4. Discussion .............................................................................................................................................129
5.5. Limitations ...........................................................................................................................................133
5.6. Conclusion ............................................................................................................................................134
5.7. References ............................................................................................................................................135

CHAPTER 6: IMPACT OF HYPOXIA ON LUNG METABOLISM .................... 138
6.1. Introduction .........................................................................................................................................138
6.2. Study Design and Methodology ..........................................................................................................140
6.2.1. Animal Preparation, Imaging and Hypoxia Protocol .....................................................................140
6.2.2. Comparison of Healthy, Hypoxic and Injured Rats .......................................................................142
6.3. Results ...................................................................................................................................................143
6.3.1. Hypoxia Study................................................................................................................................143
6.3.2. Comparison of Imaging Data from Hypoxia and Injury Studies ...................................................147
6.3.3. Histological Analysis of the Lung Sections ...................................................................................151
7.4. Discussion .............................................................................................................................................152
6.5. Limitations ...........................................................................................................................................156
6.6. Conclusion ............................................................................................................................................157
6.7. References ............................................................................................................................................158

x

CHAPTER 7: TRANSLATION OF HYPERPOLARIZED

13

C PULMONARY

IMAGING TO LARGER SPECIES ........................................................................... 160
7.1. Introduction .........................................................................................................................................160
7.2. Materials and Methods .......................................................................................................................161
7.2.1. Study Design and Injury Protocol ..................................................................................................161
7.2.2. Hyperpolarization Protocol ............................................................................................................163
7.2.3. 1H and 13C Imaging Protocols ........................................................................................................163
7.2.4. MRI Data Processing .....................................................................................................................165
7.3. Results ...................................................................................................................................................166
7.3.1. 13C Spectroscopy ............................................................................................................................166
7.3.2. 13C Chemical Shift Imaging ...........................................................................................................168
7.4. Discussion .............................................................................................................................................177
7.5. Conclusion ............................................................................................................................................181
7.6. References ............................................................................................................................................182

CHAPTER 8: DEVELOPMENT OF A PLATFORM FOR HIGH-RESOLUTION
PULMONARY METABOLIC IMAGING USING HYPERPOLARIZED

13

C MRI

......................................................................................................................................... 183
8.1. Introduction .........................................................................................................................................183
8.2. Materials and Methods .......................................................................................................................184
8.2.1. Animal Preparation ........................................................................................................................184
8.2.2. 1H and 13C Imaging ........................................................................................................................185
8.2.3. MRI Data Processing .....................................................................................................................188
8.3. Results ...................................................................................................................................................188
8.4. Discussion .............................................................................................................................................192
8.5. Lung Metabolic Imaging Strategies using the HASTE Pulse Sequence .........................................194
8.6. Conclusion ............................................................................................................................................196

xi

8.7. References ............................................................................................................................................197

CHAPTER 9: CONCLUSION AND FUTURE WORK ........................................... 198
9.1. Conclusion ............................................................................................................................................198
9.2. Future Work ........................................................................................................................................199
9.2.1. Specifying the Source of Increased Lactate Production ................................................................199
9.2.2. Tandem Hyperpolarized 13C and 129Xe Imaging to Improve Specificity .......................................201
9.2.3. Assessment of Treatment TRPV4 Inhibition in Lung Injury Models using Hyperpolarized MRI
Technology...............................................................................................................................................202
9.2.4. Development of High-Resolution MRI Pulse Sequences For Metabolic Imaging in Small and Large
Species .....................................................................................................................................................203
9.2.5. Explore the Use of 13C MRI to Study Other Pulmonary Disorders ...............................................204
9.3. References ............................................................................................................................................205

xii

LIST OF TABLES

Table 4.1

Summary of imaging parameters for the protocols established for imaging

84

lungs of rats and mice.
Table 5.1

Summary of post-hoc analysis performed using the Tukey honest significant

123

difference test, performed when the results of the one-way ANOVA test (with
Bonferroni adjustment for four time points aadj.=0.05/4 = 0.0125) for each
time point was significant. Initial two-way ANOVA of the average lactate-topyruvate ratio showed discrimination among groups (F2,74=8.242, p<0.001)
and pyruvate injections (F3,74=7.023, p<0.001). The average lactate-topyruvate ratio was similar among groups at both healthy baseline (F2,18=0.648,
p=0.535) and 1 hour after acid/saline instillation (F2,18=0.514, p=0.513), but
was significantly different both 2.5 hours (F2,14=8.843, p=0.003) and 4 hours
(F2,14=5.533, p<0.001) after instillation. The initial ANOVA of the pulmonary
compliance (Cdyn) showed significant inter-group difference (F2,74=16.56,
p<0.001). Cdyn was also significantly different among groups 1 hour
(F2,18=7.866, p=0.003), 2.5 hours (F2,18=16.1, p<0.001) and 4 hours
(F2,18=20.8, p<0.001) after acid/saline instillation. (# Time from instillation of
acid/saline).
Table 5.2

Pearson correlation coefficients between the global lactate-to-pyruvate ratio

126

and other experimental parameters. Pulmonary compliance and oxygen
saturation were measured at the beginning of

13

C imaging. Histological

features were only correlated with the last imaging time-point. Bonferroni
correction was applied for 8 univariate correlation tests (significance for
adjusted aadj.=0.05/8 = 0.00625).
Table 6.1

Summary of experimental parameters for rat studies.

143

Table 6.2

Summary of post-hoc analysis of both pulmonary and cardiac lactate-to-

150

pyruvate ratios in all groups. Analysis was performed using the Tukey honest
significant difference test, performed when the results of the one-way
ANOVA test (with Bonferroni adjustment for four time points aadj.=0.05/4 =
0.0125) for each time point was significant. Initial two-way ANOVA of the

xiii

average

pulmonary

and

cardiac

lactate-to-pyruvate

ratios

showed

discrimination among groups (F5,180=10.230, p<0.001 and F5,178=2.256,
p=0.034) and pyruvate injections (F3,180=17.240, p<0.001 and F3,180=9.956,
p<0.001). Both pulmonary and cardiac lactate-to-pyruvate ratios were similar
among groups at healthy baseline (F5,47=1.212, p=0.318 and F5,47=1.893,
p=0.113) and 1 hour after intervention (F5,46=2.201, p=0.070 and F5,45=0.518,
p=0.761), while pulmonary lactate-to-pyruvate ratio alone was different
among groups 2.5 hours after the intervention (F3,37=9.657, p<0.001,
F5,38=3.237, p=0.0157). There was discrimination for both ratios among
groups 4 hours (F5,35=20.290, p<0.001 and F5,33=4.986, p=0.001) after
intervention.
Table 7.1

Summary of the average lactate-to-pyruvate ratio, lactate and pyruvate signal-

162

13

to-noise ratios, heart-rate and oxygen saturation recorded at the time of C
injection.
Table 7.2

Pyruvate linewidth (Hz) quantification in the heart, native lung and grafted

173

lung in syngeneic and allogeneic cohorts on days 3, 7 and 14
Table 7.3

Summary of arterial blood gas results at baseline (pre) and after imaging

177

(post) in injured animals.
Table 8.1

Summary of the estimated T2 measured in the lungs after injection of
hyperpolarized [1-13C] pyruvate (numbers are reported as Mean ± SD).

xiv

191

LIST OF ILLUSTRATIONS

Figure 2.1

Classical picture of the distribution of nuclear spins (spin 1/2) in the presence

15

of the main magnetic field, B0. The difference in quantum energy between
these states increases with the magnetic field and at any field is specific to
each atomic species.
Figure 2.2

Graphical representation of Larmor precession frequency.

17

Figure 2.3

(A) At t=0, the ensemble of spins in the transverse plane are all in phase. (B)

18

The local fluctuations in the field cause spins to precess at slightly different
frequencies, resulting in dispersion of the spins and loss of precessional
coherence.
Figure 2.4

Pictorial description of an (left) excitation RF pulse and (right) an inversion

20

RF pulse.
Figure 2.5.

(A) A typical free induction decay acquired after excitation; the signal decays

20

exponentially. (B) The Fourier transform of the FID leads to the NMR
spectrum.
Figure 2.6

The isolated nucleolus (A) is subject to the external magnetic field B0.

21

However, atomic nuclei are surrounded by an electron cloud which generates
a weak magnetic field in the opposite direction to the external field (B). This
shields the nucleus from the external field, so the nucleus is subject to a
smaller effective magnetic field.
Figure 2.7

13

C NMR spectrum of ethanol. The carbons on the carboxyl (label 1) and the

22

methyl (label 2) groups have chemical shifts of 200ppm and 30ppm
respectively. The NMR spectrum of the reference molecule TMS appears at
0 ppm.
Figure 2.8

Orientation of the nuclear spins at thermal equilibrium (A) and in the
hyperpolarized state (B). The population difference of the spins significantly
increases in the hyperpolarized state, resulting in increased NMR signal.

xv

24

Figure 2.9

Thermal polarization of electron, proton and

13

C species as a function of

27

temperature over magnetic field. At T/B < 0.1 Kelvin/Tesla, electrons are
100% polarized. This condition can be achieved at temperatures of T<2K
and magnetic fields greater than 3T. The high degree of magnetization can
be transferred from electrons to 13C or proton species via dynamic nuclear
polarization (DNP).
Figure 2.10

(Left) Preclinical commercial polarizer (HyperSense, Oxford Inc.) and

29

clinical polarizer (SpinLab, GE Healthcare).
Figure 2.11

Metabolites and their biochemical pathways that can be interrogated using
13

[1- C] pyruvate. MRI. The red circle indicates atoms with

13

33

C labeled

nuclei. The fate of the pyruvate beyond Acetyl-CoA into the Tricarboxylic
Acid (TCA) cycle cannot be probed using [1-13C] pyruvate as the 13C labeled
nucleolus remains on the 13CO2 molecule. Cofactors are not shown in this
diagram for simplicity (LDH: lactate dehydrogenase, ALT: alanine
transaminase, PDH: pyruvate dehydrogenase, CA: carbonic anhydrase).
Figure 2.12

(A) NMR spectrum obtained from a mouse after administration of

34

13

hyperpolarized [1- C] pyruvate via the tail-vein. (B) Spectra obtained every
second shows how different peaks vary over time. (C) Area under each peak
depicted as a function of time to represent the relative concentration of each
peak.
Figure 2.13

MRI data acquired in the k-space represents the Fourier transform of the

37

object. The actual image (right) can be obtained by applying inverse Fourier
transform to the k-space data.
Figure 2.14

(A) gradient-echo and (B) echo-planar readout trajectories are basic cartesian

38

trajectories commonly used in both preclinical and clinical settings.
Commonly used non-cartesian trajectories include (C) radial and (D) spiral
trajectories. The imaging methods in this thesis obtain the data in a Cartesian
grid.
Figure 2.15

Basic gradient-echo pulse sequence with a cartesian read-out trajectory. The
components shown by the pulse sequence diagram are repeated regularly at

xvi

39

the repetition time (TR) interval until the desired portion of the k-space is
covered.
Figure 2.16

(A) Proton cardiac MRI, (B) 13C-bicarbonate, (C) [1-13C] lactate and (D) [113

40

13

C] pyruvate maps after administration of hyperpolarized [1- C] pyruvate

to a healthy human subject.
Figure 2.17

(A) 2D FID-CSI chemical shift imaging pulse sequence diagram, and (B) its

42

associated k-space trajectory along the (kx,t) plane. The dashed lines with
arrowheads show the direction of data acquisition per one excitation.
Figure 2.18

(A) Pulse sequence diagram of the EPSI sequence and (B) its k-space

43

trajectory. The gradients along the readout result in data acquisition with an
echo-planar trajectory in the (kx,t) plane.
Figure 2.19

Magnetization of both water and fat molecules is excited and an in-phase

44

image (IP) is acquired. After a certain delay, the water (Mwater) and fat (Mfat)
magnetizations become out of phase due to their different chemical shifts, at
which point an out-of-phase (OP) image is acquired. Separate images of
water and fat then can be reconstructed from the IP and OP images.
Figure 2.20

Pulse sequence diagram for an EPI sequence with spectral-spatial excitation

46

(SPSP). The SPSP excitation pulse consist of multiple RF pulses
accompanied by an EPI-type slice selection gradient (Gz).
Figure 3.1

Pulmonary vessels branch in the same treelike fashion as the airways. (A)
Systemic venous blood flows through the pulmonary arteries into the
alveolar capillaries and back to the heart via the pulmonary veins, to be
pumped into systemic circulation. (B) A mesh of capillaries surrounds each
alveolus. As the blood passes through the capillaries, it gives up carbon
dioxide and takes up oxygen. (C) Blood–gas interface, formed by pulmonary
capillaries and alveoli, is the site of gas exchange. Thick arrows indicate the
direction of blood flow and ventilation, while thin arrows indicate the
diffusion paths for O2 and CO2. The alveolar–capillary membrane is thin
(∼0.5μm), and therefore the diffusion distance for gases is small.

xvii

56

Figure 3.2

Etiologies, manifestations and sequelae of ARDS/ALI. Upon diagnosis,

59

patients undergo supportive therapy using protective ventilation (described
in section 3.4.2). The patient’s overall condition is assessed by chest
radiography, computed tomography, ventilatory parameters and ABG.
Treatment either results in resolution of ARDS/ALI or in the syndrome’s
progression into severe respiratory failure, pulmonary fibrosis and eventual
multi-organ failure.
Figure 3.3

The healthy lung (left), and the acute phase of ARDS/ALI (right). In

63

ARDS/ALI, injury is initiated by either direct or indirect insults to the
delicate

alveolar

structure

of

the

distal

lung

and

associated

micro-vasculature. In the exudative phase, resident alveolar macrophages are
activated, leading to the release of potent pro-inflammatory mediators and
chemokines that promote the accumulation of neutrophils and monocytes.
Activated neutrophils further contribute to injury by releasing toxic
mediators. The resultant injury leads to loss of barrier function as well as
interstitial and intra-alveolar flooding. (AECI: type I alveolar epithelial cell
(pneumocyte),

AECII:

type

II

alveolar

epithelial

cell,

MPO:

myeloperoxidase, ROS: reactive oxygen species and sICAM: soluble
intercellular adhesion molecule). More detailed information can be found in.
Figure 3.4

(A) Lung lactate production measured by the difference in the lactate

65

concentration across the lungs (arteriovenous difference in lactate) in various
groups of patients shows that lungs of ALI patients produce significant
amounts of lactate. (B) Lung lactate production measured in 43 patients with
acute injury showed that it is proportional to injury severity as determined
by Murray’s lung injury score29. (ALI: acute lung injury, CPE: acute
pulmonary edema, BPN: bronchopneumonia, LTx: lung transplantation,
Other: other types of respiratory failure, mEq/min.M2: mmoles per minute
per square meter). Reprinted with permission of the American Thoracic
Society. Copyright © 2019 American Thoracic Society from2. The American
Journal of Respiratory and Critical Care Medicine is an official journal of
the American Thoracic Society.
Figure 3.5

Chest imaging in patients with acute respiratory distress syndrome (ARDS).
(A) A plain chest radiograph demonstrates symmetric widespread hazy

xviii

69

infiltrates. (B) A computed tomography scan in the same patient confirms
the bilateral infiltration observed on plain chest radiograph; however, the
infiltrate is predominantly in the dorsal lung (black arrow), while the ventral
lung regions are aerated (green arrow). (C) Computed tomography scan
showing typical ground glass opacities, indicating severely decreased
aeration but without complete loss of gas content. (D) Computed
tomography scan of a patient 16 days after ARDS-onset, showing diffuse
interstitial thickening predominantly at the lung bases, suggesting evolving
fibrosis; in addition, ventral bullae (yellow arrow), pneumomediastinum
(blue arrow), and soft tissue emphysema (red arrow) represent barotrauma
from mechanical ventilation. Reproduced with permission from.
Figure 3.6

Representative images of cross-registered computed tomography (CT) and
18

72

18

[ F]-fluorodeoxyglucose ( F-FDG) positron emission tomography from
two patients with ALI/ARDS. The CT image was acquired during a
respiratory pause at mean airway pressure: the gray scale is centered at -500
Hounsfield Units with a width of 1250 Hounsfield Units. Positron emission
tomographic

images

represent

the

average

pulmonary

18

F-FDG

concentration during the last 20 minutes of acquisition (from 37 to 57
minutes after

18

F-FDG administration): the color scale represents

radioactivity concentration (kBq/mL). (A)

18

F-FDG distribution parallels

that of the opacities detected on CT. (B) Intense

18

F-FDG uptake can be

observed in normally aerated regions (square 1), while activity is lower in
the dorsal, “nonaerated” regions of both lungs (square 2). Reproduced with
permission from.
Figure 3.7

(Top Row) Coronal images of the lungs in a human subject obtained using
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conventional MRI. (Bottom Row) Images from the same subject after
inhalation of hyperpolarized 3He gas to allow visualization of the airways.
Figure 4.1

(Left) The k-space trajectory used in the proposed acquisition technique,
where the acquisition returns to the center of the k-space every 11th
acquisition. (Right) Signal obtained during the course of imaging shows the
exponential signal decay due to the T1 relaxation of the sample as well as the
destructive effect of RF excitation on magnetization. The blown-up view of
the initial 1.5 seconds of the data shows the FID obtained during each phase-
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encoded acquisition and every 11th FID from the center of the k-space; this
has a larger amplitude due the absence of spatial phase distortion across the
object due to the phase encoding gradients.
Figure 4.2

Study design for hyperpolarized pyruvate studies. Three cohorts of rats (5
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13

each) were used. Each rat received 3 injections of hyperpolarized [1- C]
pyruvate (Pyr) at approximately 60, 130 and 240 minutes after the start of
ventilation. The injured-1 cohort received 1 ml/kg HCl (A1), while the
injured-2 cohort received 2 ml/kg HCl (A2) intratracheally 10 minutes after
the first pyruvate injection. Compliance was measured before each pyruvate
injection.
Figure 4.3

Representative 13C MRSI overlay on 1H images in (A) healthy, (B) injured-
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1 and (C) injured-2 rats. The bottom panels show the close-up view of the
average of spectra in the posterior (D, F, H) and anterior voxels (E, G, I)
outlined in (A-C) for healthy, injured-1 and injured-2 lungs. The pyruvate
and lactate signal in both anterior and posterior voxels of the control rat
appear similar. In the injured-1 rat, the overall pyruvate and lactate signal
increased in the posterior voxels (F), while the lactate signal increased in the
interior voxels (G); the pyruvate signal increased significantly in the injured2 rat in both areas (H, I). At the same time, the linewidth in the injured-2 rat
became narrower, likely due to the formation of edema and consequent
improvement in local field homogeneity.
Figure 4.4

Representative pyruvate and lactate maps overlaid on their corresponding
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proton images. The left panel shows a healthy rat 60 (baseline) and 240
(follow-up) minutes after the start of ventilation. The middle and right panels
show representative metabolite maps in injured-1 and injured-2 animals at
the same time points, before (baseline) and 240 minutes after (follow-up)
acid aspiration injury. The color bar maps the intensity of each metabolite
image as a fraction of the maximum value in the same image.
Figure 4.5

(A) Average pulmonary lactate-to-pyruvate ratio in control (white), injured1 (light gray) and injured-2 (dark gray) cohorts for all injections. Average
(dark filled circles) and individual (gray hollow circles) pulmonary lactate-
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to-pyruvate ratios in (B) control, (C) injured-1 and (D) injured-2 cohorts for
all three injections. (*** p<0.001, ** p <0.01, * p <0.05, † p <0.1)
Figure 4.6

Average (A) pyruvate and (B) lactate signals, corrected for solid-state
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polarization levels, for all three cohorts at all three injections.
Figure 4.7

(A) Average pulmonary compliance in control (white), injured-1 (light gray)
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and injured-2 (dark gray) cohorts for all injection time points. Average (dark
filled circles) and individual (gray hollow circles) pulmonary compliance in
(B) control, (C) injured-1 and (D) injured-2 cohorts for all injections. (****
p <0.0001, *** p <0.001, ** p <0.01, * p <0.05)
Figure 4.8

Lactate-to-pyruvate vs. pulmonary compliance for control (circles), injured-
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2 (triangles) and injured-2 (crosses) cohorts at the first (A), second (B) and
third (C) injection time points. Inner and outer ellipses represent 95% and
99% confidence intervals, respectively.
Figure 4.9

T2-weighted axial scan over the lungs, showing the primary tumor as well as
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a secondary tumor protruding out of the thoracic cavity. Metabolite maps are
overlaid on the T2 scan, and the lactate map shows enhanced lactate signal
over both primary and secondary tumors (white arrows).

13

C spectra

averaged over the non-cancerous lung tissue next to the tumor (A), the
primary tumor (B) and the secondary tumor (C) are shown on the right. The
spectra show elevated lactate-to-pyruvate ratio over the tumors relative to
the healthy lung tissue.
Figure 4.10

Pyruvate and lactate maps overlaid on the corresponding T2-weighted axial
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scans over the lungs in four mice with different presentations of lung tumor.
The white arrow shows regions with elevated lactate signal that are
colocalized with the lung tumors.
Figure 5.1

Summary of hyperpolarized

13

C imaging studies. A healthy baseline

13

C

image was initially acquired. Rats received 0.5ml/kg of either hydrochloric
acid (N=14) or saline (N=7) 10 minutes after the baseline scan; positive-end
expiratory pressure (PEEP) was then immediately increased to 10 cmH2O
during a 10-minute stabilization period before being lowered back to 5
cmH2O. The first follow-up 13C image was acquired 1 hour after instillation.
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PEEP was then lowered to 0 cmH2O in all rats receiving saline (Sham group)
and in seven injured rats (ZEEP group). Subsequent

13

C images were

acquired 2.5 and 4 hours after acid/saline instillation. (Note that four animals
from the ZEEP group did not receive the third injection. Statistics are
corrected for the unbalanced data.)
Figure 5.2

Representative pyruvate and lactate maps overlaid on their corresponding

119

proton images. The left panels show the images acquired at healthy baseline
and 4 hours after acid/saline instillation in a sham rat. The middle and right
panels show similar maps for the PEEP and ZEEP rats. Note the dramatic
increase in lactate signal in the ZEEP rat 4 hours after acid instillation. For
display, the pyruvate and lactate maps are normalized to their own maximum
intensity for each pulmonary map.
Figure 5.4

(A) Pyruvate, lactate and lactate-to-pyruvate segmented maps overlaid on
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their corresponding proton image of a ZEEP rat 4 hours after the acid
instillation shows injury to the posterior right lung marked by increased
intensity in the proton image (white arrow). The metabolite maps show
increased lactate signal intensity and lactate-to-pyruvate ratio colocalized
with the injured area. (B) Hematoxylin and Eosin (H&E) axial slide of the
whole lung clearly shows damaged lung tissue in the same area (black
arrow). Magnified images taken from the injured area (black box) with (C)
10´ and (D) 40´ magnifications show severe damage and inflammatory
infiltrates in the tissue. The bar in (C) is 100 µm.
Figure 5.4

(A) Average lactate-to-pyruvate ratio was significantly higher in the ZEEP
group compared to sham and PEEP groups 2.5 (p<0.01 for both
comparisons) and 4 hours (p<0.001 for both comparisons) after acid/saline
instillation. There was no significant difference between the latter two
groups at either 2.5 or 4 hours. (B) Pulmonary compliance (Cdyn) declined in
the injured rats 1 hour after acid instillation, and continued to decline in the
ZEEP group compared to the sham and PEEP groups (p<0.001). Cdyn was
not statistically different between sham and PEEP rats during the rest of the
experiment. (C) Oxygen saturation (SpO2) was similar among all groups at
healthy baseline and 1 hour after acid/saline instillation, but declined over
time in the ZEEP group while remaining unchanged in sham and PEEP
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groups. Groups were statistically different 4 hours after acid/saline
instillation (c2(2) = 10.004, p=0.006), with the ZEEP group having
significantly lower oxygen saturation than sham (p=0.003) and PEEP
(p=0.035) groups, which did not differ from one another (p=0.804). ($ p<0.1,
* p<0.05, ** p <0.01, *** p <0.001), (1ZEEP vs. Sham, 2PEEP vs Sham,
3

PEEP vs. ZEEP). (Note that for lactate-to-pyruvate ratio at 2.5 hours, N=3

for the ZEEP group. For all groups and all other time-points, N=7).
Figure 5.5

Correlation between average lactate-to-pyruvate ratio and (A) pulmonary
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compliance (r=-0.581, p<0.001) and (B) oxygen saturation (r=-0.687,
p<0.001).
Figure 5.6

(Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each
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group. Representative images shown are at 10´ and 40´. In ZEEP lungs,
arrows show the presence of fluid within the alveolar space; solid arrows
delineate infiltrates and debris. In lungs subjected to PEEP, alveolar structure
is more intact; infiltrates are shown by solid arrows. The scale bar is 100 µm.
(Middle) Average injury scores for various morphological features for
different groups. ANOVA showed a significant difference among groups
(infiltration: c2(2)= 11.273, p=0.003, alveolar damage: c2(2)= 10.000,
p=0.007, hyaline membrane deposition: c2(2)= 10.678, p=0.005 and edema:
c2(2)= 12.154, p=0.002). Infiltration (A) and alveolar damage scores (B)
were significantly higher in the ZEEP group than in the sham group
(p=0.001, p=0.012), while infiltration was significantly higher in the ZEEP
group than the PEEP group (p=0.035). Hyaline membrane deposition (C)
and edema severity (D) were both significantly higher in the ZEEP group
relative to both PEEP (p=0.048, p=0.041) and sham (p=0.014, p=0.006)
groups. (Bottom) Among the histological features, hyaline membrane
deposition (r=0.612, p=0.003) (G) and edema severity (r=0.663, p=0.001)
(H) were strongly correlated with lactate-to-pyruvate ratio. (* p<0.05, ** p
<0.01, *** p <0.001).
Figure 5.7

(Top) ICAM-1 expression in lung sections measured by fluorescence
microscopy (40´ magnification). Green fluorescence denotes ICAM-1
expression, which is higher in the ZEEP group in response to inflammatory
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stimuli. Additionally, the green fluorescence is higher along the endothelial
layer that lines the vessels (indicated by white arrows (V)). (Middle) MPO
expression in the lung sections measured by fluorescence microscopy (40´
magnification). Red fluorescence denotes higher MPO expression, which is
similar in both sham and PEEP lungs, but much higher in ZEEP lungs. The
white arrows illustrate the punctate staining from neutrophils. The phase
images for the same sections show the structure of the lung tissue. The scale
bar is 50 µm. (Bottom) ICAM-1 expression was significantly different
among groups (F2,18= 37.76, p<0.001), and was significantly higher in the
ZEEP group relative to PEEP (p=0.002) and sham (p=0.002) groups (A).
ICAM-1 expression was strongly correlated with the average lactate-topyruvate ratio measured 4 hours after acid/saline instillation (r=0.782,
p<0.001) (B). There was significantly different MPO expression among
groups (c2(2)= 16.416, p<0.001); the measured activity was significantly
higher in the ZEEP group compared to PEEP (p=0.002) and sham (p=0.002)
groups (C), and was strongly correlated with average lactate-to-pyruvate
(r=0.817, p<0.001) (D). The activity was also significantly different between
PEEP and sham groups (p=0.004). (** p<0.01, *** p <0.001).
Figure 5.8

The right panel shows a selection of the voxels in the hyperpolarized 13C

128

spectroscopic image overlay. Lactate-to-pyruvate ratio was similar at
baseline in all regions across all groups, and increases 2.5 hours after acid
instillation in all lung regions in ZEEP rats. The ratio continues to increase
in the posterior region on both sides 4 hours after acid instillation. The
lactate-to-pyruvate ratio measured in the myocardium and heart chambers
remains unchanged over time in all groups (AL: anterior left, PL: posterior
left, AR: anterior right and PR: posterior right).
Figure 6.1

Summary of hyperpolarized 13C imaging studies. Arterial blood gases (ABG)
were obtained first. A healthy baseline

13

C image was initially acquired.

Fraction of inspired oxygen (FiO2) was reduced to 0.17 (N=8) and 0.1 (N=8)
to induce moderate and severe hypoxia, respectively, throughout the rest of
the experiment. Follow-up 13C images were acquired after 1 hour, 2.5 and 4
hours.
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Figure 6.2

Representative pyruvate and lactate maps overlaid on their corresponding
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proton image acquired at healthy baseline and 4 hours after start of systemic
hypoxia. FiO2 was kept at 1.0 in the control group. Lactate to pyruvate ratio
and lactate signal remained unchanged over time in the control rats. While
the lactate signal did not change noticeably after 4 hours of moderate
hypoxia, it increased dramatically after 4 hours of severe hypoxia.
Figure 6.3

(A) Average lactate-to-pyruvate remained unchanged in the control group
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but increased in both hypoxic groups over time. This ratio increased much
more significantly in the severely hypoxic rats (Hyp75), and was
significantly higher than in both moderately hypoxic (Hyp90) and control
rats 2.5 and 4 hours after the start of hypoxia. The ratio was slightly higher
in the moderately hypoxic rats than the control rats, but this difference did
not reach the level of statistical significance. (B) Pulmonary compliance
(Cdyn) remained unchanged in all rats. (C) Oxygen saturation (SpO2)
remained unchanged in the control group but declined in both moderately
and severely hypoxic groups to around 90% and 75%, respectively (p<0.01
for all group-wise comparisons at any time except the first time point). (*
p<0.05, ** p <0.01, *** p <0.001), (1Hyp75 vs. control, 2Hyp75 vs Hyp90).
Figure 6.4

(A) Arterial lactate concentration measured from arterial blood samples in
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control (N=3), Hyp90 (N=3) and Hyp75 (N=5) groups before and after
imaging. Post-imaging arterial blood lactate was significantly higher in the
Hyp75 group than in both Hyp90 and control groups. (B) Pulmonary
hyperpolarized lactate-to-pyruvate ratio is strongly correlated with arterial
blood lactate concentration (** p<0.01, *** p<0.005).
Figure 6.5

Average lactate-to-pyruvate ratios in all groups for different injections in the
(A) lungs and (B) heart; (C) oxygen saturation 4 hours after the start of injury
or hypoxia. Post-hoc analysis results are included in Table 6.2. The error bars
represent the standard error for each measurement. (D) The pulmonary
hyperpolarized lactate-to-pyruvate ratio vs. oxygen saturation at individual
timepoints shows the overall trend of each cohort during the course of the
experiment. The lactate-to-pyruvate ratio significantly increases in injured
rats (dark gray box) 2.5 hours after acid instillation, while oxygen saturation
declines to ~90%. In moderately hypoxic rats, the lactate-to-pyruvate does
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not increase despite oxygen saturation decreasing to 90%, suggesting that the
source of increased lactate-to-pyruvate ratio is not hypoxia but severe
inflammatory response. The lactate-to-pyruvate ratio increases 1 hour after
the start of severe hypoxia, consistent with other findings suggesting that the
lung tissue produces high concentrations of lactate if exposed to severe but
not moderate hypoxia. (Note that intervention for ZEEP and PEEP groups is
acid instillation, for Sham group is saline instillation, and for Hyp75 and
Hyp90 groups is reducing the fraction of inspired oxygen) (* above a bar
indicates that data is significantly different from all other groups. Groups
with letters “a” or “b” on top are statistically different from groups with “a*”
or “b*” on top, respectively. Finally, “ab” on top of a bar indicates statistical
difference from both groups with “a*” and “b*” on top.).
Figure 6.6

(Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each
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group. Representative images shown are at 10´. The scale bar is 100 µm.
Average injury scores for various morphological features for different
groups assessed from H&E stained lung sections. (Groups with letters “a” or
“b” on top are statistically different from groups with “a*” or “b*” on top,
respectively; “ab” on top of a bar indicates statistical difference from both
groups with “a*” and “b*” on top.)
Figure 7.1

(A) Representative axial T2-weighted image obtained over the lungs and the
location of the receive channels of the

13

167

C RF coil around the pig. Time-

course of each metabolite obtained by (B) individual channels and (C) the
combined channels shows that the maximum lactate signal in an axial slice
over the lungs is attained 45 seconds after the start of injection. The inset
shows the spectrum obtained 50 seconds after the start of injection.
Figure 7.2

13

C MRSI acquired by (A) individual channels and (B) all channels
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combined together, overlaid on the corresponding T2-weighted proton
image. The spectra are from two voxels outlined with white boxes over the
vessel and the left lung, labeled with V and L. (C) Metabolite maps obtained
from the area under their corresponding peaks.
Figure 7.3

T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C]
lactate maps of the non-injured pigs (pigs 1-4).
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Figure 7.4

T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C]
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lactate maps of the injured pigs (pigs 4-7). Pig 4 was imaged 140 minutes
after acid instillation, while Pigs 5-7 were imaged approximately 8 hours
after acid instillation. White arrows show the areas in the lungs with visible
injury and edema.
Figure 7.5

(Left) The

13

C MRSI overlaid on the axial T2-weighted image obtained 2
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hours after acid instillation in pig 4. The average spectra in the posterior (red)
and middle (blue) sections of the lung before and after acid instillation show
a ~20% and ~50% increase in the lactate-to-pyruvate ratio in these areas,
respectively; the linewidth became narrower in the posterior region due to
the presence of edema. (Right) Two images were obtained within 15 minutes
of injury induction. Spectra in the posterior lungs shows an approximately
10% difference in lactate signal between the repeated scans.
Figure 7.6

13

C MRSI overlaid on the T2-weighted image of pigs with long-term injury
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(pigs 5-7). On the right, spectra obtained by averaging the signal over four
voxels positioned in the anterior right (AR), anterior left (AL), posterior right
(PR) and posterior left (PL) regions of the lungs are shown. The linewidth of
the NMR peaks is significantly narrower in bright regions in the T2-weighted
images, suggesting the presence of edema. Although the lactate-to-pyruvate
ratio is higher than in an average healthy pig across the entire the lung, this
ratio is highest in the injured right lung.
Figure 8.1

Excitation with a 90° RF pulse followed by a series of 180o refocusing pulses
forms a spin-echo train. The transverse magnetization initially generated
after the excitation decays with a T2* relaxation time constant. Each
refocusing pulse recovers the part of transverse magnetization lost due to
magnetic field inhomogeneity. The signal generated via the spin-echo train
therefore decays with T2 relaxation time constant. Since T2 >> T2* in the lung
tissue, the spin-echo formation can recover a major fraction of the transverse
magnetization that is otherwise de-phased due to field inhomogeneity. Note
that while the refocusing can occur with any flip angle, it is most efficient
with 180o RF pulses.
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Figure 8.2

The HASTE pulse sequence used for hyperpolarized 13C imaging in mice.
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Each readout loop forms an echo train, followed by the flip-back module that
used an additional refocusing and excitation pulses to transfer the leftover
transverse magnetization to longitudinal magnetization. Higher resolution
imaging (48×48 matrix size) was performed using the single-echo imaging
confirmation, where only the first readout loop was used. T2 maps were
calculated from the two lower resolution images (32×32 matrix size)
acquired using the dual-echo imaging configuration of the sequence, where
both readout loops were used to generated two images per excitation.
Figure 8.3

(A) T2-weighted proton image, (B) representative high resolution
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13

hyperpolarized C image overlaid on the T2 image, and (C) the grey scale
13

Figure 8.4

C image of the lungs.

Dynamic high resolution hyperpolarized 13C imaging of the lungs; t=0s is the
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moment from the first image acquisition.
Figure 8.5

First (left) and second (middle) echo images obtained from a mouse lung
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after injection of hyperpolarized [1-13C] pyruvate. Images were obtained
using the dual-echo version of the sequence with 32×32 matrix size. The
effective echo times were TE1 = 2.98ms and TE2 = 50.66ms. An estimated
masked T2 map of [1-13C]-pyruvate in the lungs (right) is also shown.
Figure 8.6

13

C Imaging using a multi-slice TrueFISP sequence in one healthy (pig 2)
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and one injured pig (pig 6). The signal intensity in the injured areas of the
posterior lung (pig 6; outlined areas) was 3×higher than in the anterior lung.
The white arrow shows the signal in the descending thoracic aorta.
Figure 8.7

Proposed HASTE pulse sequence implementation with SPSP excitation and
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flip-back RF pulses. The SPSP pulse individually excites pyruvate and
lactate peaks.
Figure 8.8

Proposed HASTE pulse sequence implementation with a multi-echo readout
for Dixon reconstruction. The initial saturation pulse minimizes the
contributions of the alanine and pyruvate hydrate peaks, located between the
pyruvate and lactate peaks, for more effective use of the IDEAL approach.
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Figure 9.1

Proposed study design to assess metabolic changes in injured and non-

201

injured ex-vivo perfused rat lungs.
Figure 9.2.

Representative hyperpolarized

129

Xe and hyperpolarized

13

C MRI scans

obtained 6 and 8 hours after acid aspiration lung injury in an injured pig (pig
5, chapter 7). Lactate signal is elevated in posterior region of both lungs,
however, the

129

Xe scan shows low ventilation and gas uptake only in the

right lung (white arrow). While 13C MRI highlight regions with abnormal
metabolism,

129

Xe MRI can provide additional information regarding gas

uptake and ventilation, thereby differentiating hypoxic and inflamed regions.
129

Xe and 13C images were acquired using two different clinical scanners at

1.5T and 3T field-strength respectively since RF coils were only available at
those fields for each nucleus. However, both scans can be performed in a
single session within minutes of each other with RF coils designed for the
same field-strength.
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LIST OF ABBREVIATIONS

ABG

Arterial blood gas

AECI

Type I alveolar epithelial cell (pneumocyte)

AECII

Type II alveolar epithelial cell (pneumocyte)

AL

Anterior left

ALA

Alanine transaminase

ALI

Acute lung injury

ANOVA

Analysis of variance
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ARDS
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Carbonic anhydrase
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Acute pulmonary edema
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Electron paramagnetic agent
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Echo planar imaging
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Echo planar spectroscopic imaging
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Chapter 1: Introduction

1.1. Background and Significance
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) is
diagnosed in approximately 200,000 patients each year in the US, proving fatal
approximately 40% of the time1-3. Lung injury in ARDS/ALI is characterized by an
inflammatory response that propagates in the lungs, causing capillary leakage and impaired
gas exchange. While ARDS/ALI is managed in the intensive care unit through careful
optimization of mechanical ventilation to protect the lungs from ventilator-induced
injury3,4, existing ventilator protocols are not currently designed to limit the spread of
inflammation3,5. Early detection of ARDS-related lung injury through cellular changes may
therefore lead to improved outcomes by suggesting appropriate interventions.
Several imaging modalities have been used to investigate lung injury, including
computed tomography (CT), contrast-enhanced proton MRI and hyperpolarized MRI4,6-9.
In our previous studies using serial CT imaging4, we were able to visualize the spatial
propagation of radiological abnormalities in the early stages of experimental injury. Other
studies used hyperpolarized gas MRI to quantify alterations in the lung microstructure
during mechanical ventilation10 or assess alveolar wall thickness caused by
inflammation11,12. Although these imaging modalities elucidate the structural and
functional manifestations of inflammation, they do not probe the metabolic and molecular
processes that drive these changes. Positron emission tomography (PET) enables the
visualization of metabolic changes due to lung inflammation13-18 but is limited to
1

examining abnormalities in the uptake of the glucose analogue fluorodeoxyglucose and is
therefore unable to reveal changes in downstream metabolism that may be crucial to the
evolution of inflammation and injury19-21. Understanding these downstream pathways may
open up new therapeutic approaches aimed at mitigating lung injury progression at early
stages at attenuating its consequences22.
Hyperpolarized

13

C MRI is an emerging non-radioactive molecular imaging

technique that provides an over 10,000-fold temporary signal enhancement over
conventional MRI, highlighting changes in cellularity and metabolic pathways by
quantifying downstream metabolites through their unique
(chemical shifts)23. Hyperpolarization of the

13

13

C resonance frequencies

C nuclei is typically achieved through a

process called dynamic nuclear polarization (DNP), which transfers spin alignment from
the sparse unpaired electrons of an electron paramagnetic agent (EPA) to the adjacent 13C
labeled nuclei using resonant microwave irradiation at high magnetic fields (~3.3T) at ~1K
temperature24. Once the sample reaches the desired polarization level (usually within 1-3
hours), it is dissolved rapidly using a hot isotonic buffer to yield a highly polarized
neutralized solution for injection. After administering the probe, data must be obtained
quickly using rapid imaging techniques, as the signal enhancement decays at a rate
determined by the T1 relaxation time constant of the probe (10-120s, depending on the
probe).
The most widely used hyperpolarized DNP probe is [1-13C] pyruvate, a small and
highly soluble molecule with high polarizability (up to 60% polarization reported) and a
long T1 relaxation time constant (40-60s). Because it acts as a central branching point in
2

several key metabolic pathways, pyruvate can be used to study a wide variety of metabolic
perturbations in tissues with inflammatory diseases or cancer25-28. These physical and
biological properties make [1-13C] pyruvate perhaps the most attractive hyperpolarized 13C
imaging probe to date.
Hyperpolarized [1-13C] pyruvate has been used extensively to study metabolic
alterations in heart29, liver30, kidneys31 and tumors32 in intact animals and has more recently
been used in a number of human studies33-35. In our earlier ex-vivo perfused lung studies,
we showed a significantly increased rate of hyperpolarized lactate labeling after injection
of hyperpolarized [1-13C] pyruvate in inflamed lungs25. Unfortunately, extending the use
of this technology to in-vivo metabolic imaging of the lungs is challenging due to the
limited metabolic signal and rapid spin de-phasing at air-tissue interfaces. The lungs remain
a diagnostically attractive target, however, as they receive the full blood supply during each
circulation and perform a variety of biochemical functions to maintain body homeostasis.
These functions can undergo substantial and detrimental changes in patients suffering from
ARDS or other conditions such as pulmonary fibrosis or sepsis, resulting in the release of
lactic acid from the lungs22,36 as part of a spectrum of multi-organ dysfunctions associated
with high mortality3,37,38. The development of molecular imaging techniques that facilitate
the direct interrogation of pulmonary metabolism and its spatial heterogeneity can provide
increased insight into the relationship between abnormalities in the mechanics and
cellularity of diseased lung tissue. Addressing this knowledge gap is also relevant to
clinical efforts to improve evaluation of lung disorders and could potentially result in more
effective and targeted early intervention. Despite the inherent challenges, then,
3

hyperpolarized

13

C technology provides us with unique opportunities to characterize

metabolic flux in acute lung injury models.

1.2. Objective and Specific Aims
The goal of this project is to implement hyperpolarized [1-13C] pyruvate MRI
acquisition and quantification techniques to characterize in-vivo lung tissue metabolism in
small animals and to test its feasibility in large species. The key deliverables of this project
are 1) an MRI acquisition method for metabolic imaging of the lungs using hyperpolarized
[1-13C] pyruvate, 2) characteristics of lung metabolism under various ventilation protocols
in small animals, and 3) feasibility testing of hyperpolarized

13

C MRI’s clinical

translatability. These goals were pursued by completing the following specific aims:

I. Development of an imaging technique for hyperpolarized 13C MRI of the lungs
a. Develop a chemical shift imaging pulse sequence for lung imaging using
hyperpolarized [1-13C] pyruvate
b. Develop a quantification method to assess alterations in pulmonary pyruvate
metabolism
c. Demonstrate hyperpolarized [1-13C] pyruvate MRI’s ability to assess alterations in
pyruvate to lactate conversion in injured lungs and lung cancer

II. Characterization of ALI using hyperpolarized [1-13C] pyruvate MRI
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a. Investigate the impact of positive end-expiratory pressure on pulmonary pyruvate
metabolism during progression of ALI
b. Study the role of systemic hypoxemia on lung metabolism

III. Translation of the studies to larger animals and human subjects
a. Test feasibility of lung imaging using hyperpolarized 13C in large animals
b. Develop a high-resolution imaging pulse sequence framework for future studies

1.3. Thesis Organization
The remainder of this dissertation is organized as follows:

Chapter 2 provides an overview of the fundamentals of nuclear magnetic resonance
(NMR), NMR signal dynamics, T1 and T2 relaxation mechanisms and RF pulse excitation
and signal reception. It then introduces the concept of chemical shift and its ability to
differentiate different molecular species using spectroscopy. It then introduces the concept
of hyperpolarization and discusses its utility in medical imaging. An overview of different
hyperpolarization methods is given, including optical pumping, parahydrogen-induced
polarization (PHIP) and dynamic nuclear polarization (DNP). Practical aspects of
developing 13C hyperpolarized biomarkers are then discussed before moving on to the use
of hyperpolarized

13

C to assess metabolic pathways: e.g., for the detection and

characterization of diseases such as cancer and inflammation. It the continues to present
the foundations of NMR signal spatial encoding and introducing the concept of k-space to
5

acquire and reconstruct MRI and spectroscopic images. The chapter ends by presenting a
brief overview of current state-of-the-art imaging methods and pulse sequences and
provides important imaging considerations for the effective and efficient use of irreversible
hyperpolarized signal.
Chapter 3 begins by offering a brief overview of lung physiology and biochemistry
and goes on to describe both gas-exchange and pulmonary glycolytic metabolism. ARDS
is then introduced, and its etiologies, clinical manifestations and current clinical guidelines
are summarized. The concept of protective ventilation and the role of PEEP as a therapeutic
and preventative measure in ARDS/ALI progression are then discussed, followed by the
animal models commonly used to study lung injury. The chapter ends with a summary of
the radiological methods used to diagnose and characterize ARDS/ALI.
Chapter 4 presents our implementation of a modified free-induction decay chemical
shift imaging (FID-CSI) pulse sequence for imaging pulmonary metabolism in small
animals using hyperpolarized 13C MRI, including results of our serial lactate-to-pyruvate
measurements in healthy and injured lungs during the course of ventilation. In addition to
demonstrating the reproducibility of our measurement in heathy animals, the data also
shows hyperpolarized 13C MRI’s ability to assess alterations in lung pyruvate metabolism
in animals injured using a two-hit model of acid aspiration and ventilator-induced lung
injury (VILI). Finally, in order to show that our imaging method is extendable to other
diseases characterized by altered lung metabolism, we demonstrate our technique’s ability
to detect higher conversion of pyruvate to lactate in cancerous tissue in a murine model of
lung cancer.
6

Chapter 5 covers the experimental methodologies developed to assess the impact
of PEEP on lung pyruvate metabolites, demonstrating that PEEP contains the progression
of inflammatory injury during the course of ventilation in the presence of mild lung injury.
The chapter also highlights the strong correlation between glycolytic and neutrophilic
activity in the lungs, as well as a strong correlation between the former and reduced
systemic oxygenation as measured by oxygen saturation. These results indicate that
inflammation and hypoxia are the likely causes of altered pyruvate metabolism in the lung.
Chapter 6 describes of our methodology for investigating the role of systemic
hypoxia on lung metabolism and presents our results: although mild hypoxemia (SpO2 ~
90%) contributes negligibly to increased lactate-to-pyruvate ratio, severe hypoxemia (SpO2
<80%) leads to significant changes in pulmonary pyruvate metabolism. Our data further
suggests that the increased metabolic activity observed in the injured lungs in data
presented in the previous chapter is primary caused by inflammatory injury rather than
systemic hypoxemia.
Chapter 7 details the methodology for implementing our imaging technique for
imaging large species (i.e. pigs) to demonstrate the potential clinical translatability of
hyperpolarized 13C imaging and presents the results of several such studies in healthy and
injured pigs. We show elevated lactate signal intensity and lactate-to-pyruvate ratio in areas
colocalized with injured lung.
Chapter 8 describes the use of a half-Fourier acquisition single-shot turbo spin-echo
(HASTE) imaging pulse sequence, as a general platform for high-resolution dynamic 13C
MRI of the lungs in mice and pigs. We then conclude by offering a number of strategies to
7

implement high-resolution hyperpolarized 13C metabolic lungs to map spatial distributions
of pyruvate and lactate using the HASTE pulse sequence.
Finally, chapter 9 summarizes key results of this project and outlines the limitations
of our findings. We then propose a number of studies to perform in future aimed to address
these limitations and to demonstrate the potential of hyperpolarized

13

C MRI to assess

response to potential treatments for ARDS/ALI. We move on to discussing technical
obstacles to the continued use hyperpolarized

13

C MRI for research and its clinical

translation for pulmonary metabolic imaging and discuss ideas that can be implemented to
address these challenges. We conclude by discussing the potential use of hyperpolarized
13

C MRI for imaging other pulmonary diseases.
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Chapter 2: Magnetic Resonance Imaging and Hyperpolarization

2.1. Introduction
Magnetic resonance imaging (MRI) is a relatively new, versatile imaging and
spectroscopy tool used in a variety of applied sciences. It is wildly used in medicine, both
to visualize soft tissue with superb contrast and to monitor metabolic processes with great
sensitivity primarily by visualizing the hydrogen nuclei (protons). Perhaps most exciting
about this technology, however, is the fact that it is safe and non-invasive by nature. Unlike
other imaging modalities such as x-ray radiographs or computed tomography, MR imaging
does not expose the patient to harmful ionizing radiation. Today, MRI scans are performed
routinely on patients of any age, and are considered one of the most important radiological
tools available to physicians for the diagnosis and treatment of numerous diseases. MRI is
also a valuable scientific instrument with a variety of applications including drug
development, the study of disease models, food screening and elucidating the molecular
structure of proteins and various biological media.
Despite its advantages, MRI suffers from an intrinsically low sensitivity that limits
its clinical utility to imaging significantly abundant molecules in the body, such as water
and fat, within a reasonable timeframe. Hyperpolarization is a method to dramatically
increase the sensitivity of the NMR/MRI signal by a factor of 10,000-100,000, thereby
enabling the detection of numerous molecules and their biochemical reactions in the body
despite their very low natural concentration. The life-time of hyperpolarization is limited
by irreversible molecular interactions that decrease this temporary signal enhancement to
12

its thermal equilibrium, creating challenges and opportunities in the field of hyperpolarized
MRI to develop new data acquisition methods with promising applications for molecular
imaging.

2.2. A Brief History
MRI is based on the nuclear magnetic resonance (NMR) phenomena discovered by
Felix Bloch (Stanford) and Edward Purcell (Harvard) in 19461, for which both shared the
1952 Nobel Prize in Physics. More sophisticated spectroscopic methods were developed
in the 1950s, including spin echo by Eriwn Hahn in 19502. In 1954, Carr and Purcell used
magnetic field gradients for the first time to study the impact of diffusion on the NMR
signal of compounds 3. The first in vivo data was generated almost a decade later in 1968
by Jackson and Langham4, who produced a proton spectrum for a rat using their homebuilt low-frequency NMR spectrometer. Raymond Damadian’s work in 1971 demonstrated
the utility of NMR in medicine by showing that its measurements were capable of
discriminating between malignant tumors and healthy tissue in rats5.
The first MRI images were produced in samples Paul Lauterbur in 19736 and later
in animals by Raymond Damadian in 19777 by using a magnetic field gradient together
with a back-projection technique to generate images, in a method dubbed magnetic
resonance zeugmatography. This worked earned Lauterbur the Nobel Prize in Medicine in
2003. In 1974, Richard Earnst discovered Fourier reconstruction of images by controlling
the timing and the intensity of the magnetic field gradients in a particular sequence to
collect data, for which he received the 1991 Nobel Prize in Chemistry. Substantial
13

advancement has since been made to MRI hardware and imaging methods, significantly
improving image quality and reducing overall scan time; sub-millimeter high quality
images can now be generated in a matter of minutes, real-time functional images of the
cardiovascular system can be obtained, and diffusion-weighted MRI can visualize neutral
tracts at high resolution.
These advances have made MRI one of the most ubiquitous tools for the anatomical
assessment of soft tissues. However, recent developments show that MRI is also capable
of delivering functional and cellular information about tissue. Today, molecular imaging
using MRI is an active and multifaceted area of clinical and preclinical research, with many
applications for drug development and delivery, as well as early diagnosis and non-invasive
monitoring of response to treatment.

2.3. Fundamentals of Nuclear Magnetic Resonance
The source of NMR signal is the interaction between an ensemble of atomic nuclei
in objects with a main magnetic field (B0). The nuclei with an odd number of protons and
neutrons have a non-zero nuclear spin, which can result in a net magnetic moment (µ). In
the absence of the main magnet field, magnetization of the atomic nuclei in objects is
randomly oriented, resulting in a net zero magnetization. In the presence of the main
magnetic field, for spin-1/2 nuclei such as 1H, 3He, 13C and
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Xe, the nuclei can exist in

either a +1/2 or -1/2 spin state, as shown in Figure 2.1. The discussion of systems with higher
spin orders is omitted here, as all the nuclei discussed in this thesis are spin-1/2 systems.
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Figure 2.1. Classical picture of the distribution of nuclear spins (spin 1/2) in the presence of the main
magnetic field, B0. The difference in quantum energy between these states increases with the magnetic field
and at any field is specific to each atomic species.

The two quantum states have different quantum energy levels. Under thermal
equilibrium, the lower energy state is slightly more populated that the higher one. The ratio
between the excess number of spins populating the lower energy state (usually +1/2) to the
total number of spins is referred to as polarization8:
𝑃=

𝑁& − 𝑁(
𝑁& + 𝑁(

[2.1]

where N+ and N- are the number of +1/2 and -1/2 spins in an ensemble of nuclei. The classical
description states that the nuclear spins populating these states have magnetic moments
that are aligned in the same or opposite direction in relation to the main magnetic field:
polarization describes the degree to which the spins are aligned with the main magnetic
field, and depends on the temperature, main magnetic field strength and magnetic moment
of the nucleus. At thermal equilibrium, polarization can be calculated as:
𝑃 = tanh 3

𝛾ℏ𝐵7
𝛾ℏ𝐵7
:≈
2𝑘𝑇
2𝑘𝑇
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[2.2]

where γ is the gyromagnetic ratio of the nucleus in units of MHz/T and is unique to each
atom , ℏ is Planck’s constant (6.63 × 10-34 m2.kg.s-1), k is the Boltzmann constant (1.38 ×
10-23 m2.kg.s-2.K-1) and T is the temperature in kelvin. Because thermal polarization is
typically a very small number, the approximation in equation 2.2 is valid. For example, at
room temperature (~300K) and the field strength of a typical clinical MRI system (B0=3T),
polarization (P) for hydrogen atoms or protons (g=42.58 MHz/T) is 10.2 × 10-6, or
approximately 0.001%. Despite such low polarization levels, thermal polarization is the
basis of every MRI/NMR study and is what generates the NMR/MRI signal, as the
abundance of molecules that contain hydrogen atoms with a spin-1/2 nuclei, such as water
and fat, lead to a detectable NMR/MRI signal.
The polarization of an ensemble of spins in the presence of the main magnetic field
along the z-axis leads to a net magnetization vector M in the same direction as B0. The
time-evolution of vector M in the presence of the main magnetic field B0 can be represented
using a simplified version of the Bloch equation9:
???⃗(𝑡)
𝑑𝑴
???⃗(𝑡) × ??⃗
= 𝛾𝑴
𝑩(𝑡)
𝑑𝑡

[2.3]

The magnetization vector can be divided into two components: the longitudinal
component Mz, which has the same orientation as static magnetic field B0 along the z-axis,
and the transverse component Mxy =Mx +iMy in a plane perpendicular to the static magnetic
field. The solution to equation 2.3 describes the clockwise rotation of the transverse
magnetization about the z-axis at a radial frequency w, known as the Larmor precession
frequency, expressed as:
𝜔7 = 2𝜋𝑓7 = 𝛾𝐵7
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[2.4]

This precession is graphically depicted in Figure 2.2. The Larmor frequency
determines the frequency at which the NMR signal is detected and depends on the strength
of the static magnetic field as well as the nucleus.

Figure 2.2. Graphical representation of Larmor precession frequency.

2.3.1. T1 and T2 Relaxation Mechanisms
In an ideal system where there is no interaction between the individual neighboring
nuclei and the magnetization remains undisturbed, the longitudinal magnetization and the
intensity of the transverse magnetization remain unchanged, so equation [2.5] is valid. In
practice, however, random molecular motion inevitably causes fluctuations in the local
magnetic field. As a result, spins interact with their local environment and the net
magnetization returns to a state of thermal equilibrium, aligning with the main magnetic
field B0. This dynamic process is called relaxation and involves two mechanisms.
The spin-lattice relaxation, also known as the longitudinal or T1 relaxation, is the
process of magnetization’s return to its thermal equilibrium value in the direction of the
main field B0, which occurs with an exponential time constant of T1. This relaxation
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mechanism is due to the gradual loss of energy of the spins to other nuclei and electrons in
the lattice.
The spin-spin relaxation, also known as the transverse or T2 relaxation, is the
mechanism by which the net transverse component of magnetization returns to zero. This
is the result of the interaction of the spins with the local fluctuations in the magnetic field.
These fluctuations alter the local precessional frequency of the neighboring spins, causing
them to gradually become out of phase in time. A graphical description of the T2 relaxation
mechanism is shown in Figure 2.3:

Figure 2.3: (A) At t=0, the ensemble of spins in the transverse plane are all in phase. (B) The local
fluctuations in the field cause spins to precess at slightly different frequencies, resulting in dispersion of the
spins and loss of precessional coherence.

T2 relaxation is generally caused by the molecular environment. However,
imperfection of the main magnetic field, or distortions caused by the presence of a variety
of material with different magnetic properties in the sample or tissue, can lead to magnetic
field inhomogeneities. These cause additional dephasing of the transverse component of
the magnetization which shortens the T2 relaxation time constant. The effective transverse
relaxation time constant is characterized by the exponential time constant T2* and can be
expressed as:
18
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1
+ M
∗ =
𝑇K 𝑇K 𝑇K

[2.5]

where T2` is the contribution of the magnetic field inhomogeneity to the overall relaxation
time constant. This equation implies that T2 > T2*. In pulmonary imaging, T2` is the
dominant factor due to the abundance of air-tissue interfaces in the lung structure, which
causes severe magnetic field fluctuations10. However, because this structurally-induced
inhomogeneity is not random, its effect can be recovered using the refocusing RF pulses
discussed in the next section.

2.3.2. Radio-frequency Excitation and Signal Detection
As previously discussed, magnetization always reaches a thermal equilibrium state
by relaxation mechanisms. In order to perturb this equilibrium state, an oscillating radio
frequency (RF) pulse must therefore be applied to the sample, and must have the same
frequency as the Larmor precession frequency in order to excite the nuclear spins from a
low to a higher energy state. This process is called RF excitation and be visually depicted
as tipping the longitudinal magnetization vector to generate a precessing transverse
magnetization component (Figure 2.4). The angle at which this vector is tipped relative to
the z-axis angle is called the flip angle and is a function of the total energy of the RF pulse
used. An RF pulse with a 180° flip angle is called a refocusing RF pulse (Figure 2.4) and
is commonly used in NMR and MRI after an excitation pulse in order to flip the spins and
recover the part of transverse magnetization that was de-phased due to static field
inhomogeneity. RF pulses are generated by a transmit RF coil situated near the sample or
19

region of interest9. The coil is oriented such that this generated magnetic field is
perpendicular to B0 and Mz, and is denoted by B1.

Figure 2.4. Pictorial description of an (left) excitation RF pulse and (right) an inversion RF pulse.

The return of the excited spins to their original equilibrium state generates an RF
signal called a free induction decay (FID) that can be detected with a receive RF coil. As
shown in Figure 2.5, a typical FID is an oscillating decaying exponential. The Fourier
transform of the FID is the NMR spectrum that can be mathematically described by a
Lorentzian function.

Figure 2.5. (A) A typical free induction decay acquired after excitation; the signal decays exponentially. (B)
The Fourier transform of the FID leads to the NMR spectrum.
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2.3.3. Chemical Shift
The Larmor precession frequency depends on the effective magnetic field to which
nuclei are subjected. However, the magnetic environment of the nuclei is impacted by the
orbital motion of the surrounding electrons. The electron cloud around the nucleus creates
a shielding effect by inducing an additional magnetic field that opposes the main field B0,
as shown in Figure 2.6. The effective magnetic field to which the nucleus is subjected is
therefore described as:
𝐵OPP = (1 − 𝜎)𝐵7

[2.6]

where Beff is the effective magnetic field and 𝜎 is the shielding constant. We can rewrite
the Bloch equation described by Equation 2.4 to calculate the effective resonant frequency
of the nucleus as:
𝜔OPP = (1 − 𝜎)𝜔7

[2.7]

Figure 2.6. The isolated nucleolus (A) is subject to the external magnetic field B0. However, atomic nuclei
are surrounded by an electron cloud which generates a weak magnetic field in the opposite direction to the
external field (B). This shields the nucleus from the external field, so the nucleus is subject to a smaller
effective magnetic field.
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The degree of shielding depends the atomic structure and the adjacent atoms in the
molecule, and can be used as a molecular signature in NMR spectroscopy. This is more
commonly described by chemical shift of the nuclei defined in units of parts per million
as:
𝛿 [ppm] =

𝜔OPP − 𝜔WOP
× 10Y
𝜔WOP

[2.8]

where d is the chemical shift in ppm and wref is the Larmor precession frequency of a
reference molecule. The chemical shift and the shielding constant are mathematically
related by:
𝛿 [ppm] ≈ (𝜎WOP − 𝜎OPP ) × 10Y

[2.9]

Tetramethylsilane (TMS) is the generally accepted reference molecule for 1H and
13

C spectroscopy, with a chemical shift of 0 ppm. Figure 2.7 shows a sample 13C spectrum

obtained from ethanol and TMS. The chemical shift of the peaks in the spectrum provides
information about the molecular composition of the sample, and the area under each peak
is indicative of the relative concentration of different molecules in the sample.

Figure 2.7. 13C NMR spectrum of ethanol. The carbons on the carboxyl (label 1) and the methyl (label 2)
groups have chemical shifts of 200ppm and 30ppm respectively. The NMR spectrum of the reference
molecule TMS appears at 0 ppm.
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2.4. Hyperpolarization
MRI has a very low intrinsic sensitivity; the population difference between the +1/2
and -1/2 spin states, which is the source of NMR signal, is on the order of 0.001%. This
limits the use of MRI as a clinically viable molecular imaging tool to detect molecules
other than water and fat in the body, as the signal from these dominates that of other
endogenous biomolecules and metabolites. A number of methods have been developed to
suppress the strong background signal from water and fat11,12. However, since the chemical
shift of protons in biological molecules is spread across a limited range (~10ppm),
detecting of such molecules is only possible in tissues with long T2 and T2* relaxation time
constants, as several NMR peaks need to be resolved within a small range in the NMR
spectrum.
While MRI of non-proton nuclei such as carbon has potential for molecular
imaging, it is similarly challenging due to the low concentration of biomolecules in the
body. This challenge is further exacerbated by the lower natural abundance of isotopes that
are detectable with MRI. For example, while all organic biomolecules have carbon atoms,
~1% of them consist of 12C nuclei which have a spin angular momentum of 0 and are thus
undetectable via MRI. Lastly, non-proton nuclei have a smaller magnetic moment, further
limiting their detection sensitivity. As Figure 2.8 shows, however, hyperpolarization can
overcome these challenges by temporarily enhancing the sensitivity of the NMR signal
several thousand-fold by increasing the population difference between nuclear spin states.
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Figure 2.8. Orientation of the nuclear spins at thermal equilibrium (A) and in the hyperpolarized state (B).
The population difference of the spins significantly increases in the hyperpolarized state, resulting in
increased NMR signal.

This dramatically increases the NMR signal beyond what is otherwise available by
just placing the object in the magnetic field, thereby enabling different applications
including imaging biological molecules present at low concentrations. The lifetime of
hyperpolarization is limited by an irreversible T1 relaxation that decreases polarization
levels to thermal equilibrium, limiting the available imaging window. Imaging
hyperpolarized nuclei therefore requires special considerations to ensure maximum utility
of the available signal.

2.4.1. Methods of Hyperpolarization
There are three methods to hyperpolarize a variety of atomic nuclei. Optical
pumping-based methods can be used on molecules in gas phase and are most commonly
used to hyperpolarize inert gases for functional lung imaging. Parahydrogen-induced
polarization (PHIP)-based methods are used to polarize samples in their liquid states.
Lastly, dynamic nuclear polarization (DNP) polarizes samples in their solid state. Both
PHIP and DNP methods are capable of polarizing a broad range of molecules discussed in
section 2.5, but DNP is the method primarily used to hyperpolarize
24

13

C species. As the

primary focus of this thesis is the use of hyperpolarized 13C MRI for pulmonary imaging,
DNP is discussed in more detail and its potential for molecular and metabolic imaging is
highlighted.

2.4.2. Optical Pumping
In optical pumping, circularly polarized laser light is used to transfer the electronic
spins from alkali metal vapors to the atomic nuclei of inert gases such as 3He and
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Xe.

The target gas typically flows into a glass cell covered with rubidium (Rb); the cell is then
heated to 150-170°C to vaporize the metal, dramatically increasing the probability of
collisions between the rubidium and gas atoms. A laser light is then emitted on the glass
cell for several hours, allowing for the gas atoms to hyperpolarize through collisional spinexchange with the rubidium atoms. Details of this process are described in13,14.
Polarization levels ranging from 30-50% have been reported for 3He and

129

Xe

species—a sufficiently high level of enhancement to obtain high resolution images of
human lungs. Many regional functional parameters of the lung can be obtained from these
images such as specific ventilation, gas diffusion, alveolar oxygen tension using 3He15 and
functional alveolar thickness, and gas exchange and transport16-18 using hyperpolarized
129

Xe imaging.
Optical pumping is capable of generating large quantities of highly-polarized inert

gases for biomedical imaging. However, it is not suitable for the polarization of liquid state
samples for molecular imaging.
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2.4.3. Parahydrogen Induced Polarization
Parahydrogen induced polarization (PHIP) uses a chemical reaction between an
unsaturated substrate and the parahydrogen molecules to increase nuclear polarization19.
Parahydrogen is a spin isomer of the hydrogen molecule (H2) in which the spins of the
protons in the molecule are anti-parallel20. At room temperature, "normal hydrogen" gas
consists of 25% parahydrogen molecules21, although this increases at lower temperatures
(T<298K) or as a result of the paramagnetic catalysis of the hydrogen.
In PHIP, hydrogenation must occur such that the parahydrogen molecule is
transferred onto the target substrate as a unit. Parahydrogen has a large spin order which
can be transferred to the substrate using special polarization transfer NMR pulse
sequences22,23. Alternatively, this high spin order can be transferred to the adjacent atomic
nucleus using a diabetic field cycling method described by24. Although the parahydrogen
molecule itself is not hyperpolarized in this process, the transfer of the large spin order in
the parahydrogen molecule hyperpolarizes the nearby spin-1/2 nucleus (e.g. 13C, 15N) to a
large degree. In fact, the use of hyperpolarized

13

C MRI was first demonstrated using

PHIP25.

2.4.4. Dynamic Nuclear Polarization
Dynamic nuclear polarization (DNP) is used to hyperpolarize solid state samples.
The process involves transfer or spin polarization via cross-relaxation from a source of
highly polarized spin bath (paramagnetic impurity) to the target nuclei nearby. This is
achieved via the Overhauser effect, described thoroughly in26,27: unpaired electrons have a
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significantly larger magnetic moment than atomic nuclei, and thus have thermal
polarization of approximately 100% at low temperature and high magnetic field, as can be
graphically presented from Equation 2.2 as shown in Figure 2.9. Unpaired electrons are
thus an ideal polarization source in DNP, which is performed at >2K temperatures and <3T
field strengths.

Figure 2.9. Thermal polarization of electron, proton and

13

C species as a function of temperature over

magnetic field. At T/B < 0.1 Kelvin/Tesla, electrons are 100% polarized. This condition can be achieved at
temperatures of T<2K and magnetic fields greater than 3T. The high degree of magnetization can be
transferred from electrons to 13C or proton species via dynamic nuclear polarization (DNP).

A suitable sample for DNP contains a homogenous mixture of the target molecule,
a glassing agent (e.g. glycerol) and approximately 1% stable free radical to supply the
unpaired electron

28

. The sample is prepared in its aqueous form and is subsequently

inserted into the DNP polarizer, where it is submerged into liquid helium and freezes.
Sample homogeneity is imperative to enable effective transfer of spin order from the
unpaired electrons to the target nuclei. The glassing agent prevents crystallization of the
sample at low temperatures, which is known to expel foreign molecules from the mixture
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and thus results in poor polarization28-30. However, no glassing agent is necessary certain
target molecules (e.g pyruvic acid) which are amorphous at low temperatures.
Within several minutes to hours, the polarization from the unpaired electron is
transferred to the target nucleus by microwave irradiation at the resonance frequency of the
unpaired electron at the magnetic field of the polarizer. However, the precise mechanism
of DNP may vary depending on the sample characteristics. DNP was originally described
by two distinct electron-nuclear interactions: solid effect and cross effect31. Solid effect
involves dipolar coupling between a nearby nucleus and an electron, while cross effect is
the interaction between two electrons and one nucleus. The contribution of each process is
complex and mainly depends on the characteristics of the frozen mixture. DNP is therefore
best characterized by the theory of thermal mixing, which describes the process by
thermodynamic state transitions in the coupled electron-nuclear system32.
Once the sample is polarized in its solid state, it is rapidly melted using a hot
dissolution buffer to yield a 37°C liquid solution. The latter is typically chosen to yield a
neutral isotonic hyperpolarized substrate28 that is suitable for administration into biological
species. For samples that are gaseous at room temperature and pressure (e.g. 129Xe, 15N2O),
the solution leads to sublimation of the gas, which can be collected for imaging and
spectroscopy33.
While DNP and PHIP are both capable of producing highly polarized liquid
substrates for metabolic imaging, PHIP is far more cost efficient and requires shorter
polarization times34. Despite these advantages, however, a number of technical challenges
limit the use of PHIP in molecular imaging, chief among which is the fact that many
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precursors for producing biologically relevant molecules (e.g. pyruvate and acetate) are
unstable or toxic35, thereby limiting the number of molecules which can be polarized using
PHIP. Yet many of these technical challenges can be addressed by an appropriate choice
of precursors and catalysts as described in the literature36-38. DNP, on the other hand,
requires an expensive polarizer device (shown in Figure 2.10); it has nevertheless been
more commonly used for metabolic imaging since it is capable of directly polarizing the
substrates. In fact, DNP was the method of choice for demonstrating the utility of
hyperpolarized 13C imaging in human subjects39,40.

Figure 2.10. (Left) Preclinical commercial polarizer (HyperSense, Oxford Inc.) and clinical polarizer
(SpinLab, GE Healthcare).

2.5. DNP: Practical Aspects for Medical Imaging
The practicality of imaging hyperpolarized nuclei by any method relies on
sufficiently long T1 relaxation time. For this, magnetic interactions between the target
nuclei and other magnetic moments present in its vicinity must be minimized. A number
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of conditions must therefore be met. First, only atomic nuclei with spin-1/2 must be used.
Nuclei with a spin number zero (e.g. 12C, 16O, etc.) have no magnetic moment and thus do
not interact with the magnetic field, while nuclei with higher spin numbers (2H, 14N, 23Na,
etc.) have an electric quadrupole moment and therefore strongly interact with the local
electric field gradients, considerably shortening the relaxation time constants8. Second, the
intramolecular distance between the target nuclei and other magnetic moments, including
unpaired electrons and other nuclei within the molecule, must be sufficiently large so as to
minimize dipolar interactions8. Lastly, all residual magnetic interactions with the target
atomic nuclei must be randomly oriented or limited in duration in order to prevent
hyperpolarization loss35.
The biological safety of molecules is also crucial in choosing appropriate
biomarkers for imaging. All conditions combined, then, hyperpolarization becomes
effectively limited to a few nuclear species. Inert non-toxic gases such as 3He and

129

Xe

are suitable for lung functional imaging—however, discussion of gas-MRI is beyond the
scope of this work and is therefore omitted. For molecular imaging, the study of 13C, 15N
and

31

P nuclei are all valuable due to their abundance in organic molecules in vivo.

However, the use of 13C-labeled molecules is preferred due their larger gyromagnetic ratio
compared to

15

N based molecules, which leads to improved sensitivity, as well as their

significantly larger range of chemical shifts compared to 31P species, enabling the detection
of a wider range of biomolecules.
Smaller 13C labeled molecules are preferred over larger molecules due to a more
rapid molecular reorientation rate which minimizes intermolecular magnetic interactions
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and leads to longer T1 relaxation times35. The optimal position of the 13C nucleus is on a
magnetically isolated carboxyl or carbonyl group to minimize intramolecular magnetic
interactions35. Lastly, solubility of the target molecule is crucial for proper DNP sample
preparation. Because many biologically relevant molecules have low solubility in water,
the solvent must be chosen carefully to provide both sufficient sample solubility as well as
glassing-like properties at low temperatures41.

2.6. Molecular Imaging Using Hyperpolarized 13C MRI
The enhanced sensitivity of hyperpolarized

13

C nuclei facilitates sub-second

imaging of exogenous substrates. What is more, once the substrate is metabolized by the
cells, the product molecules, also known as downstream metabolites, can be distinguished
from the substrate by their distinct resonance frequencies. While absolute quantification of
the concentration of molecules is challenging due to variability in polarization levels and
T1 relaxation times of the substrates after injection, relative concentrations of the
exogenous hyperpolarized substrate and its downstream metabolites can be used to
highlight alterations in metabolic pathways. Furthermore, enzymatic and reaction
conversion rate constants can be quantified in real-time35.
Other molecular imaging methods such as positron emission tomography (PET)
and single-photon emission computed tomography (SPECT) can provide absolute
quantification and uptake of the radioactively labeled exogenous substrates with high
sensitivity42, but do not report the fate of the substrate. This ability is unique to
hyperpolarized

13

C MRI, making it a powerful, non-invasive imaging platform for both
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diagnosis and monitoring therapeutic response, and which is capable of providing
complementary information to PET and SPECT35,43.

2.6.1. Hyperpolarized [1-13C] Pyruvate: Probing Glycolysis
Several substrates have been successfully polarized and used for perfusion imaging
as well as to assess various metabolic pathways44. [1-13C] pyruvate is the most commonly
used probe for several reasons: it is a safe and small molecule that can be highly polarized,
the first carbon on the carboxyl group has a long T1 relaxation time constant (40-60s exvivo and 15-25s in-vivo)

35,45,46

, and, lastly, pyruvate is a byproduct of glycolysis, the

pathway by which glucose is converted to pyruvate, and is also an intermediate in several
important metabolic pathways for energy production35. Figure 2.11 illustrates pyruvate’s
metabolic properties.
Pyruvate is catalyzed to lactate and alanine by enzymes lactate dehydrogenase
(LDH), also known as glycolysis, and alanine transaminase (ALT), respectively. Pyruvate
is also metabolized to CO2 and acetyl coenzyme A (Acetyl-CoA); this process, also known
as oxidative phosphorylation, is the preferred pathway for energy production when oxygen
is available in healthy cells. The conversion of the pyruvate to CO2 is facilitated by the
enzyme pyruvate dehydrogenase (PDH), and the CO2 is subsequently converted to
bicarbonate by the enzyme carbonic anhydrase (CA). The conversion of pyruvate to each
of the metabolites depends on the activity of their corresponding enzymes and the
availability of cofactors (e.g. nicotinamide adenine dinucleotide (NAD) in its oxidized
(NAD+) and reduced (NADH) forms that is participates in the conversion of pyruvate to
32

lactate). While this conversion can be probed using [1-13C] pyruvate, conversion of the
pyruvate to acetyl-CoA and beyond in the tricarboxylic acid cycle requires the use of [213

C] pyruvate, as discussed further in35,44.

Figure 2.11. Metabolites and their biochemical pathways that can be interrogated using [1-13C] pyruvate.
MRI. The red circle indicates atoms with 13C labeled nuclei. The fate of the pyruvate beyond Acetyl-CoA
into the Tricarboxylic Acid (TCA) cycle cannot be probed using [1-13C] pyruvate as the 13C labeled nucleolus
remains on the

13

CO2 molecule. Cofactors are not shown in this diagram for simplicity (LDH: lactate

dehydrogenase, ALT: alanine transaminase, PDH: pyruvate dehydrogenase, CA: carbonic anhydrase).

Figure 2.12.A shows a representative 13C NMR spectrum obtained from a rat 25
seconds after the injection of hyperpolarized [1-13C] pyruvate via the tail vein: the
downstream metabolites of pyruvate are distinguished by their unique chemical shifts. In
this case, the signal-to-noise of the CO2 peak was too small to be visible. Data acquisition
started at the beginning of the 12-second injection and was repeated every second for 2
minutes, as shown in the waterfall plot of Figure 2.12.B. We can obtain the time-course of
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the individual metabolites by calculating the area under the peak for each metabolite at all
time points, as demonstrated in Figure 2.12.C.

Figure 2.12 (A) NMR spectrum obtained from a mouse after administration of hyperpolarized [1-13C]
pyruvate via the tail-vein. (B) Spectra obtained every second shows how different peaks vary over time. (C)
Area under each peak depicted as a function of time to represent the relative concentration of each peak.

Conversion of pyruvate to lactate is referred to as anaerobic glycolysis since in the
absence of oxygen, pyruvate is preferentially converted to lactate. However, in numerous
pathologies including many types of cancers and inflammation LDH activity and thus
pyruvate to lactate conversion is upregulated even when oxygen is sufficiently availability;
in cancer, anaerobic glycolysis is the preferred pathway to produce energy for
proliferation47,48. Similarly, anaerobic glycolysis and thus lactate production increases
during inflammation as the activation of the immune system increases the bioenergetic
needs of the tissue49-53. Elevated anaerobic glycolysis can be highlighted by hyperpolarized
34
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C MRI by measuring the lactate-to-pyruvate ratio as a marker for conversion of [1-13C]

pyruvate to [1-13C] lactate. [1-13C] pyruvate is thus a versatile molecular imaging probe,
and has been used in several animal studies35,44,54 as well as more recently in human
patients40,43,55.

2.7. Spatial Encoding, K-Space and Image Formation
The NMR signal has no inherent spatial information, and therefore cannot be used
to produce an image. In order to spatially encode the spins, three sets of gradient coils are
built into MRI machines to spatially-vary the magnetic field, thereby altering the Larmor
precession frequency in a spatially dependent fashion. The magnetic field can be
represented as:
𝐵\ (𝒓) = 𝐵7 + 𝐺_ 𝑥a + 𝐺b 𝑦a + 𝐺\ 𝑧̂

[2.10]

In the presence of the gradient fields, the transverse magnetization precesses with
a spatially dependent Larmor frequency, accruing a different amount of phase that depends
on the location of the spins as well as the intensity and duration of the gradient field:
?km
⃗. 𝒓n 𝑡
𝜑(𝒓, 𝑡) = h𝜔
+ 𝛾𝑮
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[2.11]

Omitting the w0 term, we can define the following parameters for a twodimensional image in the xy plane:
𝑘_ (𝑡) =

𝛾
𝛾
𝐺_ 𝑡 , 𝑘b o𝑡b p =
𝐺 𝑡
2𝜋
2𝜋 b
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[2.12]

Given this, we can mathematically describe the NMR signal obtained for each
acquisition with the gradients on for a total duration of t9:
𝑆Kr o𝑘_ , 𝑘b p = s 𝑚_b (𝑥, 𝑦)𝑒 (Kvwoxy (z)_&x{ (z)bp 𝑑𝑥 𝑑𝑦

[2.13]
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where mxy(x,y) is the spatial distribution of the magnetization in the xy plane. Equation
[2.13] suggests that Fourier transform of this distribution in space describes the NMR
signal represented in k-space. The duality property of the Fourier transform implies that
the two-dimensional inverse Fourier transform of the k-space yields the spatial distribution
of the spins, which is the image:
𝑚_b (𝑥, 𝑦) =

s 𝑆Kr o𝑘_ , 𝑘b p𝑒 Kvwoxy _&x{ bp 𝑑𝑘_ 𝑑𝑘b

[2.14]
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This equation implies that MR image acquisition involves obtaining enough
information in the k-space and calculating its inverse Fourier transform, as shown in Figure
2.13. The range of k-space covered by the acquisition method controls the resolution of the
image along the x and y axes:
Dx =

1
2𝑘_,…†_

,

Dy =

1
2𝑘b,…†_

[2.15]

The sampling interval k-space, Dkx and Dky, determine the field-of-view (FOV) of
the image along the x and y axes:
FOV_ =

1
,
D𝑘_

FOVb =

1
D𝑘b

[2.16]

As data in k-space are obtained in a discrete fashion, the Nyquist criterion must be taken
into account when selecting the sampling interval. This dictates that the selected FOV must
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be equal to or larger than the desired object, otherwise the signal outside of the FOV folds
back onto itself and creates an artifact known as aliasing. The relationship between the
sampling interval and the FOV along the x and y axes is:

D𝑘 ≤

1
FOVŒ•Ž

[2.17]

Figure 2.13. MRI data acquired in the k-space represents the Fourier transform of the object. The actual
image (right) can be obtained by applying inverse Fourier transform to the k-space data.

2.7.1. Acquisition Methods and MRI Pulse Sequences
The order by which an acquisition method covers the k-space is called the k-space
trajectory. A few commonly used k-space trajectories are shown in Figure 2.14. The
method by which the k-space data is acquired is described by an MRI pulse sequence, which
describes the timing, shape and strength of the gradient fields, the shape and the power of
the RF pulses with pulse sequence diagram, an example of which is shown in Figure 2.15.
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The majority of MRI pulse sequences have a number of components in common
including slice selection, phase encoding, frequency encoding and data acquisition.

Figure 2.14. (A) gradient-echo and (B) echo-planar readout trajectories are basic cartesian trajectories
commonly used in both preclinical and clinical settings. Commonly used non-cartesian trajectories include
(C) radial and (D) spiral trajectories. The imaging methods in this thesis obtain the data in a Cartesian grid.

To obtain data to form a two-dimensional image, the first step is to excite the spins
selectively in a given slice by turning the gradient on in the direction that slices are
arranged. The thickness of the slice is determined by the bandwidth of the RF pulse, its
shape and the strength of the gradient. Data is then spatially encoding using phase encoding
or frequency encoding gradients. Phase encoding occurs between excitation and data
acquisition, and spatially alters the phase of the transverse magnetization. Frequency
encoding, on the other hand, occurs during the data readout and spatially alters the
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frequency of the transverse magnetization. This acquisition method, called a gradient-echo
(GRE) acquisition, is repeated every TR until the desired section of the k-space is traversed
and is the most common method for collecting MRI data.

Figure 2.15. Basic gradient-echo pulse sequence with a cartesian read-out trajectory. The components shown
by the pulse sequence diagram are repeated regularly at the repetition time (TR) interval until the desired
portion of the k-space is covered.

The time between the center of the excitation pulse and the point at which the
maximum signal is formed during spatial encoding is called the echo time (TE) and is
crucial for generating images with different types of tissue contrast. For instance, the signal
from tissues with a short T2* time constant, such as the lungs, decay much more rapidly,
and therefore require the use of a short TE. The MRI pulse sequences and other acquisition
methods are discussed more thoroughly in9.
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2.8. Chemical Shift Imaging
The spatial encoding described in the previous section ignores the presence of molecular
species with different chemical shifts. However, effective use of hyperpolarized 13C MRI
for molecular imaging requires methods that can resolve the spatial distribution of the
individual metabolites (e.g. pyruvate and lactate) with different chemical shits. This
method is known as chemical shift imaging (CSI) or magnetic resonance spectroscopic
imaging (MRSI). Sample metabolite maps obtained from a human heart using chemical
shift imaging is shown in Figure 2.1640.

Figure 2.16. (A) Proton cardiac MRI, (B) 13C-bicarbonate, (C) [1-13C] lactate and (D) [1-13C] pyruvate maps
after administration of hyperpolarized [1-13C] pyruvate to a healthy human subject. (Reproduced with
permission from40)
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Several imaging and spectroscopic pulse sequences have been developed to address
challenges and limitations associated with hyperpolarized 13C imaging. A number of these
exploit the long T2, and T2*relaxation times of 13C species in many organs [refs from paper],
while others take advantage of 13C species’ large range of the chemical shift to selectively
excite individual metabolites56. The various methods are briefly described below.

2.8.1. Spectroscopic Imaging Approaches
The most basic spectroscopic method encodes the magnetization spatially and
spectrally. Similar to Equation 2.14, the spectroscopic image can be described by
mxy(x,y,f), where f is the resonance frequency. We can rewrite Equation 2.14 as:
𝑚_b (𝑥, 𝑦, 𝑓) =

• 𝑆Kr o𝑘_ , 𝑘b , 𝑘• p𝑒 Kvwoxy _&x{ b&z•p 𝑑𝑡𝑑𝑘_ 𝑑𝑘b

[2.18]
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This suggests that the spectroscopic imaging data can be resolved if the k-space
data is repeatedly acquired over time after each excitation. The Fourier transform along the
time dimension resolves the spectral information for each image voxel.
The most basic method for performing this acquisition to obtain the necessary
(kx,ky,t) points is to apply a phase-encoding gradient after excitation in order to traverse to
(kx,ky) in the k-space and acquire an FID for a duration of Tacq. This simple pulse sequence
is called the free induction decay-chemical shift imaging (FID-CSI) pulse sequence and its
diagram is shown in Figure 2.17. The Nyquist criterion applies along the t as well; the
spectral bandwidth of the NMR spectrum obtained by the pulse sequence is given by:
𝐵𝑊 =

1
∆𝑡
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[2.19]

The FID-CSI pulse sequence is one of the most frequently used CSI pulse
sequences due to its simplicity and availability on all MRI scanners. In fact, due to its
ability to image organs with short T2* relaxation time constants such as the lungs, the pulse
sequence primarily used in this thesis is a modified version of the FID-CSI pulse sequence.
It suffers from a long acquisition time, however, as obtaining each point on the (kx,ky)
plane requires a single RF excitation. This is not ideal, especially for imaging
hyperpolarized media, where a large number of excitations cause severe and irreversible
RF-induced hyperpolarization decay

Figure 2.17. (A) 2D FID-CSI chemical shift imaging pulse sequence diagram, and (B) its associated k-space
trajectory along the (kx,t) plane. The dashed lines with arrowheads show the direction of data acquisition per
one excitation.

An alternative approach is to take advantage of long T2 relaxation time of the 13C
species by combining the acquisition of both spatial and spectral information into one
single excitation using an echo-planar readout strategy57. This pulse sequence is known as
the Echo-Planar Spectroscopic Imaging (EPSI) sequence, and its pulse sequence diagram
is shown in Figure 2.18. The effective combination of spatial and spectral encoding during
each acquisition significantly accelerates data acquisition compared to the FID-CSI pulse
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sequence; for example, acquiring a 16´16 spectroscopic image using the EPSI pulse
sequence requires 16 times fewer excitations. However, implementing EPSI is challenging,
as it requires optimization due to rapid cycling of the gradients during data acquisition.
Additionally, acquiring spatial and spectral data together necessarily increases the duration
of data collection, which may not be feasible for imaging tissues with short T2 or T2* r
relaxation time constants, such as the lungs or bones.

Figure 2.18. (A) Pulse sequence diagram of the EPSI sequence and (B) its k-space trajectory. The gradients
along the readout result in data acquisition with an echo-planar trajectory in the (kx,t) plane.

2.8.2. Iterative Decomposition Using Echo Asymmetry and Least Square Estimation
The previous methods relied on general knowledge of the peaks in the spectrum.
However, given a prior knowledge of the exact frequency of the NMR peaks, chemical
shift imaging can be performed more efficiently. For the basic case in which two NMR
peaks are separated by a chemical shift Df, a gradient-echo sequence with two echoes
separated by DTE = Df-1 can be used to acquire two images where the NMR peaks are in
phase (IP) or out-of-phase (OP) shown Figure 2.19. The image of each peak can then be
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reconstructed by either summing or subtracting the (IP) and (OP) images. This method is
known as Iterative Decomposition with Echo Asymmetry and Least Square Estimation
(IDEAL) and is used regularly to separate water and fat signals in proton MRI images58,59.

Figure 2.19. Magnetization of both water and fat molecules is excited and an in-phase image (IP) is acquired.
After a certain delay, the water (Mwater) and fat (Mfat) magnetizations become out of phase due to their
different chemical shifts, at which point an out-of-phase (OP) image is acquired. Separate images of water
and fat then can be reconstructed from the IP and OP images.

The IDEAL method can be extended to a larger number of resonance frequencies
provided that the number of echoes obtained per excitation exceeds the number of spectral
peaks60. This method can be combined with a variety of acquisition schemes and has been
used with gradient echo-based pulse sequences with both cartesian61-63 or spiral readout
trajectories64, as well as with a single-shot spin-echo based pulse with multiple Cartesian
readouts45.
The use of IDEAL-based pulse sequences eliminates the need to obtain full spectral
information by shortening the overall readout time relative to spectroscopic methods,
thereby shortening the overall scan time. For example, the combining the IDEAL method
with a single-shot spin-echo pulse sequence was shown to provide a 30-fold reduction in
imaging time compared to the standard FID-CSI pulse sequence65, enabling dynamic
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imaging of the metabolites. One major limitation of this method is that, even with prior
knowledge of the chemical shifts, it remains susceptible to 𝐵7 inhomogeneities. However,
this problem can be addressed by acquiring a field-map image before the start of the
acquisition and incorporating it into the reconstruction.

2.8.3. Spatial-Spectral Excitation for Chemical Shift Imaging
The last approach is to exploit the sparse nature of the

13

C NMR spectrum to

selectively excite individual metabolites using narrow-band spatial spectral (SPSP)
composite pulses while only spatially encoding the produced signal using an imaging pulse
sequence. SPSP pulses consist of multiple lobes of short RF excitations accompanied by
time-varying slice selection gradients. The spatial selectivity is determined by the shape of
each lobe and its gradient, while the spectral selectivity depends on the envelope of the
lobes. This strategy enables separate excitation of individual NMR peaks, allowing one to
only detect the contribution of the desired peak to the MRI image; it is extensively
discussed in66,67 A sample imaging pulse sequence with SPSP RF pulse is shown in Figure
2.20.
The frequency of the excitation pulse can be shifted to selectively excite the other
NMR peaks individually, thereby obtaining images specific to each one. This approach
eliminates the need to spectrally encode the NMR signal; it therefore considerably reduces
the total acquisition time, enabling dynamic imaging68,69. However, similar to the IDEAL
method, it requires a priori knowledge of the exact chemical shifts, which may not always
be feasible due to the inherent inhomogeneity of the main field causing spatial variations
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in the frequency of the NMR peaks. Furthermore, SPSP pulses are generally very long (1020ms) and are not suitable for imaging tissues with short T2 or T2*, such as the lungs. Many
newer multiband RF pulses that offer superior spectral selectivity with minimal duration
have been designed specifically for hyperpolarized 13C imaging. However, the design and
optimization of such RF pulses is still an ongoing area of research and development.

Figure 2.20. Pulse sequence diagram for an EPI sequence with spectral-spatial excitation (SPSP). The SPSP
excitation pulse consist of multiple RF pulses accompanied by an EPI-type slice selection gradient (Gz).

2.9. Imaging Considerations
Previous sections provided an overview of the fundamentals of MRI and MRSI, as
well as principles of image formation. In practice, a number of issues must be taken into
consideration that affect the quality of MRI images. Given the short availability of the
signal, additional considerations need to be taken into account for imaging hyperpolarized
media, several of which are discussed here.
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2.9.1. General Considerations
Generally, the major consideration in MRI is the signal-to-noise ratio (SNR). The major
sources of noise are the body, the RF coil and the electronics. The dominant source is the
body itself, since it is a conductive medium and generates random fluctuating magnetic
fields that are near the coil. The overall noise intensity is approximately proportional to the
main field strength B0. In practice, it is extremely challenging to manufacture MRI systems
to operate and very high field strengths. Today, the majority of the clinical systems operate
at 3T field strength.
The imaging parameters also impact the overall SNR. In summary, this relationship
can be described as:
𝑆𝑁𝑅 ∝ (∆𝑥)(∆𝑦)(∆𝑧)•o𝑇†–— po𝑁†˜™ p

[2.20]

where Dx, Dy and Dz are the size of voxels in each direction, Tacq is the acquisition time,
and Navg is the number of times the image is obtained9. A smaller voxel size or slab
generally improves the resolution; however, it also compromises the SNR. To obtain higher
resolution images, signal averaging can be used or the acquisition time can be increased.
However, the impact of increased acquisition time is only effective as long as it is shorter
than the transverse relaxation time constant (Tacq < T2*). Data acquisition beyond this only
increases the noise. This is especially critical for imaging tissues with short T2* such as the
lungs, where increasing the acquisition time can lower the SNR.
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2.9.2. Special Considerations for Hyperpolarized MRI
The significant enhancement in sensitivity after hyperpolarization is only
temporary and the magnetization decays back to thermal equilibrium due to irreversible
signal loss caused by T1 relaxation. Additionally, the RF pulse excitation needed to produce
detectable NMR signal causes additional non-recoverable decay of the longitudinal
magnetization. This limits the availability of signal for imaging to a brief period after
administration of the hyperpolarized substrate. A number of considerations are therefore
necessary to ensure optimal use of the enhanced signal.
First, the timing of the data acquisition is of key importance for obtaining images
with maximum signal-to-noise ratio. Generally, the optimal time to start acquiring the
signal is when the amplitude of the downstream metabolite of interest has the maximum
signal. For many hyperpolarized substrates, this has been found to occur approximately 25seconds after the start of injection. This is demonstrated in Figure 2.14, panel C, which
shows the lactate and time-course of hyperpolarized [1-13C] pyruvate and its downstream
metabolites obtained from a mouse using NMR spectroscopy of the abdominal area. The
initial build-up of the pyruvate signal occurs as the substrate is administered and its
concentration builds up. This is followed by its subsequent conversion to its downstream
metabolites lactate, alanine and bicarbonate, marked by the increase in their corresponding
signals. The peak signal of the metabolites occurs about 25s after the start of injection, after
which the signal of all the metabolites decease due to T1 relaxation.
The second consideration is that the signal dynamics must be taken into account for
image reconstruction. Typically, a constant longitudinal magnetization is assumed for each
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excitation. However, due to the T1 relaxation effects as well as the RF-induced signal
decay, this does not hold true for imaging hyperpolarized substrates. Such changes in the
signal dynamic introduce blurring artifacts into the image, effectively lowering the
resolution70. One strategy is to use a small excitation flip-angle to minimize RF-induced
signal loss. However, this carries a significant signal-to-noise penalty. A more effective
strategy is to gradually increase the flip-angle over time to compensate for reduction in
available longitudinal magnetization and have a fixed transverse magnetization after each
excitation70. Another method that we introduce in chapter 5 of this thesis is to repeatedly
acquire the spectrum from the center of the k-space and compensate for the signal decay
by adjusting the signal intensity of the data acquired over time. This has the advantage of
allowing us to independently correct the signal decay for various metabolites.
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Chapter 3: Lungs and Acute Respiratory Distress Syndrome

3.1. Introduction
As the primary respiratory organ, the main function of the pulmonary system is to
transfer oxygen from the air to the bloodstream and to remove carbon dioxide from the
blood through gas exchange. In addition to this primary task, however, the lungs also
perform a variety of critical metabolic and cellular functions that can alter rapidly due to
increased energy demand of the tissue in the presence of various lung pathologies such as
cancer and lung injury1-11.
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) occurs in
approximately in 10% of the patients admitted to the intensive care unit (ICU)12,13, and is
characterized by increased endothelial permeability in the alveoli, pulmonary edema,
impaired gas exchange and inflammation13,14. Despite being defined approximately fifty
years ago15, ARDS/ALI remains a significant source of mortality in critically ill patients12:
it has a reported mortality rate of 40%12, and survivors may experience numerous
difficulties including physical and psychological sequelae, exercise limitation and
increased use of health care services12,16. The availability of several mammalian animal
models that mimic ARDS/ALI in humans17 has led to significant progress in understanding
this condition’s pathogenesis, and imaging tools has played a major role in defining the
characteristics of ARDS/ALI. Unfortunately, there are currently limited treatment options
available for improving survival significantly once ARDS/ALI has developed18; according
to the protocol recommended by the ARDS network trial19, current therapeutic approaches
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are primarily limited to supportive mechanical ventilation and, more recently, prone
positioning of patients18,20.
This chapter begins with an overview of the physiology and respiratory mechanics
of healthy lungs before moving on to a short summary of ARDS/ALI, its clinical
manifestations and pathogenesis. Mechanical ventilation and the concept of protective
ventilation as a supportive strategy to minimize progression of ARDS/ALI is then
discussed, and the chapter ends with a brief overview of state-of-the-art imaging tools used
in the study and clinical management of ARDS/ALI.

3.2. Healthy Lungs

3.2.1. Anatomy and Physiology
The lungs are a spongy organ that consist of a highly branched structure of airways
and vessels. The airways consist of two zones: conducting and respiratory. The conducting
zone includes the larger airways, starting from the trachea at the top before branching into
two smaller airways called the main bronchi, which conduct air into the left and right lung,
respectively. The airways in the conducting zone branch down (sixteen generations in
humans), becoming progressively smaller until reaching the terminal bronchioles, where
the respiratory zone of the lung begins. In this zone, the airways branch down further (seven
more generations in humans) into alveolar ducts where air travels into the alveolar sacs,
each consisting of several alveoli. The main vessels are the pulmonary artery and vein,
which carry the blood from the heart to the lungs and from the lungs back the heart. The
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pulmonary artery and vein divide into left and right pulmonary arteries along the bronchi
and, similar to the airway, branch down into progressively smaller vessels, eventually
reaching the small arterioles and venules that carry the blood to a network of capillaries
surrounding the exterior of the alveoli. The structure of the airways, lung vasculature and
alveoli is shown in Figure 3.1.A.

Figure 3.1. Pulmonary vessels branch in the same treelike fashion as the airways. (A) Systemic venous blood
flows through the pulmonary arteries into the alveolar capillaries and back to the heart via the pulmonary
veins, to be pumped into systemic circulation. (B) A mesh of capillaries surrounds each alveolus. As the
blood passes through the capillaries, it gives up carbon dioxide and takes up oxygen. (C) Blood–gas interface,
formed by pulmonary capillaries and alveoli, is the site of gas exchange. Thick arrows indicate the direction
of blood flow and ventilation, while thin arrows indicate the diffusion paths for O2 and CO2. The alveolar–
capillary membrane is thin (∼0.5μm), and therefore the diffusion distance for gases is small. Reproduced
with permission from21.

Gas exchange in the lungs occurs via passive diffusion of gases through the
alveolar-capillary membrane from the alveolar space into the capillaries, where the gas
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binds to the hemoglobin molecule in the red blood cell and vice versa (Figure 3.1.B). The
alveolar-capillary membrane consists of three layers: the alveolar epithelium, interstitial
fluid (also known as the blood-air barrier) and the capillary endothelium. The alveolar
epithelium primary consists of thin cells known as type I pneumocytes (Figure 3.2, AECI).
The blood circulatory system returns non-oxygenated blood from other organs to
the lungs via the pulmonary artery. The carbon-dioxide (CO2) carried by red-blood cells
diffuses through the alveolar-capillary membrane into the alveolar air-space and is replaced
by the oxygen molecule that passes through this membrane to oxygenate the blood. The
oxygenated blood then returns to the heart via the pulmonary vein and is delivered to the
rest of the body via the aorta and major arteries.
The lungs’ overall capacity to oxygenate can be assessed by performing arterial
blood gas (ABG) analysis to measure the arterial blood oxygen tension (PaO2). PaO2 can
also be estimated by measuring oxygen saturation (SpO2), which is defined as the fraction
of oxygen-bound hemoglobin relative to total hemoglobin available. This measurement can
be performed non-invasively using infrared pulse oximeters that are widely available. In
healthy subjects, the oxygen saturation remains above 95% when breathing air with ~21%
fraction of inspired oxygen (FiO2) 21. The state of reduced oxygen availably (SpO2 < 95%)
is known as hypoxia.

3.2.2. Respiratory Mechanics
Breathing is an active process that uses the chest and diaphragm muscles to expand
or contract the pleural cavity for respiration. During inhalation, the expansion of the pleural
57

cavity generates a negative pressure that expands the lungs and conducts air into them
through the nasal cavity. Exhalation, on the other hand, is a passive process whereby lung
recoil pushes the air out of the lungs until the pressure in the pleural cavity and the
environment equilibrate.
The mechanics of respiration can be assessed via the pressure-volume curve of the
lungs. This curve describes the lungs’ ability to expand, known as pulmonary compliance,
and is defined as the ratio between the change in the volume of inhaled gas and the change
in the pleural pressure21. In healthy lungs, the secretion of pulmonary surfactants by type
II pneumocytes (Figure 3.2. AECII) reduces the alveolar surface tension, thereby
increasing pulmonary compliance. The surfactant also prevents the alveoli from collapsing
of the alveoli—also known as atelectasis—which can result in reduced gas-exchange.
Pulmonary compliance is reduced in many lung pathologies, however, due various factors
including loss of the lung’s elastic recoil, the presence of edema, and surfactant depletion
in the lungs21.

3.3. Acute Respiratory Distress Syndrome and Acute Lung Injury

3.3.1. Characterization and Clinical Definition
Acute respiratory distress syndrome and acute lung injury (ARDS/ALI) is
characterized by sudden onset of respiratory failure, pulmonary edema, diffused alveolar
damage and widespread inflammation of the lung12. Primary injury to the lungs is caused
by a direct (pneumonia, gastric aspiration, traumatic injury or toxin inhalation) or indirect
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(sepsis, burn injury or cardiopulmonary bypass) insult to the lung tissue which may
progress to ARDS, as shown in Figure 3.2. Such progression is followed by resolution of
ARDS/ALI in response to treatment or further progression into severe respiratory and
multi-organ failure.

Figure 3.2. Etiologies, manifestations and sequelae of ARDS/ALI. Upon diagnosis, patients undergo
supportive therapy using protective ventilation (described in section 3.4.2). The patient’s overall condition is
assessed by chest radiography, computed tomography, ventilatory parameters and ABG. Treatment either
results in resolution of ARDS/ALI or in the syndrome’s progression into severe respiratory failure,
pulmonary fibrosis and eventual multi-organ failure.

ARDS/ALI patients are nearly always admitted to the intensive care unit (ICU), where
they receive mechanical ventilation. The most recent clinical definition of ARDS, the
Berlin definition, was proposed in 2012 and consists of four criteria for diagnosis13:
a) Occurrence of lung injury within seven days of the insult
b) Presence of pulmonary edema detected by bilateral diffused opacities in chest
radiographs or chest computed tomography images
c) Hypoxemia diagnosed by PaO2 / FiO2 < 300mmHg
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d) Mechanical ventilation with a minimum positive end-expiratory pressure (PEEP)
of 5 cmH2O (described in section 3.4.2)
The severity of ARDS can be categorized by the degree of hypoxemia as12:
a) 201 mmHg <PaO2 / FiO2 < 300mmHg, with ~27% mortality rate
b) 201 mmHg <PaO2 / FiO2 < 200mmHg, with 32% mortality rate
c) PaO2 / FiO2 < 100mmHg, with 45% mortality rate

3.3.2. Mechanical Ventilation
While it is crucial to identify the underlying cause of lung injury in order to provide
the appropriate course of treatment, supportive therapy in is required the limit the
progression of lung injury12. The primary supportive approach for ARDS/ALI patients is
mechanical ventilation, which allows the respiratory muscles to rest while providing
adequate oxygenation and minimizing lung injury22. In mechanical ventilation, a ventilator
is directory connected to the trachea using either an endotracheal tube inserted through the
mouth or a tracheostomy tube inserted into the trachea through an incision in the anterior
neck.
Although used as a supportive therapy, mechanical ventilation can cause injury in
patients with healthy lungs, or lead to secondary injury in ARDS/ALI patients by
exacerbating the primary injury. Ventilator-induced lung injury (VILI) is caused when
large mechanical forces are applied to the lung microstructure, and can occur either when
ventilation with large tidal volumes (barotrauma) leads to alveolar rupture or when
ventilation with small tidal volumes (atelectrauma) results in regional hypoxia and repeated
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opening and closing of the alveoli (unstable inflation)22. Careful selection of ventilation
parameters is therefore essential to limit progression and resolve injury.
The protective ventilation strategy recommended by the ARDS network
(ARDSNet) trial consists of ventilation with 4-6ml/kg tidal and use of a minimum positive
end-expiratory pressure (PEEP) of 5 cmH2O such that SpO2 > 88%19. The PEEP/FiO2 ratio
can be adjusted to maintain oxygenation as needed.
PEEP is alveolar pressure at the end of expiration that is higher than the
atmospheric pressure, and is applied using a ventilator to improve overall oxygenation by
preventing atelectasis from recruiting the collapsed regions of the lungs23,24. However,
while PEEP has been shown to reduce tidal lung strain and the incidence of VILI, it can
lead to decreased cardiac output and increased pulmonary vascular resistance24. Several
strategies have therefore been proposed for the optimal titration of the PEEP in ARDS/ALI
patients; one commonly used strategy is to minimize either the peak inspiratory pressure
(PIP) or the driving pressure (the difference between the end-inspiratory pressure and
PEEP). However, because trials have shown similar outcomes among the various
strategies24, the optimal titration of PEEP and its impact on lung injury progression remains
an important area of ongoing research in ARDS.

3.3.3. Pathogenesis
In the acute, or exudative, phase of ARDS/ALI (Figure 3.3), the alveoli become
filled with protein-rich edema fluid and resident macrophages (a type of white blood cell)
secrete pro-inflammatory proteins and cytokines (e.g. interleukin-8 (IL-8)), which recruit
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the innate immune cells (primarily neutrophils). Neutrophils adhere to the endothelial
lining of the vessels and roll on this lining until they migrate through the alveolar-capillary
membrane into the airspace, thereby damaging it. Neutrophil adherence to the endothelial
wall can be measured via markers of endothelial injury such as soluble intercellular
adhesion molecule-1 (sICAM-1 or ICAM-1)25. Neutrophils are activated in the alveolar
space, releasing toxic mediators, granula proteins and reactive oxygen species (ROS) into
this space which and causing further epithelial and alveolar injury as well as the formation
of hyaline membranes. Neutrophil activity can be measured by the expression of enzymes
and proteins released by activated neutrophils, such as elastase or myeloperoxidase
(MPO)25. The pathogenesis of ARDS/ALI is described in more detail in12.
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Figure 3.3. The healthy lung (left), and the acute phase of ARDS/ALI (right). In ARDS/ALI, injury is
initiated by either direct or indirect insults to the delicate alveolar structure of the distal lung and associated
micro-vasculature. In the exudative phase, resident alveolar macrophages are activated, leading to the release
of potent pro-inflammatory mediators and chemokines that promote the accumulation of neutrophils and
monocytes. Activated neutrophils further contribute to injury by releasing toxic mediators. The resultant
injury leads to loss of barrier function as well as interstitial and intra-alveolar flooding. (AECI: type I alveolar
epithelial cell (pneumocyte), AECII: type II alveolar epithelial cell, MPO: myeloperoxidase, ROS: reactive
oxygen species and sICAM: soluble intercellular adhesion molecule). More detailed information can be
found in12. Reproduced with permission from12.

63

3.3.4. Pulmonary Lactate Production
Healthy lung tissue predominantly relies on glucose utilization to sustain function,
although its energy and metabolic needs are relatively modest compared to other organs
such as the heart and liver26. Approximately 50% of the glucose utilized by the lung tissue
converts to lactate27. The lungs typically maintain the glycolytic intermediary balance
(lactate-to-pyruvate ratio) in the blood by utilizing the excess blood lactate, which results
in a negligible difference in transpulmonary lactate concentration28. However, this function
of the lung is compromised in many lung pathologies—especially in ARDS/ALI—
resulting in a systemic release of lactate by the lung, as shown in Figure 3.4.A2,3, which
has been shown to be strongly correlated with lung injury score as shown in Figure 3.4.B.
The injury score is representative of the severity of opacities observed in chest radiographs
and computed tomography images, as well as the severity of overall respiratory failure
measured by PaO2/FiO2 ratio and loss of pulmonary compliance29.
Although increased lactate production by the lung tissue may reflect the presence
of hypoxia due to elevated anaerobic metabolism, several studies suggest that the elevated
lactate production by the lungs in ARDS/ALI is primarily associated with increased lung
inflammation and neutrophil activity, and can occur even in the absence of tissue hypoxia.
This suggests that increased lactate concentration and lactate-to-pyruvate ratio in the lung
tissue may be a surrogate for lung injury and inflammation1,2,8.
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Figure 3.4. (A) Lung lactate production measured by the difference in the lactate concentration across the
lungs (arteriovenous difference in lactate) in various groups of patients shows that lungs of ALI patients
produce significant amounts of lactate. (B) Lung lactate production measured in 43 patients with acute injury
showed that it is proportional to injury severity as determined by Murray’s lung injury score29. (ALI: acute
lung injury, CPE: acute pulmonary edema, BPN: bronchopneumonia, LTx: lung transplantation, Other: other
types of respiratory failure, mEq/min.M2: mmoles per minute per square meter). Reprinted with permission
of the American Thoracic Society. Copyright © 2019 American Thoracic Society from2. The American
Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.

3.3.5. Animal Models of ALI and ARDS
Nearly fifty years of research in human ARDS patients have significantly improved
our understanding of the mechanisms of lung injury and its progression to ARDS/ALI30,
which in turn has led to significantly improved patient care. Nevertheless, ARDS is a
complex and heterogenous disorder that remains a common and lethal syndrome in ICUs.
Further hypothesis-driven studies are therefore required to better elucidate the
physiological and cellular mechanisms involved in ARDS/ALI and to better evaluate the
efficacy of novel therapeutic strategies. Conducting such studies in humans is challenging,
however, due to a myriad of clinical variables (e.g. different etiologies, severities and
patient history). Alternatively, studies using animal or in-vitro laboratory models that
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mimic the pathophysiology of ARDS/ALI in humans while tightly controlling such
variables offer the opportunity to generate additional insights.
There are several rodent models (e.g. acid aspiration, bleomycin-induction and
chlorine inhalation) used to study mechanisms of acute lung injury17. To be sure, none of
these models perfectly reproduce the characteristics and pathophysiology of lung injury in
humans, which has various etiologies and depends on clinical variables including
comorbidities and genetic factors for its progression. There are also significant differences
between the innate immune response in humans and rodents17. Nevertheless, rodent models
can be chosen to appropriately to mimic particular features of ARDS/ALI for study.
Many studies utilize two-hit models of lung injury, in which first model of primary
injury is followed by second model to exacerbate the injury4,17,30. In this thesis, we used
acid instillation as our direct injury model, followed by VILI for injury exacerbation
(sections 4.2 and 5.2.1). The acid instillation causes alveolar/capillary barrier disruption
and neutrophilic infiltration within an hour. Although its closest clinical correlate is gastric
aspiration, the features of this injury model are common to most ARDS/ALI and acute lung
injury patients17,31. What is more, the severity of the primary injury in this model can be
controlled reproducibly by adjusting the volume and pH of the acid instilled31. Since
patients with acute lung injury and ARDS/ALI are often mechanically ventilated, the
second model we used in our study is also clinically relevant in addition to enabling us to
control the trajectory of the primary injury by adjusting the ventilator parameters (section
5.2.1).
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3.3.6. Emerging Treatments
Protective ventilation is the primary supportive therapy approach used clinically in
ARDS/ALI patients, while prone positioning has also recently been shown to be an
effective strategy for improving ARDS survival18, possibly due to its ability to minimize
regions with unstable alveolar inflation32. Nevertheless, ARDS/ALI remains a highly lethal
condition.
A number of pharmacologic therapeutics have been explored for treating
ARDS/ALI. However, few has been shown to improve patient outcomes: e.g., inhalation
of nitric oxide briefly improves oxygenation but does not appear to improve survival rate.
A number of small trials have also attempted to use anti-inflammatory medications to
inhibit neutrophilic activity, but have not produced conclusive evidence of improved
outcome. Another recently investigated approach is the inhibition of the calcium channel
transient receptor potential vanilloid 4 (TRPV4) substantially mitigates pulmonary injury
and edema. TRPV4 channel has been implicated in initialing acute endothelial
hyperpermeability resulting in disruption of alveolar/capillary membrane and edema33.
Finally, the use of stem cell therapeutic approaches is another method currently under
investigation.
Recent data has revealed ARDS/ALI to be a condition characterized by substantial
heterogeneity12. For instance, approximately 30% of ARDS/ALI patients are considered to
have a hyper-inflammatory phenotype marked by elevated systemic levels of inflammatory
markers and carrying a mortality rate that is double the average rate for all ARDS/ALI
patients12. In another study, two distinct phenotypes of ARDS/ALI patients were found that
67

responded differently to different PEEP settings and fluid management strategies34. These
findings suggest that identifying more phenotypes of ARDS/ALI based on their molecular
and biological characteristics may be a promising approach for identifying the therapeutic
approaches that can improve outcomes for specific phenotypes.

3.4. Current Lung Imaging Tools
Chest radiography has been an integral part of the clinical definition of ARDS13. At
the same time, several other imaging modalities such as computed tomography (CT),
proton and hyperpolarized gas MRI have been used to investigate lung injury for clinical
and preclinical applications that are further discussed in this section.

3.4.1. Radiography
Radiography is among the most accessible and commonly used imaging techniques
in the clinic. A generator produces x-ray beams that are projected toward the patient from
one side and detected on the other side by sensors. The signal intensity depends on the
amount of x-ray energy absorbed by the tissue. Chest radiography is extensively used for
the diagnosis and clinical management of ARDS/ALI. The healthy lungs have a large
contrast in the image relative to the surrounding tissues and rib cage. In ARDS/ALI
patients, however, non-aerated regions of the lungs due to edema and infiltrates can be
conveniently detected as opacities in the image (Figure 3.5.A)35. According to the Berlin
definition, the detection of bilateral infiltrates in the lung via x-ray is one criteria for
ARDS/ALI diagnosis13.
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Chest radiography is an inexpensive, quick and safe imaging modality which, with
the development of portable imagers, can now be performed on ARDS/ALI patients whom
it is difficult to transport for imaging due to severe illness and or mechanical ventilation.
Despite these advantages, however, chest radiography can only provide a projection image
of the lungs, making the detection of vascular, cardiac and diaphragmatic margins from
opacities caused by edema and infiltrates challenging.

Figure 3.5. Chest imaging in patients with acute respiratory distress syndrome (ARDS). (A) A plain chest
radiograph demonstrates symmetric widespread hazy infiltrates. (B) A computed tomography scan in the
same patient confirms the bilateral infiltration observed on plain chest radiograph; however, the infiltrate is
predominantly in the dorsal lung (black arrow), while the ventral lung regions are aerated (green arrow). (C)
Computed tomography scan showing typical ground glass opacities, indicating severely decreased aeration
but without complete loss of gas content. (D) Computed tomography scan of a patient 16 days after ARDSonset, showing diffuse interstitial thickening predominantly at the lung bases, suggesting evolving fibrosis;
in addition, ventral bullae (yellow arrow), pneumomediastinum (blue arrow), and soft tissue emphysema (red
arrow) represent barotrauma from mechanical ventilation. Reproduced with permission from34.
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3.4.2. Computed Tomography (CT)
Computed tomography (CT) uses x-ray energy similar to radiography. In CT,
however, the x-ray energy is emitted through the patient from multiple directions using a
rotating x-ray source and detectors. The data can then be reconstructed into threedimensional images to visualize anatomical structures. CT is widely used for lung imaging
and is critical to the management of many lung pathologies, including ARDS. Figure 3.5.BD shows representative CT images obtained in three ARDS patients with different
radiological presentations. Since CT images can be reconstructed in three dimensions, they
enable much better localization of non-aerated regions of the lungs and opacities in ARDS
patients compared to chest radiographs. However, CT may still be unable to distinguish
opacities caused by infiltration, edema or atelectasis35.
The use of quantitative CT methods can provide more insight into the progression
of lung injury. For example, recent studies have demonstrated that CT images acquired
from ventilated rats and pigs at both end-inspiration and end-expiration can be registered
and compared to assess lung aeration during the ventilation cycle20,36. This methodology
was able to identify regions of the injured lungs that were more prone to injury progression
as a result of overdistension during ventilation. What is more, this methodology was also
able to predict mortality in previously imaged ARDS patients better that qualitative
assessments of routinely performed CT scans36. These findings suggest that quantitative
approaches using CT could significantly improve the clinical management of ARDS/ALI.
Contrast-enhanced dual-energy CT, which employs an x-ray source that operates
at two energy levels, is another approach that has recently been used for quantitative lung
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imaging. Because the lung tissue has similar photo absorption at these energy levels, a
contrast agent (e.g. iodine) that has a different photon absorption at these two energy levels
is administered intravenously. This difference can be used to obtain images before and after
injection of the contrast in order to quantify blood flow and volume in the lungs35,37.
Despite its capabilities, however, the fact that CT exposes patients to a significant dose of
ionizing radiation limits its repeated use in patients over a short period of time.

3.4.3. Positron Emission Tomography (PET)
In positron emission tomography (PET), radiolabeled analogues of specific
molecules (e.g. [18F]-fluorodeoxyglucose (18F-FDG), an analogue of glucose) are injected
intravenously into the patient. The nucleolus of the radiolabeled atom then undergoes b
radioactive decay, in which a positron is released and travels for a short distance in the
tissue (<1mm) before colliding with an electron to produce two g-ray photons that travel in
opposite directions38. These photos are then detected and localized using a large ringshaped sensor around the patient. PET scanners do not obtain anatomical information and
thus are often combined with CT scanners (PET/CT scanners) to overlay the functional
information on the anatomical images.
While 18F-FDG-PET is routinely used in clinical oncology39, it has not been used
clinically for the management of ARDS/ALI. However, several studies have demonstrated
its capability as a molecular imaging tool to delineate regions in the injured lungs with
elevated glycolysis due to neutrophilic infiltration and activation as measured by increased
18

F-FDG uptake35,40-42. Given the previously mentioned studies showing that
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approximately 33% of ARDS patients have a “hyper-inflammatory” sub-phenotype with a
significantly higher mortality rate12,

18

F-FDG-PET would appear capable of providing

invaluable insight into patient outcomes in ARDS/ALI41. Figure 3.6 shows representative
CT and PET scans from two ARDS patients.

Figure 3.6. Representative images of cross-registered computed tomography (CT) and [18F]fluorodeoxyglucose (18F-FDG) positron emission tomography from two patients with ALI/ARDS. The CT
image was acquired during a respiratory pause at mean airway pressure: the gray scale is centered at -500
Hounsfield Units with a width of 1250 Hounsfield Units. Positron emission tomographic images represent
the average pulmonary

18

F-FDG concentration during the last 20 minutes of acquisition (from 37 to 57

18

minutes after F-FDG administration): the color scale represents radioactivity concentration (kBq/mL). (A)
18

F-FDG distribution parallels that of the opacities detected on CT. (B) Intense

18

F-FDG uptake can be

observed in normally aerated regions (square 1), while activity is lower in the dorsal, “nonaerated” regions
of both lungs (square 2). Reproduced with permission from43.
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While 18F-FDG-PET enables the visualization of metabolic changes in the lung, it
also exposes patients to ionizing radiation and requires a long scan time (between 10-40
minutes)35. It is further limited to examining abnormalities in the uptake of the glucose
analogue fluorodeoxyglucose, and is therefore unable to reveal changes in downstream
metabolism that may be crucial to the evolution of inflammation and injury (18-20).
Understanding these downstream pathways may open up new therapeutic approaches
aimed at controlling early injury and/or attenuating its consequences in the early stages
(21), goals which may be facilitated by the use hyperpolarized 13C MRI described in this
thesis.

3.4.4. Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging was extensively discussed in chapter 2. Proton MRI
offers superb contrast between different soft tissues without exposing the patient to
ionizing radiation. Its clinical use for lung imaging is limited, however, by the lung’s low
tissue density and severe magnetic field inhomogeneity due to air/tissue interfaces. These
challenges may be overcome by using robust ultra-short echo time (UTE) imaging methods
capable of visualizing of the airways and lung tissue with high spatial resolution44.
Nevertheless, UTE-based sequences are challenging enough to develop that they have yet
to be used clinically. Contrast-enhanced MRI has also been used to quantify pulmonary
blood flow and perfusion45, although it is not yet part of the clinical management of ARDS.
The further development of these techniques may facilitate the widespread use of MRI as
a standard lung imaging tool in ARDS/ALI patients.
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More recently, hyperpolarized gas MRI (129Xe and 3He) has been used extensively
to study pulmonary disorders in small and large animals as well as human subjects46,47.
Patients can safely inhale the hyperpolarized gas, and anesthetized animals can be
ventilated with the gas and subsequently imaged to probe airway structure and assess lung
functional by regionally measuring fractional ventilation, oxygen tension, gas diffusion and
uptake. Figure 3.7 shows MRI images of the lung obtained from a human subject using
conventional MRI and after inhalation of hyperpolarized 3He gas to visualize the airways.
Although hyperpolarized gas MRI is expensive and not ubiquitously accessible, several
studies have demonstrated its ability to provide valuable quantitative information about
alterations

in

the

lung

microstructure

during

mechanical

ventilation48

and

inflammation49,50.

Figure 3.7. (Top Row) Coronal images of the lungs in a human subject obtained using conventional MRI.
(Bottom Row) Images from the same subject after inhalation of hyperpolarized 3He gas to allow visualization
of the airways.
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Finally, while proton and hyperpolarized gas MRI elucidate the structural and
functional manifestations of inflammation, they do not target the metabolic and molecular
processes that drive these changes. In this thesis, we will demonstrate the use of
hyperpolarized [1-13C] pyruvate to probe these changes in both small and large species.

3.4.5. Ultrasound Imaging and Electrical Impedance Tomography (EIT)
Ultrasound is an inexpensive and ubiquitous tool that emits high-frequency sound
waves (1-10MHz) through tissue and measures its reflection using piezoelectric sensors to
characterize the acoustic properties of that tissue. While not traditionally used for lung
imaging, recent studies suggest that ultrasound imaging is capable of detecting non-aerated
areas and edematous regions of the lungs35. What is more, ultrasound imaging offers the
dual advantages of using portable scanners and visualizing the changes in lung aeration in
real-time. However, it also offers suffers from diagnostic error and poor specificity, though
these disadvantages can be limited by properly training the operator as well as by
developing probes that are specifically designed for lung ultrasound35.
Another recently developed method for imaging the lungs is electrical impedance
tomography (EIT), which uses several electrodes positioned around the chest to conduct a
small alternating electrical current through the body in order to estimate the impedance
across the thorax35. This impedance drastically changes in well-aerated areas during a
respiratory cycle, thereby localizing such areas. EIT currently suffers from low spatial
resolution. However, it offers tremendous potential as an imaging tool, since it is
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inexpensive and can be used to obtain images in real-time. Information provided by EIT
could potentially be used to adjust the ventilator strategy for each patient at point-of-care35.
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Chapter 4: Metabolic Imaging of Acute Lung Injury using Hyperpolarized 13C MRI

This chapter has been adapted from the published article, Pourfathi et al. ‘In vivo imaging of the progression
of acute lung injury using hyperpolarized [1‐13C] pyruvate’ in Magnetic Resonance in Medicine, 78:21062115 (2017)

4.1. Introduction
In our earlier ex-vivo perfused lung studies using spectroscopy, we showed a
significantly increased rate of hyperpolarized lactate labeling after injection of
hyperpolarized [1-13C] pyruvate in injured lungs1. What is more, the lactate-to-pyruvate
ratio was significantly correlated with the severity of neutrophilic infiltration, suggesting
increased metabolic activity due to the presence of infiltrates.
Extending this technology’s use to in-vivo pulmonary imaging is challenging due
to lung tissue’s severe B0 inhomogeneity, which causes rapid spin dephasing at air-tissue
interfaces, as well as the lung's low overall tissue density (section 2.3.1). In the case of
metabolic imaging, this difficulty is further exacerbated by lung’s modest overall energy
needs. Taken together, these challenges limit both signal-to-noise ratio (SNR) and the
suitability of rapid pulse sequences that have proven useful for imaging other organs.
Therefore, development and optimization of imaging and spectroscopic pulse sequences to
address the challenges of the lung MRI are required.
Despite these obstacles, however, the use of hyperpolarized [1-13C] pyruvate MRI
for pulmonary metabolic imaging is diagnostically and therapeutically attractive since the
lungs of patients suffering from conditions such as ARDS/ALI, pulmonary fibrosis or
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sepsis releases high concentrations of lactic acid due to high inflammatory activity2,3.
Given that the lungs receive the full blood supply during each circulation and perform a
variety of biochemical functions to maintain body homeostasis such metabolic changes in
the pulmonary system can lead substantial detrimental alterations. Such changes are part
of a spectrum of multi-organ dysfunctions and, unsurprisingly, are associated with high
mortality4-6. Consequently, the development of molecular imaging techniques capable of
directly interrogating lung metabolism as well as its spatial heterogeneity could provide
valuable insight into the relationship between abnormalities in the mechanics and
cellularity of diseased lung tissue. Addressing this knowledge gap is relevant to clinical
efforts aimed at improving the evaluation of inflammatory lung disorders and could
potentially result in more effective and specific early interventions.
This chapter describes the development of a pulse sequence based on the FID-CSI
sequence, as well as its first successful test in healthy ventilated rats. Experiments were
subsequently extended to rats injured with a combination of hydrochloric acid aspiration
and ventilator-induced lung injury. Lastly, utility of our method was also assessed for
imaging other pulmonary disorders, namely lung cancer in a mouse model of lung
adenocarcinoma.

4.2. Development and Optimization of a Lung Imaging Protocol
We used a single-slice two-dimensional FID-CSI pulse sequence (described in
section 2.8.1) for metabolic imaging of the lungs and optimized it for two field strengths
(4.7T and 9.4T) in order to image rats and mice, respectively. Unlike other MRSI methods,
81

this method requires neither a long spectroscopic/spatial readout time nor long RF pulses
to excite individual metabolites—thus enabling detection of the short T2* components in
the NMR signal that come primarily from the lung tissue.
The fact that the FID-CSI pulse sequence requires both a long scan time and a large
number of excitations is a major drawback, as the availability of hyperpolarized signal is
limited by irreversible signal loss caused by a combination of T1 relaxation and RF pulse
excitation, which alter pyruvate and lactate signal dynamics. This time-dependent signal
change results in image blurring that can reduce true spatial resolution—an issue which is
exacerbated by the fact the heart is significantly more metabolically active than the lungs,
potentially masking the signal from the latter. In order to address this issue, we introduced
a method by which signal variability during an extended hyperpolarized imaging protocol
may be observed and analytically corrected. This is possible using a custom-designed
outward spiral k-space trajectory (shown in Figure 4.1) in which the center of k-space is
re-measured every eleventh excitation. The observed signal dynamics require an
independent correction for each chemical species to minimize blurring due to motion or
relaxation-induced dynamics7.
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Figure 4.1. (Left) The k-space trajectory used in the proposed acquisition technique, where the acquisition
returns to the center of the k-space every 11th acquisition. (Right) Signal obtained during the course of
imaging shows the exponential signal decay due to the T1 relaxation of the sample as well as the destructive
effect of RF excitation on magnetization. The blown-up view of the initial 1.5 seconds of the data shows the
FID obtained during each phase-encoded acquisition and every 11th FID from the center of the k-space; this
has a larger amplitude due the absence of spatial phase distortion across the object due to the phase encoding
gradients.

After careful optimization of the imaging parameters, we were able to produce
images with sufficient SNR and spatial localization, with parameters that are summarized
in Table 4.1 for both rat and mice experiments:
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Table 4.1. Summary of imaging parameters for the protocols established for imaging lungs of rats and mice.
Parameter

Rats

Mouse

Field (Tesla)

4.7

9.4

Repetition Time (ms)

36

22

Acquisition Time (ms)

32

21

Acquisition Bandwidth (Hz)

4000

6000

Number of Spectral Points

128

128

In-plane Field-of-View (mm2)

45´45

20´20

Slice Thickness (mm)

8-15

5

Matrix Size

16´16

16´16

Total Scan Time (s)

9.2

5.6

Injection Dose for 80mM Pyruvate (ml/kg)

4

10

Injection Duration (s)

6

3

Scan Start time (s after start of injection)

18

10

Flip Angle (°)

9

9

Number of Excitations

256

256

RF Pulse Shape

Gaussian

Gaussian

RF Pulse Duration (µs)

200

200

Crusher Duration (ms)

2.5

1

Crusher Strength (G/cm)

6.5

10

Since we are primarily interested in the lung signal that has a short T2* relaxation
time, we used a shorter acquisition time. Given the long T2* of the carbon species in the
majority of tissues (muscles, heart, etc.) 8, this lowers the SNR of the overall image
(equation 2.20); however, as the signal decays considerably during the data acquisition
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period, this shortened readout time does not compromise the SNR of the short T2*
components. The use of a shorter acquisition time also leads to a shorter repetition time,
reducing the overall scan time to 9 seconds—quite short for a breath-hold maneuver that
can be applied to mechanically ventilated rats and mice in order to minimize respiratory
motion artifacts.
Lastly, as previously covered in Section 2.9.1, the timing and duration of the data
acquisition with respect to dose administration are of key importance in obtaining
metabolic images with maximum SNR. Because pyruvate uptake by lug tissue is limited,
administering a large amount of pyruvate does not improve the SNR of the metabolites,
and can in fact make it more difficult to accurately distinguish / quantify metabolite peaks
that are closely positioned in the NMR spectrum, as the large pyruvate peak will dominate
the small metabolite peaks. Our experiments suggested that the optimal protocol for
hyperpolarized

13

C imaging of rat lungs using our sequence FID-CSI sequence is to

administer 0.32 mmols/kg of hyperpolarized pyruvate within 6 seconds and to start image
acquisition 18 seconds after the start of the injection. The optimal protocol was slightly
different in mice: administering 0.8 mmols/kg of pyruvate within 3 seconds and starting
image acquisition 10 seconds after the start of injection. The typical hyperpolarized [1-13C]
pyruvate sample in small animals after neutralization with the buffer has a concentration
of 80mM. To achieve the desired dosage, we administered 4ml/kg and 10ml/kg of the
pyruvate sample obtained from the polarizer to rats and mice, respectively. However, this
thesis will primarily focus on imaging rat injury models.
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4.3. Study Design and Methodology
We hypothesize that hyperpolarized [1-13C] pyruvate imaging can be used to
monitor progressive changes in downstream pyruvate metabolism due to the progression
of experimental lung injury induced by acid-aspiration. We chose a two-hit model of acid
aspiration and ventilation-induced lung injury for our studies to mimic the pathophysiology
of acute lung injury in humans, including severe inflammatory response and edema in the
lung tissue (section 3.3.3). The degree of initial injury can be controlled by the pH and
dosage amount of acid instilled into the trachea, while injury progression can be adjusted
using the appropriate ventilation mechanism.

4.3.1. Animal Preparation and Injury Protocol
A summary of the study is shown in Figure 4.2. A total of fifteen male Sprague
Dawley rats (335±45 g) were imaged (5 healthy, 10 injured). All animal procedures were
approved by the Institutional Animal Care and Use Committee (IUCAC) of the University
of Pennsylvania (Philadelphia, PA). General anesthesia was induced (40-60 mg/kg) and
maintained (20 mg/kg) through intra-peritoneal administration of sodium pentobarbital
every 60 minutes. The trachea was intubated with a 2-inch long, 14-gauge angio-catheter
(BD, Franklin Lakes, NJ) with a sealant (UHU Tac adhesive putty; Saunders Mfg. Co.
Readfield, ME) placed around the glottis to prevent gas from leaking out of the lungs. Rats
were then connected to either a custom-built MR-compatible small animal ventilator or a
VentElite small animal ventilator (Harvard Apparatus) and were ventilated with 100%
oxygen in supine position. Animals were placed in the magnet within 10 minutes of
86

beginning ventilation (t=10 min). Ventilation parameters were 8.1±0.6 ml/kg tidal volume
and 8±2 cmH2O positive end expiratory pressure (PEEP) to prevent atelectasis (alveolar
collapse) and minimize ventilator-induced injury9.
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Figure 4.2. Study design for hyperpolarized pyruvate studies. Three cohorts of rats (5 each) were used. Each
rat received 3 injections of hyperpolarized [1-13C] pyruvate (Pyr) at approximately 60, 130 and 240 minutes
after the start of ventilation. The injured-1 cohort received 1 ml/kg HCl (A1), while the injured-2 cohort
received 2 ml/kg HCl (A2) intratracheally 10 minutes after the first pyruvate injection. Compliance was
measured before each pyruvate injection.

Animals remained on this ventilator setting for the remainder of the study (3-4
hours) except during imaging acquisition and shimming, when PEEP was briefly reduced
to 0 cmH2O to improve field homogeneity. Peak inspiratory pressure (PIP) was monitored
using an MR-compatible pressure sensor (Samba Sensors). Body temperature was
monitored using a rectal thermometer and adjusted using warm air. Blood oxygen
saturation levels were monitored during the scan using a pulse oximeter to ensure sufficient
oxygenation (SPO2 > 90%).
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Injury was induced in twelve animals via intratracheal instillation of pH 1.25
hydrochloric acid (HCl) 70 minutes after beginning ventilation, similar to the injury
protocol used in10. Five animals (injured-1) received 1ml/kg HCl, while another seven
animals (injured-2) received 2ml/kg HCl in order to induce more severe injury. Mechanical
ventilation was resumed after acid instillation. The 2ml/kg dosage for the injured-2 cohort
was chosen based on our previous studies with quantitative CT imaging10, which suggested
progression of severe injury and edema at this same dosage. The 1ml/kg dosage aimed to
mimic less severe mechanical injury while also activating an inflammatory response in the
lung tissue. Finally, peak inspiratory pressure (PIP) and dynamic compliance
(Cdyn=VT/(PIP-PEEP)) of the respiratory system were obtained at ZEEP immediately
before each image acquisition.

4.3.2. Hyperpolarization Protocol
Pyruvate samples were prepared by mixing 14 M [1-13C] pyruvate (Cambridge
Isotopes), 15 mM OX063 radical (GE Healthcare) and 1.5 mM of Dotarem (Guerbet LLC).
22 µL aliquots were polarized using a commercial Hypersense DNP polarizer (Oxford
Instruments) for approximately one hour at a temperature of ~1.4K. Samples were melted
with 4 mL dissolution buffer (80 mM NaOH, 40 mM Trizma buffer, 50 mM NaCl and 0.1
mg/L EDTA) at 10-bar pressure and 180 °C to yield 80 mM isotonic neutral polarized [113

C] pyruvate at 37 °C. Solid-state polarization was estimated to be 20±6% based on the

solid-state build-up curve and separate measurements. 4 ml/kg of the sample was
administered through the tail vein over 6 seconds, followed by a 300-µL saline dose over
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2 seconds to flush the pyruvate from the catheter’s dead volume. To minimize respiratory
motion during data acquisition, a 12-second breath-hold was applied using the ventilator;
data acquisition was initiated 18 seconds after the start of injection. This timing was chosen
based on previous measurements of the time-course of the individual metabolites to yield
maximum SNR for the lactate peak in rodents (Figure 2.14).

4.3.3. MRI/MR Spectroscopic Imaging Protocol
All animals were imaged using a dual-tuned 1H/13C quadrature transmit/receive
birdcage coil (m2m) in a 4.7T horizontal-bore magnet (Varian Inc.) equipped with a direct
drive console. Axial and coronal T1-weighted proton images were acquired using a multislice gradient echo sequence as anatomical references and to monitor injury progression.
Imaging parameters were TR/TE=80/1.5 ms, α=20°, 128×128 matrix size, 60×60 mm2 inplane field of view (FOV), 100 kHz bandwidth and 16 averages. A total of sixteen 2 mmthick slices were acquired to cover the lungs. Manual shimming was carried out at end
expiration using a slice-selective pulse-and-acquire sequence over a 15-mm axial slice
covering the lungs.
A summary of the hyperpolarized

13

C imaging studies is shown in Figure 4.2.

Fifteen animals were used for this study (5 healthy, 5 injured-1 and 5 injured-2). Each
animal received three injections of hyperpolarized pyruvate, at 60±6, 133±4 and 230±11
minutes after the start of ventilation, except for one injured rat (injured-2) that did not
survive until the third injection. Injection timing was chosen based on previous studies
suggesting that inflammatory infiltration starts to occur one hour after acid instillation in
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this model11. Both injured cohorts (injured-1 and injured-2) received intratracheal HCl 70
minutes after starting ventilation, as described earlier. 13C imaging was performed using
the pulse sequence described in section 4.2. A 5-mm NMR tube containing 15 M solution
of labeled 13C urea and 5 mM gadolinium (Gd) (Omniscan, GE Healthcare) was placed in
the coil next to the rat for flip angle calibration of the 13C channel.

4.3.4. MRI Data Processing and Statistical Analysis
All data were processed using custom routines programmed in MATLAB 2014a
(MathWorks, Inc.). A 30 Hz exponential line broadening was applied to the individual
FIDs. The spatially resolved spectra were computed by applying a 3D Fourier transform to
the broadened data. As previously described, the periodic acquisition of the k-space center
(kx,y=0) allowed us to observe the time dependence of pyruvate and its metabolites
independently. These time-dependences were then used to compensate for the signal loss
due to T1 decay and other factors through amplitude normalization. This mitigated the
associated blurring artifact and improved spectra localization. Global first order and local
zero order phase corrections were applied to the real part of the spectra in each voxel,
followed by a 4th order polynomial baseline correction. For each spectrum, the pyruvate
peak was fit to a Lorentzian function. The linewidth and the chemical shift estimates were
used to fit individual Lorentzian functions to the metabolite peaks (lactate, pyruvate
hydrate, bicarbonate and alanine). Metabolite maps were generated by integrating the area
under the peak of the corresponding fit Lorentzian. Processed metabolite maps were
converted to DICOM format and overlaid on their corresponding proton images using
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OsiriX 7.1 (Pixmeo SARL, Switzerland). On average, 12 voxels covering the lungs were
manually selected from the MRSI/proton overlays, and average pyruvate and lactate values
for the lung were calculated. Average pulmonary lactate-to-pyruvate ratios were obtained
by dividing the average lactate and pyruvate signals obtained from the selected voxels. We
omitted quantification of alanine and bicarbonate metabolites in the lungs since their
intensities are too low for accurate quantification.
Average pulmonary pyruvate and lactate signals, lactate-to-pyruvate ratios and
pulmonary compliances were exported to R (R Development Core Team, 2005) for
statistical analysis. Mean values and standard errors of the pulmonary metabolite ratios and
pulmonary compliance at each time point were computed for each of the three study
cohorts. Two-way repeated ANOVA was used to test statistical significance between
pulmonary compliance and the average pulmonary lactate-to-pyruvate ratio among
different cohorts and injection times. Two-sample paired, two-tailed student’s t-tests were
used for post-hoc analysis of each cohort to identify statistical significance between
different injections. Two-sample unequal variance, two-tailed student’s t-tests were used
for each injection to assess statistical significance between the cohorts.

4.4. Results
Figure 4.3 shows representative spectroscopic images overlaid on the
corresponding proton images in healthy, injured-1 and injured-2 lungs. Edematous regions
are clearly visible in the posterior regions of the lungs in both injured-1 and injured-2 rats
(Figure 4.3.B-C). Panels D-I show the close-up view of the average of the spectra in the
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posterior and anterior voxels in the lungs outlined in 4.3.A-C for representative healthy,
injured-1 and injured-2 rats.
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Figure 4.3. Representative 13C MRSI overlay on 1H images in (A) healthy, (B) injured-1 and (C) injured-2
rats. The bottom panels show the close-up view of the average of spectra in the posterior (D, F, H) and
anterior voxels (E, G, I) outlined in (A-C) for healthy, injured-1 and injured-2 lungs. The pyruvate and lactate
signal in both anterior and posterior voxels of the control rat appear similar. In the injured-1 rat, the overall
pyruvate and lactate signal increased in the posterior voxels (F), while the lactate signal increased in the
interior voxels (G); the pyruvate signal increased significantly in the injured-2 rat in both areas (H, I). At the
same time, the linewidth in the injured-2 rat became narrower, likely due to the formation of edema and
consequent improvement in local field homogeneity.

The average pyruvate linewidth in the healthy, injured-1 and injured-2 lungs was
estimated (by the fit described in the methods section) to be 126±31Hz (2.5±0.6ppm),
97±41Hz (1.9±0.8ppm) and 57±12Hz (1.2±0.2ppm), respectively. Additionally, the
pyruvate signal in both visibly edematous and non-edematous regions of the injured-2 lung
increased post-injury relative to the signal in the heart, as shown in Figure 4.3.H-I. While
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the pyruvate signal seemed to increase only in the posterior region of the injured-1 lung
(Figure 4.3.F), the lactate signal increased in both anterior and posterior regions (Figure
4.3.F-G). Pyruvate and lactate signals are visually similar in anterior and posterior regions
of the control lung (Figure 4.3.D-E). The signal-to-noise ratio (SNR) of the pyruvate and
lactate peaks in the spectrum obtained by averaging over the lungs was 245±70 and 58±16
and 340±190 and 99±45 for healthy and injured animals, respectively. Similarly, the SNR
of pyruvate and lactate peaks in the individual voxels was 93±24 and 21±5 for healthy rats,
compared to 117±63 and 31±12 for injured rats.
Figure 4.4 shows representative pyruvate and lactate maps at 60 and 240 minutes
after the start of ventilation in control (left panel), injured-1 (middle panel) and injured-2
(right panel) rats. The pyruvate and lactate maps are superimposed on the corresponding
proton images and are scaled to their own maximum intensity (the color map represents
the intensity as a fraction of the maximum value in that image). The lactate and pyruvate
maps show the outline of the heart and the major vasculature in the lungs. In the control
rat, there is no significant change in the pyruvate and lactate maps at these time points,
indicating no detectable alteration in lung metabolism or perfusion. In the injured-1 animal,
the middle panel shows a significant increase in both lactate and pyruvate signals. The left
panel shows a similar pattern for the injured-2 rat; however, the pyruvate signal in the lungs
increased much more significantly relative to the heart.
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Figure 4.4. Representative pyruvate and lactate maps overlaid on their corresponding proton images. The
left panel shows a healthy rat 60 (baseline) and 240 (follow-up) minutes after the start of ventilation. The
middle and right panels show representative metabolite maps in injured-1 and injured-2 animals at the same
time points, before (baseline) and 240 minutes after (follow-up) acid aspiration injury. The color bar maps
the intensity of each metabolite image as a fraction of the maximum value in the same image.

Figure 4.5.A shows the average pulmonary lactate-to-pyruvate ratio measured for
each injection time point in all three cohorts. There was a statistically significant difference
in lactate-to-pyruvate ratio between the three groups (F2,36=17.34, p<0.005). Further post
hoc analysis revealed that there was no significant difference between the metabolite ratios
of the cohorts before HCl instillation, as illustrated in Figure 4.5.A. There was no observed
difference between the lactate-to-pyruvate ratio of the injured-1 and control cohorts at the
second injection (p=0.4), while the lactate-to-pyruvate ratio of the injured-2 cohort was
48% lower than that of the control group at this time point, although this difference did not
reach the level of statistical significance (p=0.06). The average lactate-to-pyruvate ratio of
the injured-1 cohort at the third injection time point was significantly higher than in both
healthy (p=0.005) and injured-2 (p<0.0001) cohorts, while this ratio was significantly
lower in the injured-2 cohort than in the control group (p=0.05) at the same time point.
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Figure 4.5. (A) Average pulmonary lactate-to-pyruvate ratio in control (white), injured-1 (light gray) and
injured-2 (dark gray) cohorts for all injections. Average (dark filled circles) and individual (gray hollow
circles) pulmonary lactate-to-pyruvate ratios in (B) control, (C) injured-1 and (D) injured-2 cohorts for all
three injections. (*** p<0.001, ** p <0.01, * p <0.05, † p <0.1)

Figures 4.5.B-D depict the evolution of the lactate-to-pyruvate ratio for each cohort
(mean and individual values) over time. Figure 4.5.B shows that the lactate-to-pyruvate
ratio of the control cohort remains unchanged. The lactate-to-pyruvate ratio of the injured1 cohort (Figure 4.5.C) does not differ significantly from baseline at the second injection
time point (~1 hour after the injury), but increases dramatically by the third injection time
point (~3 hours after the injury; p=0.002). The average lactate-to-pyruvate ratio of the
injured-2 cohort (Figure 4.5.D) continuously declines relative to baseline (p=0.18 at the
second injection time point, and p=0.08 at the third).
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Figures 4.6.A and 4.6.B depict the average pyruvate and lactate signal intensities
for all three cohorts at different time points. The intensities reported are normalized to the
last solid-state NMR signal level measured by the polarizer’s polarimeter to account for
variability in sample composition, freezing dynamics and polarizer operation. Figure 4.A
shows that the average pyruvate signal in the injured-2 cohort is larger than in the healthy
and injured-1 cohorts, although the variability of the absolute signal is large enough that
this difference did not reach the level of significance (F2,36= 2.25, p=0.12). Figure 4.6.B
shows that the absolute lactate signal of the injured-1 rats is larger than that of the other
cohorts at the third injection time-point. There was no significant difference among the
cohorts’ absolute lactate signals at any injection time point (F2,36= 2.78, p=0.18).

Figure 4.6. Average (A) pyruvate and (B) lactate signals, corrected for solid-state polarization levels, for all
three cohorts at all three injections.

Figure 4.7.A shows the average pulmonary compliance for all three cohorts before
each injection. There was significant difference in compliance between the three groups
(F2,36=56.12, p<0.0001). Further post-hoc analysis showed that there was no significant
difference in pulmonary compliance between the three cohorts before HCl instillation prior
to the first injection time point at 60 minutes. Compliance was significantly lower in both
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injured cohorts before the second and third injections compared to the control group
(p<0.01). There was no significant difference in compliance between the injured cohorts
before the second (p=0.76) and third (p=0.16) injection time points.
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Figure 4.7. (A) Average pulmonary compliance in control (white), injured-1 (light gray) and injured-2 (dark
gray) cohorts for all injection time points. Average (dark filled circles) and individual (gray hollow circles)
pulmonary compliance in (B) control, (C) injured-1 and (D) injured-2 cohorts for all injections. (**** p
<0.0001, *** p <0.001, ** p <0.01, * p <0.05)

Figures 4.7.B-D depict the evolution of compliance for each cohort (mean and
individual values) before each injection time point. Figures 4.7.C and 4.7.D show that
pulmonary compliance had decreased significantly from the baseline value in both injured
cohorts at the second injection time point (p<0.005), and decreased even further by the
time of the third injection (p<0.05).
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The lactate-to-pyruvate ratios vs. pulmonary compliance for each animal in all three
cohorts at the three injection time points are plotted in Figures 4.8.A-C. The inner ellipses
represent the 95% confidence interval of each cohort and show no segregation among the
cohorts after the first injection. On the other hand, there is partial and complete delineation
of all three cohorts at the second and third injections, respectively.
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Figure 4.8. Lactate-to-pyruvate vs. pulmonary compliance for control (circles), injured-2 (triangles) and
injured-2 (crosses) cohorts at the first (A), second (B) and third (C) injection time points. Inner and outer
ellipses represent 95% and 99% confidence intervals, respectively.

4.5. Discussion
We report enhanced lactate and pyruvate signal in the lungs after injury. In lungs
instilled with 1ml/kg HCl, we observed a significant increase in the lactate-to-pyruvate
ratio 3 hours after the injury. In contrast, we found a progressive decrease in the lactate-topyruvate ratio starting one hour after injury in lungs instilled with 2ml/kg HCl—likely due
to greatly increased pyruvate levels in the hyperperfused lungs, as seen in Figures 4.3 and
4.4. This supposition is supported by earlier findings that showed an increase in both lung
permeability index12 and pulmonary blood flow in injured lungs using PET13. Despite
significant variability among the different cohorts’ lactate-to-pyruvate ratio trends during
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injury progression, a combination of lactate-to-pyruvate ratio and lung compliance
provides a reliable means for separating the cohorts at the third injection time point.
Declining pulmonary compliance (Figure 4.7) is a clinically relevant indicator of
lung injury14, and results from an accumulation of excess fluid in the extracellular matrix
and thickening of the alveolar walls associated with edema and inflammation11. The
significant decrease in lung compliance observed within the first hour (Figure 4.7) is due
to the reduced airspace volume arising from both the initial acid delivery and the
subsequent collection of fluid in the lungs at the onset of acute injury12. Although no
significant difference in lung compliance was observed between the injured-1 and injured2 cohorts within the first hour, injury exacerbation in both injured groups is evidenced by
the significant decline in pulmonary compliance between the second and third injection
time points (Figures 4.7.C and 4.7.D), suggesting both further thickening of the alveolar
walls and progression of inflammation12. This observation is also consistent with
hyperpolarized
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Xe studies showing alveolar wall thickening in the presence of

inflammation15,16.
Elevated lactate signal post-injury is visible in Figure 4.6, and is likely due to
infiltration of metabolically active neutrophils into the lungs, which is known to be a
consequence of the early stages of an innate inflammatory response1,17, although local
hypoxia in edematous regions could also have contributed to this increase. The observed
lactate elevation had a prominent dependent (dorsal) distribution, which can be explained
by multiple factors: first, the model included HCl injection in the supine position, which
likely favored a dorsal distribution of the early lesions, as shown in our published studies10;
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second, dorsal hyper-perfusion is characteristic of acute lung injury18 and is likely to
preferentially increase neutrophil density and extravasation in these areas19; it is also likely
that a higher tissue density due to atelectasis and edema accumulation increased both
lactate and pyruvate signal in the dorsal regions, as images were not normalized for proton
density; lastly, incomplete recruitment of atelectatic regions during mechanical ventilation
worsens injury, despite the use of relatively high PEEP and low tidal volume to minimize
both atelectasis and ventilator-induced stress19,20. This is evident in the significant decline
in compliance between the second and third injection time points in both injured cohorts.
Quantifying the absolute concentration of metabolites (lactate, pyruvate, etc.) from
the intensity of their corresponding signals is not trivial given the variability in polarization
levels and experimental setup. This difficulty is evident in Figure 4.6, which exhibits a
large variability in the absolute signal level of both pyruvate and lactate species. To reduce
this sensitivity to experimental and physiological conditions, the lactate-to-pyruvate ratio
can be used instead to highlight increased glycolytic activity21—an expected feature that
has been previously demonstrated under the conditions of anaerobic metabolism and
inflammatory cell recruitment found in acute injury19,22-25. The significant increase in
lactate-to-pyruvate ratio observed at the third injection time point in the injured-1 cohort
(Figure 4.6.A) can therefore serve as a surrogate for increased glycolytic activity. On the
other hand, the decreased lactate-to-pyruvate ratio observed post-injury in the injured-2
rats is at odds with the observed regional lactate elevation. To explain this discrepancy, we
postulate that locally increased pyruvate concentration, rather than decreased lactate
production, was responsible for the low lactate-to-pyruvate ratio in severely injured rats.
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The increased pyruvate concentration is due to the retention of hyperpolarized pyruvate in
the extracellular space of edematous lungs13.
Figure 4.6.A depicts this time-dependent increase in the average pyruvate signal
for the injured-2 cohort. Despite the increased availability of hyperpolarized pyruvate, its
uptake at the super-physiological concentrations achieved with our injection protocol is
limited by monocarboxylate transporter capacity26,27, while conversion to lactate is limited
by lactate dehydrogenase enzyme turnover and the rate at which the cofactor nicotinamide
adenine dinucleotide (NADH) can be regenerated26. As a consequence, the presence of
excess pyruvate in the lung tissue does not cause a proportional increase in the lactate
signal. Further, the excessive accumulation of extracellular fluid in severe lung injury leads
to regions of low cellular density in which pyruvate may also accumulate, but metabolism
is limited by large diffusion distances that limit the delivery and transport of pyruvate into
the cells11,28.
The discrepancy between the time dependence of the lactate-to-pyruvate ratio in
the injured cohorts thus complicates its interpretation as a single marker to assess the
progression of pulmonary injury and development of inflammation. On the other hand,
Figure 4.7 illustrates the fact that, despite the difference between injured cohorts in the
amount of HCl instilled, there was no significant difference between the average
pulmonary compliance—which declined significantly throughout the course of injury,
regardless of severity. The difference between compliance in injured compared to healthy
animals, as well as the significant difference in lactate-to-pyruvate ratio among the three
cohorts at the third injection time point (Figure 4.6.A), suggest that the combination of
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lactate-to-pyruvate and compliance may enable us to better characterize the type and
severity of the initial lung injury. Figure 4.8.A shows great overlap among the 95%
confidence regions of all three cohorts on the lactate-to-pyruvate vs. compliance graph at
the first injection time point, indicating no statistically significant difference between
cohorts. As the injury progresses, however, each cohort follows a different trajectory, such
that there is remarkable separation between the confidence regions of each cohort at the
third injection time point. This suggests that the lactate-to-pyruvate ratio provides
information on the cellularity of the perfused lung volume, without which ambiguity may
arise from changes in pulmonary physiology and perfusion over the course of injury
progression.
In general, metabolic imaging of the lungs is challenging due to severe B0
inhomogeneity, low tissue density and the lung’s modest overall energy needs, all of which
limit both the achievable SNR and the suitability of rapid pulse sequences that have proven
useful for imaging other organs. Despite these limitations, we were able to generate
pyruvate and lactate maps with high SNR in order to quantify average metabolic changes
in pulmonary tissue in the presence of acute lung injury. While Figure 4.3 suggests that the
FID-CSI pulse sequence is capable of visualizing metabolic heterogeneity across the lungs
with sufficiently high SNR and modest spatial resolution, its utility for accurately
quantifying regional lactate-to-pyruvate ratio may be limited. This is primarily due to the
sequence’s long scan time and its susceptibility to artifacts caused by cardiac motion and
blood flow—challenges that may be partially addressed in the future by adding flow
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suppression gradients29. Alternatively, rapid high resolution pulse sequences designed
specifically for lung spectroscopy can be developed30.

4.6. Application for Lung Cancer Imaging
While the focus of this project was to develop a methodology for imaging
alterations in pulmonary metabolism using hyperpolarized

13

C, this method can be

extended to the study of a variety of lung pathologies. For example, tumors cells have a
significantly different metabolic profile compared to healthy tissues, including the
significantly increased glycolytic activity which makes the use of 18F-FDG-PET imaging
relevant for lung cancer screening31,32. Unfortunately, repeated PET scans for staging and
monitoring tumor response to treatment expose patients to hazardous ionizing radiation.
However, in addition to higher glucose uptake, tumor cells also preferentially
convert pyruvate to lactate at a significantly higher rate even in the presence of oxygen.
This phenomenon is known as the Warburg effect33-35, and means that hyperpolarized 13C
MRI can potentially be used to detect and monitor tumors by highlighting regions with
high pyruvate to lactate conversion without exposing the patient to hazardous radiation.

4.6.1. Cancer Induction, 1H and 13C Imaging Protocols
To test the feasibility of our method for lung cancer imaging, we induced lung
tumors in C57BL/6 mice as previously described36. Mice were anesthetized with isoflurane
(3% during the preparation and 1.5% during imagining) mixed with 100% oxygen. A oneinch 26-gauge catheter (BD, Franklin Lakes, NJ) was inserted into the tail-vein. A 60-cm
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polyurethane catheter (SAI Infusion Technologies, Lake Villa, IL) was threaded into this
catheter for administration of the hyperpolarized agent into the tail vein. The small gap
between the 26-gauge catheter and the 60-cm line was sealed using UHU Tac adhesive
putty (Saunders Mfg. Co. Readfield, ME). Respiration was recorded using a respiratory
cushion positioned on the abdomen and the body temperature was monitored using a rectal
thermometer (Small Animal Instruments, Inc., Stony Brook, NY). The animal’s
temperature adjusted using warm water circulating through the gradient insert (Bruker
Biospin, Rheinstetten, Germany).
Mice were scanned in a 9.4T Avance III vertical wide-bore (89mm) micro-imaging
MRI system (Bruker Inc., Rheinstetten, Germany) using a dual-tuned 1H/13C resonator
(Bruker Inc., Rheinstetten, Germany). Axial T2-weighted images were acquired using a
dual-echo respiratory-gated multi-slice fast-spin echo (FSE) pulse sequence with the
following parameters: TR/TE1/TE2 = 570/2.1/10.2ms, echo-train length (ETL) = 4,
192×192 matrix size, 30×30mm2 FOV, 500kHz bandwidth and 8 averages. A total of
sixteen 0.8 mm-thick slices were acquired to cover the lungs. [1-13C] pyruvate samples
were polarized and administered into the tail-vein as described in sections 4.3.2 and 4.2.
respectively. 13C Imaging was performed using the FID-CSI sequence with the parameters
listed in Table 4.1. Finally, the data was processed using custom routines in MATALB
2018b as described in section 4.3.4
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4.6.2. Cancer Imaging Results and Discussion
Figure 4.9 shows the T2-weighted image,

13

C spectroscopic image and

corresponding pyruvate and lactate maps overlaid on the T2 scan acquired from a mouse
three weeks after cancer-induction in the left lung. Elevated lactate signal is co-localized
with the tumors (white arrows) in two locations: over the primary tumor in the lung, as
well as over the secondary tumor protruding out of the thoracic cavity. The right panel
shows the spectrum averaged over the healthy lung tissue (voxel A), primary lung cancer
(voxel B) and a secondary tumor (voxel C). The lactate-to-pyruvate ratio derived from
these spectra is elevated in the tumor (0.82 for the primary, 2.63 for the secondary tumor)
relative to the adjacent normal lung tissue (Lactate-to-Pyruvate = 0.32).
Figure 4.10 shows the pyruvate and lactate maps overlaid on the T2-weighted
proton images in four mice with different presentations of cancer.
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Figure 4.9. T2-weighted axial scan over the lungs, showing the primary tumor as well as a secondary tumor
protruding out of the thoracic cavity. Metabolite maps are overlaid on the T2 scan, and the lactate map shows
enhanced lactate signal over both primary and secondary tumors (white arrows). 13C spectra averaged over
the non-cancerous lung tissue next to the tumor (A), the primary tumor (B) and the secondary tumor (C) are
shown on the right. The spectra show elevated lactate-to-pyruvate ratio over the tumors relative to the healthy
lung tissue.
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Figure 4.10. Pyruvate and lactate maps overlaid on the corresponding T2-weighted axial scans over the lungs
in four mice with different presentations of lung tumor. The white arrow shows regions with elevated lactate
signal that are colocalized with the lung tumors.
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The mouse in Figure 4.9.A was imaged 4 weeks after the tumor induction and had
only two 3mm on the posterior left side of the left ventricle. The lactate signal is higher in
the vessels and the heart; however, the elevated lactate signal extends over the tumors
(white arrow) as well. Figure 4.9.B shows another mouse with several sub-millimeter
nodules in the right posterior lung (white arrow). The lactate signal is also noticeably
elevated with respect to the background signal in healthy lung tissue. Figure 4.9.C shows
a mouse six weeks after tumor induction with several 3-7mm tumors primarily in the right
lung. Similarly, the lactate signal is elevated over these regions but is lower in the posterior
left region of the lung where no tumors are present. Lastly, Figure 4.9.D shows a severe
case imaged 8 weeks after tumor induction where tumors had grown to cover the entire
right lung and the posterior left lung. The lactate signal in this case was globally elevated
across the lungs and the posterior muscles.
Our results suggest that hyperpolarized 13C MRI has the capacity to metabolically
differentiate tumors from neighboring non-cancerous lung tissue. Furthermore, it may
provide additional information for tumor staging. In future studies, we intend to further
validate the application of hyperpolarized 13C MRI for tumor staging and to investigate its
potential to monitor response to treatment.

4.7. Conclusion
The results of aim I suggest that hyperpolarized [1-13C] pyruvate imaging can detect
differences in the conversion of pyruvate to lactate in the presence of acute lung injury,
and that lactate-to-pyruvate ratio can be used as a marker of lung injury progression in
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certain cases. This technique is also capable of showing increased metabolic activity in
other lung pathologies such as lung cancer. While the sequence is limited by its long scan
time and susceptibility to artifacts caused by cardiac motion and blood flow, it is
nevertheless capable of visualizing metabolic heterogeneity across the lungs with
sufficiently high SNR and adequate spatial resolution.
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Chapter 5: Impact of Positive-End Expiratory Pressure on Lung Metabolism

This chapter has been adapted from the published article, Pourfathi et al. ‘Lung Metabolism and Inflammation
during Mechanical Ventilation; An Imaging Approach’ in Scientific Reports 8, Article Number: 3525 (2018)

5.1. Introduction
To minimize the progression of lung injury and inflammation and to reduce
secondary lung injury due to inspiratory stretch, ARDS/ALI patients are managed in the
ICU through protective ventilation with low tidal volumes (VT) and positive-end expiratory
pressure (PEEP)2,4 (section 3.3.2). Although this strategy has been shown to decrease
mortality in more severe ARDS patients5-7, regional tissue stress due to poorly recruited
atelectasis also has the potential to worsen injury during ventilation4,8. What is more, the
effects of atelectasis and alveolar recruitment on lung cellularity9, regional inflammation10
and lung metabolism11 are incompletely characterized.
Neutrophil recruitment and activation are pivotal in the trajectory of
ARDS/ALI12,13. In addition, positron emission tomography (PET) has shown increased 18Ffluorodeoxyglucose (18F-FDG) uptake in regions with inflammatory lesions in ARDS
patients11, indicating increased glycolysis in activated neutrophils14 (sections 3.3.3 and
3.3.4). Yet FDG-PET is unable to reveal the ultimate metabolic fate of glucose in the
injured lung. Increased trans-pulmonary blood lactate as a result of anaerobic metabolism
is correlated with lung injury severity, and is generally attributed to glucose uptake and
utilization by activated inflammatory infiltrates15,16. What is more, recent studies suggest
that locally elevated lactic acid concentrations might have a role in promoting biological
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processes in lung tissue such as fibrosis17. Therefore, tissue lactate mapping could be used
as both a topographic marker of injury severity and to monitor therapeutic response.
In the previous chapter, we demonstrated that hyperpolarized 13C MRI can detect
elevated lactate-to-pyruvate ratio in an experimental model of acute lung injury23. In this
chapter, we used hyperpolarized 13C MRI to assess the impact of recruiting atelectasis on
lung anaerobic metabolism during the early progression of lung injury. We tested the
hypothesis that recruitment contains anaerobic metabolism in the lung tissue by limiting
injury due to atelectasis. Lung mechanics, oxygenation and histological analysis of lung
sections supported this hypothesis, suggesting that the increased conversion of pyruvate to
lactate in the absence of PEEP is primarily the result of recruitment and activation of
neutrophils in the lungs.

5.2. Study Design and Methodology
Figure 5.1 shows the summary of the imaging experiments.

5.2.1. Animal preparation, Injury and Imaging Protocols
Twenty-one male Sprague Dawley rats (306±10g, 8-10 weeks old) were used for
this study (7 sham, 14 injured). Animals were prepared and placed in the MRI system as
described in section 4.3.1. All animal procedures were approved by the Institutional
Animal Care and Use Committee (IUCAC) of the University of Pennsylvania
(Philadelphia, PA) and were performed in accordance with relevant guidelines and
regulations. All rats were diet-restricted to water only for 12 hours before the procedure in
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order to reduce inter-subject metabolic variability44. All animals received IV hydration (3
ml.kg-1.hr-1).

Figure 5.1. Summary of hyperpolarized

13

C imaging studies. A healthy baseline

13

C image was initially

acquired. Rats received 0.5ml/kg of either hydrochloric acid (N=14) or saline (N=7) 10 minutes after the
baseline scan; positive-end expiratory pressure (PEEP) was then immediately increased to 10 cmH2O during
a 10-minute stabilization period before being lowered back to 5 cmH2O. The first follow-up 13C image was
acquired 1 hour after instillation. PEEP was then lowered to 0 cmH2O in all rats receiving saline (Sham
group) and in seven injured rats (ZEEP group). Subsequent 13C images were acquired 2.5 and 4 hours after
acid/saline instillation. (Note that four animals from the ZEEP group did not receive the third injection.
Statistics are corrected for the unbalanced data.)
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Rats were ventilated using a small animal ventilator (VentElite, Harvard Apparatus,
Holliston, MA) in the supine position (FiO2 1.0, VT 8ml/kg, PEEP 5 cmH2O, Frequency
52 min-1). The ventilator embedded a sigh breath of 120% tidal volume every ten breaths
to prevent atelectasis. Airway pressure was monitored using an MR-compatible fiber-optic
pressure sensor (FPI-HS, FISO, Quebec, QC). After healthy baseline imaging, primary
lung injury was induced in 14 animals via intratracheal instillation of 0.5 ml/kg
hydrochloric acid (HCl, pH 1.25). HCl was injected in two equal aliquots, with 45o head
elevation and the animal in the right and left lateral positions, respectively. 7 sham rats
received 0.5 ml/kg saline in a similar manner. Mechanical ventilation was resumed
immediately after acid/saline instillation; for all animals, PEEP was set at 10 cmH2O for
10 minutes to allow the animals to stabilize and then returned to 5 cmH2O. 7 animals with
lung injury (PEEP group) remained on this ventilator setting until the end of the experiment
(PEEP group). PEEP was reduced to 0 cmH2O in the remaining seven injured animals
(ZEEP group) and in the sham group 1 hour after acid/saline instillation.
Pyruvate samples were prepared and polarized as described in section 5.3.2. Solidstate polarization was estimated to be 28±3% for the studies based on the solid-state buildup curve and separate measurements. 4 ml/kg of the sample was administered through the
tail vein as described in section 5.3.2. Proton and 13C imaging were performed as described
in section 5.3.3. Spectroscopic data were analyzed, and lactate-to-pyruvate ratios were
derived as described in section 5.3.4. Regional metabolism was quantified by manually
selecting approximately 5 voxels from four different lung quadrants (posterior/anterior and
left/right).
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5.2.2. Immunohistochemistry
Animals were euthanized and lungs were fixed in 10% formalin at 20 cmH2O
pressure for 24 hours. Lungs were then excised, sliced in axial plane, immunostained with
hematoxylin and eosin (H&E), and assessed for injury by a pathologist. Each axial plane
representing the whole lung was computationally sectioned into 10 pieces, and sections
were examined at 20X. Injury was assessed by a combination of infiltration (scale of 0-2:
0=no infiltrate, 1=infiltrate in the perivascular compartment, 2=infiltrate in alveolar
compartment), alveolar structure disruption (scale of 0-3: 0=regular, 1=distorted,
2=collapsed with torn capillary–alveolar membrane, 3=collapsed with opacity), hyaline
membrane (scale of 0-5: 0=None, 1=detected in 1 or 2 areas, 2=present in 3 or 4 areas,
3=present in 5 or 6 areas, 4=present in 7 or 8 areas and 5=present in 9 or 10 areas) and
edema (scale of 0-3: 0=regular alveolus, 1=slight thickening and 2-3=dilated vessels in
alveolar walls and proteinaceous material in alveolus). Additional slices were obtained to
assess the expression of intercellular adhesion molecule-1 (ICAM-1) and myeloperoxidase
(MPO), as reported earlier45: briefly, the paraffinized sections were deparaffinized in
xylene and, after sequential ethanol and PBS wash, were immunostained with ICAM-1 and
MPO primary antibodies with reactivity to rat species. The secondary antibodies used to
measure the expression of ICAM-1 and MPO were a goat anti-mouse Alexa 488 (green)
and goat anti-rabbit Alexa 594 (red), respectively, which measure inflammation and
neutrophilic binding and activity in the lung tissue46,47. Fluorescence imaging was
performed using a Nikon fluorescence microscope (Nikon Diaphot TMD, Melville, NY).
Images were acquired at excitations of 488 nm (for ICAM-1) and 594 nm (for MPO). All
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images were acquired at the same exposure settings (100ms). ICAM-1 expression was
quantified by integrating the fluorescence along the endothelial layer48. MPO expression
was quantified by integrating the intensity of fluorescence across the entire field. At least
3-4 fields were imaged for each rat lung section, and the data was quantified over these
fields. All quantifications were performed using Metamorph (Molecular Devices,
Downingtown PA) and ImageJ software (NIH).

5.2.3. Statistical Analysis
Statistical analyses were performed using “R” (R Foundation for Statistical
Computing, Austria, available at: http://www.R-project.org). Normality tests were
performed using the Shapiro-Wilk test. Average lactate-to-pyruvate ratio and pulmonary
compliance data were transformed to follow normal distributions via logarithmic and
quadratic transformations, respectively. Statistical significance among injections and
cohorts was tested using a two-way analysis-of-variance (ANOVA). Statistical
significance among groups was subsequently tested using a one-way ANOVA at each
injection time point. Discrimination among the ICAM-1 fluorescence was measured using
a one-way ANOVA. Post-hoc analysis was performed using Tukey’s honest significance
test. When ANOVA conditions were not met (for SpO2, MPO and H&E histology scores),
a Kruskal-Wallis test followed by a Wilcoxon signed-rank post-hoc test was used. a=0.05
was considered statistically significant. Holm-Bonferroni correction was applied when
necessary. All data were expressed as mean±SEM.
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5.3. Results
Figure 5.2. shows representative anatomical and interpolated metabolic images at
the first and last time-points for all three groups. The pyruvate signal did not significantly
change over time in any of the groups and was at its most intense in the major vasculature
close to the heart. Lactate signal intensity remained stable over time in both sham and PEEP
rats. In contrast, we observed time-dependent increases of both lactate signal in posterior
lung regions in the ZEEP (zero-end expiratory pressure) group, which were co-localized
with increased proton signal intensity. Although less pronounced, we also observed a
gradual increase in the lactate-to-pyruvate ratio map in the central and anterior lung in
ZEEP rats.

Figure 5.2. Representative pyruvate and lactate maps overlaid on their corresponding proton images. The
left panels show the images acquired at healthy baseline and 4 hours after acid/saline instillation in a sham
rat. The middle and right panels show similar maps for the PEEP and ZEEP rats. Note the dramatic increase
in lactate signal in the ZEEP rat 4 hours after acid instillation. For display, the pyruvate and lactate maps are
normalized to their own maximum intensity for each pulmonary map.
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Figure 5.3.A shows representative pyruvate, lactate and lactate-to-pyruvate ratio maps
overlaid on their corresponding anatomical image obtained 4 hours after acid instillation
in a ZEEP rat, with local injury in posterior left lung. The maps were segmented over the
lungs to better visualize the regional changes in the pulmonary pyruvate, lactate and
lactate-to-pyruvate ratio. Pyruvate signal intensity was similar in both lungs. However, the
lactate signal intensity and the lactate-to-pyruvate ratio were considerably higher the
posterior left lung where we observed increased proton signal intensity. Hematoxylin and
Eosin (H&E) stained axial lung section of the corresponding slice of the lung showed
presence of severe inflammatory injury and tissue damage predominantly in the posterior
left lung where our imaging showed elevated anaerobic metabolism (Figure 5.3.B-D).

Figure 5.4. (A) Pyruvate, lactate and lactate-to-pyruvate segmented maps overlaid on their corresponding
proton image of a ZEEP rat 4 hours after the acid instillation shows injury to the posterior right lung marked
by increased intensity in the proton image (white arrow). The metabolite maps show increased lactate signal
intensity and lactate-to-pyruvate ratio colocalized with the injured area. (B) Hematoxylin and Eosin (H&E)
axial slide of the whole lung clearly shows damaged lung tissue in the same area (black arrow). Magnified
images taken from the injured area (black box) with (C) 10´ and (D) 40´ magnifications show severe damage
and inflammatory infiltrates in the tissue. The bar in (C) is 100 µm.
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5.3.1. Global Assessment of Lung Metabolism and Function
Initial ANOVA of the average lactate-to-pyruvate ratio (Figure 5.4.A) showed
discrimination among groups (F2,74=8.242, p<0.001) and pyruvate injections (F3,74=7.023,
p<0.001). The post-hoc analysis is reported in Table 5.1: the average lactate-to-pyruvate
ratio was similar among groups at both healthy baseline and 1 hour after acid/saline
instillation, but was significantly different both 2.5 hours and 4 hours after instillation of
acid/saline. 2.5 hours after acid instillation, lactate-to-pyruvate ratio was significantly
higher in the ZEEP than in sham and PEEP groups, and these differences further increased
at 4 hours. There was no significant difference between the latter two groups at either 2.5
or 4 hours.
The initial ANOVA of compliance (Figure 5.4.B) and oxygen saturation (Figure
5.4.C) showed significant inter-group differences (Cdyn: F2,74=16.56, p<0.001 and SpO2:
c2(2) = 20.054, p<0.001). Post-hoc analysis is summarized in Table 5.1: Cdyn was also
significantly different among groups 1 hour, 2.5 hours and 4 hours after acid/saline
instillation. Cdyn declined in the injured rats 1 hour after acid instillation, and continued to
decline in the ZEEP group compared to sham and PEEP groups. Cdyn was not statistically
different between sham and PEEP rats during the rest of the experiment. SpO2 was similar
among all groups at healthy baseline and 1 hour after acid/saline instillation, but declined
over time in the ZEEP group while remaining unchanged in both sham and PEEP groups.
Groups were statistically different 4 hours after acid/saline instillation (c2(2) = 10.004,
p=0.006), with the ZEEP group having significantly lower oxygen saturation than sham
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(p=0.003) and PEEP (p=0.035) groups. PEEP and sham groups were not different
(p=0.804). Heart rate ranged between 350-400 beats-per-minute for all rats.
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Figure 5.4. (A) Average lactate-to-pyruvate ratio was significantly higher in the ZEEP group compared to
sham and PEEP groups 2.5 (p<0.01 for both comparisons) and 4 hours (p<0.001 for both comparisons) after
acid/saline instillation. There was no significant difference between the latter two groups at either 2.5 or 4
hours. (B) Pulmonary compliance (Cdyn) declined in the injured rats 1 hour after acid instillation, and
continued to decline in the ZEEP group compared to the sham and PEEP groups (p<0.001). Cdyn was not
statistically different between sham and PEEP rats during the rest of the experiment. (C) Oxygen saturation
(SpO2) was similar among all groups at healthy baseline and 1 hour after acid/saline instillation, but declined
over time in the ZEEP group while remaining unchanged in sham and PEEP groups. Groups were statistically
different 4 hours after acid/saline instillation (c2(2) = 10.004, p=0.006), with the ZEEP group having
significantly lower oxygen saturation than sham (p=0.003) and PEEP (p=0.035) groups, which did not differ
from one another (p=0.804). ($ p<0.1, * p<0.05, ** p <0.01, *** p <0.001), (1ZEEP vs. Sham, 2PEEP vs
Sham, 3PEEP vs. ZEEP). (Note that for lactate-to-pyruvate ratio at 2.5 hours, N=3 for the ZEEP group. For
all groups and all other time-points, N=7).

Oxygen saturation and pulmonary compliance were significantly and negatively
correlated with average lactate-to-pyruvate ratio (Figures 5.5.A-B, Table 5.2).
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Figure 5.5. Correlation between average lactate-to-pyruvate ratio and (A) pulmonary compliance (r=-0.581,
p<0.001) and (B) oxygen saturation (r=-0.687, p<0.001).

Table 5.1. Summary of post-hoc analysis performed using the Tukey honest significant difference test,
performed when the results of the one-way ANOVA test (with Bonferroni adjustment for four time points
aadj.=0.05/4 = 0.0125) for each time point was significant. Initial two-way ANOVA of the average lactateto-pyruvate ratio showed discrimination among groups (F2,74=8.242, p<0.001) and pyruvate injections
(F3,74=7.023, p<0.001). The average lactate-to-pyruvate ratio was similar among groups at both healthy
baseline (F2,18=0.648, p=0.535) and 1 hour after acid/saline instillation (F2,18=0.514, p=0.513), but was
significantly different both 2.5 hours (F2,14=8.843, p=0.003) and 4 hours (F2,14=5.533, p<0.001) after
instillation. The initial ANOVA of the pulmonary compliance (Cdyn) showed significant inter-group
difference (F2,74=16.56, p<0.001). Cdyn was also significantly different among groups 1 hour (F2,18=7.866,
p=0.003), 2.5 hours (F2,18=16.1, p<0.001) and 4 hours (F2,18=20.8, p<0.001) after acid/saline instillation. (#
Time from instillation of acid/saline).
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ZEEP - Sham
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Time
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2.5

-0.014
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4
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1
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-0.145, -0.067
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Pulmonary
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5.3.2. Correlation Between Imaging Markers and Biology
ZEEP lungs displayed evidence of lung injury (Figures 5.3 and 5.6), including
structural damage with edema and hyaline membrane on the alveolar wall; aggregates were
found in the alveoli, likely representing sloughed pneumocytes. Both ZEEP and PEEP
lungs had alveolar infiltrates. There was no evidence of injury in the sham lungs; alveoli
were lined with flattened healthy epithelial cells, and minimal inflammatory cells were
present. ANOVA showed a significant difference among groups (infiltration: c2(2)=
11.273, p=0.003, alveolar damage: c2(2)= 10.000, p=0.007, hyaline membrane deposition:
c2(2)= 10.678, p=0.005, and edema: c2(2)= 12.154, p=0.002). Infiltration (Figure 5.6.A)
and alveolar damage scores (Figure 5.6.B) were significantly higher in the ZEEP group
than in shams (p<0.05), while infiltration was significantly higher in the ZEEP group than
the PEEP group (p=0.035). Hyaline membrane deposition (Figure 5.6.B) and edema
severity (Figure 5.6.D) were both significantly higher in the ZEEP group compared to both
PEEP and sham groups (p<0.05). Injury scores for all morphological features were
positively correlated with average lactate-to-pyruvate ratio (Figures 5.6.E-H, Table 5.2).
However, this correlation did not reach the level of significance for infiltration and alveolar
damage scores.
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Figure 5.6. (Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each group.
Representative images shown are at 10´ and 40´. In ZEEP lungs, arrows show the presence of fluid within
the alveolar space; solid arrows delineate infiltrates and debris. In lungs subjected to PEEP, alveolar structure
is more intact; infiltrates are shown by solid arrows. The scale bar is 100 µm. (Middle) Average injury scores
for various morphological features for different groups. ANOVA showed a significant difference among
groups (infiltration: c2(2)= 11.273, p=0.003, alveolar damage: c2(2)= 10.000, p=0.007, hyaline membrane
deposition: c2(2)= 10.678, p=0.005 and edema: c2(2)= 12.154, p=0.002). Infiltration (A) and alveolar damage
scores (B) were significantly higher in the ZEEP group than in the sham group (p=0.001, p=0.012), while
infiltration was significantly higher in the ZEEP group than the PEEP group (p=0.035). Hyaline membrane
deposition (C) and edema severity (D) were both significantly higher in the ZEEP group relative to both
PEEP (p=0.048, p=0.041) and sham (p=0.014, p=0.006) groups. (Bottom) Among the histological features,
hyaline membrane deposition (r=0.612, p=0.003) (G) and edema severity (r=0.663, p=0.001) (H) were
strongly correlated with lactate-to-pyruvate ratio. (* p<0.05, ** p <0.01, *** p <0.001).
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ICAM-1 expression (Figure 5.7.A) was significantly different among groups (F2,18= 37.76,
p<0.001), and was significantly higher in the ZEEP group compared to PEEP and sham
groups (p=0.002). ICAM-1 expression was strongly correlated with the average lactate-topyruvate ratio measured 4 hours after acid/saline instillation (Figure 5.7.B, Table 5.2).
MPO expression was also significantly different (Figure 5.7.C) between groups (c2(2)=
16.416, p<0.001): the measured activity was significantly higher in the ZEEP group
compared to PEEP and sham groups (p=0.002), and was strongly correlated with average
lactate-to-pyruvate (Figure 5.7.D, Table 5.2). Activity was also significantly different
between PEEP and sham groups (p=0.004).

Table 5.2. Pearson correlation coefficients between the global lactate-to-pyruvate ratio and other
experimental parameters. Pulmonary compliance and oxygen saturation were measured at the beginning of
13

C imaging. Histological features were only correlated with the last imaging time-point. Bonferroni

correction was applied for 8 univariate correlation tests (significance for adjusted aadj.=0.05/8 = 0.00625).
Correlation Between Lactate-to-Pyruvate Ratio and Other Parameters

Final imaging data only

Parameter

r

95% C.I.

Pulmonary Compliance

-0.581

-0.709, -0.413

<0.001*

Oxygen Saturation

-0.687

-0.789, -0.553

<0.001*

Infiltration Score

0.509

0.100, 0.771

0.018

Alveolar Structure Damage

0.485

0.068, 0.758

0.025

Hyaline Membrane Score

0.612

0.245, 0.825

0.003*

Edema Score

0.663

0.325, 0.851

0.001*

ICAM-1 Expression

0.782

0.529, 0.907

<0.001*

Myeloperoxidase Activity

0.817

0.589, 0.921

<0.001*
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Figure 5.7. (Top) ICAM-1 expression in lung sections measured by fluorescence microscopy (40´
magnification). Green fluorescence denotes ICAM-1 expression, which is higher in the ZEEP group in
response to inflammatory stimuli. Additionally, the green fluorescence is higher along the endothelial layer
that lines the vessels (indicated by white arrows (V)). (Middle) MPO expression in the lung sections
measured by fluorescence microscopy (40´ magnification). Red fluorescence denotes higher MPO
expression, which is similar in both sham and PEEP lungs, but much higher in ZEEP lungs. The white arrows
illustrate the punctate staining from neutrophils. The phase images for the same sections show the structure
of the lung tissue. The scale bar is 50 µm. (Bottom) ICAM-1 expression was significantly different among
groups (F2,18= 37.76, p<0.001), and was significantly higher in the ZEEP group relative to PEEP (p=0.002)
and sham (p=0.002) groups (A). ICAM-1 expression was strongly correlated with the average lactate-topyruvate ratio measured 4 hours after acid/saline instillation (r=0.782, p<0.001) (B). There was significantly
different MPO expression among groups (c2(2)= 16.416, p<0.001); the measured activity was significantly
higher in the ZEEP group compared to PEEP (p=0.002) and sham (p=0.002) groups (C), and was strongly
correlated with average lactate-to-pyruvate (r=0.817, p<0.001) (D). The activity was also significantly
different between PEEP and sham groups (p=0.004). (** p<0.01, *** p <0.001).
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5.3.3. Regional Analysis of Lung Metabolism
At baseline, lactate-to-pyruvate ratio was similar in all regions (Figures 5.8) and followed
the same trend as the global lactate-to-pyruvate ratio shown in Figure 5.3.A: while it
remained unchanged in both sham and PEEP groups, it increased 2.5 hours after acid
instillation in the ZEEP group. This ratio further increased 4 hours after acid instillation in
the posterior regions (Figures 5.8.B and 5.8.D), but remained unchanged in the anterior
regions (Figures 5.8.A. and 5.8.C). There was no apparent difference between left and right
sides. The lactate-to-pyruvate ratio measured over myocardium and cardiac chambers was
similar among groups and remained unchanged over time (Figure 5.8.E).

AR
PR

AL
PL

Figure 5.8. The right panel shows a selection of the voxels in the hyperpolarized 13C spectroscopic image
overlay. Lactate-to-pyruvate ratio was similar at baseline in all regions across all groups, and increases 2.5
hours after acid instillation in all lung regions in ZEEP rats. The ratio continues to increase in the posterior
region on both sides 4 hours after acid instillation. The lactate-to-pyruvate ratio measured in the myocardium
and heart chambers remains unchanged over time in all groups (AL: anterior left, PL: posterior left, AR:
anterior right and PR: posterior right).
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5.4. Discussion
In this sub-aim, we assessed the impact of PEEP on lung metabolism during the
progression of experimental lung injury, showing that PEEP contains regional pulmonary
anaerobic metabolism (Figures 5.2 and 5.3.A and Table 5.1). In contrast, we observed a
progressive metabolic surge in the lungs when injured rats were ventilated without PEEP,
thereby permitting atelectasis. Ex-vivo histological and immunopathological assessment
also supported a link between anaerobic metabolism and inflammatory activation in the
lungs.
The investigation of altered pulmonary metabolism in the case of injury follows
upon several

18

F-FDG-PET studies showing increased glucose uptake in human and

experimental ARDS11,24,25. Lactate is a major product of glucose utilization in the lungs26,
and its increased production is an indication of lung injury severity in ARDS patients15.
hyperpolarized [1-13C] pyruvate MRI can measure regional lactate-to-pyruvate ratio, which
reflects the endogenous pool of non-polarized lactate in the lung tissue27, thereby
highlighting regional anaerobic glycolysis. Consequently, hyperpolarized [1-13C] pyruvate
MRI provides insight into lung bioenergetics that complements information gained with
18

F-FDG PET, and can obtain such metabolic information within minutes without exposing

patients to hazardous ionizing radiation. Perhaps most importantly, hyperpolarization lasts
for only minutes due irreversible T1 relaxation, which is significantly shorter than the halflife of 18F-FDG, which lasts for hours. As such, hyperpolarized [1-13C] pyruvate imaging
of the lungs may be repeated as frequently as desired to assess injury progression or
treatment response without the signal from different examinations performed within
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several of minutes interfering with one another. The latter is especially important in small
animal research, where lung injury progression occurs on a time scale that is significantly
shorter than in human patients.
Our findings in this study suggest a causal relationship between inflammation and
increased hyperpolarized lactate-to-pyruvate ratio, consistent with the link between
increased glycolysis and the recruitment and activation of neutrophils as part of an innate
inflammatory cascade proposed by previous FDG-PET studies14. However, other
mechanisms may also lead to increased lactate-to-pyruvate ratio—such as stabilization of
hypoxia-inducible factor 1-alpha (HIF1-a), a process which has been shown to occur
during lung injury as a mechanism to attenuate inflammation and which also leads to
elevated lactate dehydrogenase A (LDHA) expression in alveolar epithelial cells28.
Nevertheless, it is unlikely that this was the dominant source of pulmonary lactate
production in our study, as activated neutrophils are known to have significantly higher
glycolytic rates compared to their neighboring cells16,29. Hypoxemia also leads to an
increase in overall lactate levels in the blood and muscles16,30, and it is likely that regional
tissue hypoxia due to injury progression can lead to increased pulmonary anaerobic
metabolism. Again, however, it is unlikely that hypoxia was the main cause of increased
lactate-to-pyruvate ratio in our study: rats were not severely hypoxemic (SpO2>90%), and
lungs are known to release normal levels of lactate under such conditions31,32. Furthermore,
we did not observe any changes in cardiac metabolic activity (Figure 5.8) to suggest
absence of severe cardiac and systemic hypoxemia33. This may be due to the fact that the
small dose of HCl used in this study caused relatively mild pulmonary injury34. We further
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investigated the impact of hypoxia on lung metabolism using hyperpolarized 13C MRI in
chapter 6 with similar findings.
To determine the source of increased lactate-to-pyruvate ratio, we performed postmortem histology and immunopathology measurements in lung tissue (Figures 5.6 and 5.7,
Table 5.2). Overall, H&E staining showed the post-injury formation of hyaline membranes
and edema (Figure 5.6), which explains the trends of worsening lung mechanics
(compliance) and lower oxygenation (Figures 5.4.B-C and Table 5.1). The decline in both
compliance and oxygen saturation in the ZEEP group during ventilation confirmed in-vivo
progression of lung injury and atelectasis. Although compliance also declined over time in
sham lungs, this was likely due to atelectasis caused by the absence of PEEP, as we
previously documented in healthy lungs ventilated with similar settings35. However, the
decline in sham compliance was not as significant in this study, likely due the presence of
intermittent sigh breaths in our protocol36. Additionally, the H&E staining showed
widespread alveolar damage and influx of infiltrates into air spaces in both injured groups
(Figures 5.6.A-B).
We further investigated the inflammatory status in these lungs by monitoring
specific biomarkers of inflammation: the immunofluorescent staining patterns of the
intercellular adhesion molecule-1 (ICAM-1) along the pulmonary vessel endothelial layer,
and myeloperoxidases (MPO) in the entire lung section. While ICAM-1 is constitutively
expressed in the lungs, its endothelial expression was significantly higher in the ZEEP
group than in both PEEP and sham groups (Figure 5.7), indicating enhanced endothelial
activation facilitating neutrophilic transmigration across the endothelium in the absence of
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PEEP37,38. Similarly, the significantly higher MPO expression in ZEEP lungs compared to
PEEP and sham reflects enhanced endothelial activation39 and increased neutrophilic
activity in the underlying tissue38. The dramatic concomitant increase in lactate-topyruvate ratio in the ZEEP lungs (Table 5.1) and its strong correlation with the ICAM-1
and MPO activity (Table 5.2) suggests that enhanced glycolysis and anaerobic metabolism
in the absence of PEEP are associated with secondary inflammatory injury to the lungs.
Anaerobic metabolism was higher in the dependent (dorsal) regions of the ZEEP
lungs, where proton density images showed more prominent radiological infiltrates
(Figures 5.3.A and 5.8). Such gravitational distribution of the lactate signal suggests that
atelectasis is a key factor in the genesis of abnormal metabolism at ZEEP. Studies using
18

F-FDG-PET in ventilated animals have reported high FDG uptake in dependent lung

regions40 co-localized with atelectasis and inflammatory activation. In contrast, other small
animal10 and human studies11 found alveolar injury10 and accelerated glucose metabolism11
not in atelectatic tissue, but rather in non-dependent lung regions exposed to high
inspiratory stretch. The latter findings are not necessarily in discordance with our results,
however. In our previous work using hyperpolarized gas MRI in atelectasis-prone rat
models, we detected elevated inspiratory stretch of residual ventilated airspaces in lung
tissue with reduced gas content41,42, as well as higher stretch in dependent lung regions
with more atelectasis42. Although we did not perform hyperpolarized gas MRI in the
current study, the combined results of this and our previous work suggest that anaerobic
metabolism and inflammation in the absence of PEEP may have been the result of
augmented airspace stretch in lung regions with dependent atelectasis.
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5.5. Limitations
This study had a number of limitations. First, although the acid instillation model
recapitulates ARDS, it is characterized by an initial epithelial injury and increased capillary
permeability that is dependent on the instilled acid volume; while this is followed by a
secondary inflammatory response, the extent of direct, immediate inflammatory action is
minimized34. We limited direct injury in our model by instilling only 0.5ml/kg HCl, thereby
allowing us to study tissue with a preponderance of secondary inflammation, as it would
occur during ventilation with ARDS. Second, we chose to monitor dynamic compliance as
a measure of injury progression instead of static compliance. The former may be subject to
bias due to alterations in airway resistance and intrinsic PEEP (a result of gas-trapping in
the alveoli). However, previous studies showed this bias to be negligible41,42. The third
limitation is that quantification of the absolute concentration of metabolites using
hyperpolarized MRI is non-trivial, as the absolute signal level is subject to variability due
to polarization level and physiological conditions23. Although the use of hyperpolarized
lactate-to-pyruvate ratio as a surrogate for endogenous lactate concentration15 and
glycolysis18 can mitigate such variability, it can still be subject to bias caused by excess
fluid in the extracellular space resulting from capillary bed leakage25; the presence of such
excess fluid can increase pyruvate concentration or limit its uptake, thereby reducing the
lactate-to-pyruvate ratio and therefore the sensitivity of our method23. PET imaging studies
have addressed similar challenges by using compartment models to pinpoint the local
source of signal43. In the case of MRI, this bias may be corrected for by using rapid MRI
pulse sequences that allow the acquisition of multiple images to characterize metabolic flux
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in various tissues18. Finally, we only compared the averaged ICAM1 and MPO expression
across the lungs with average lactate-to-pyruvate ratio, since co-localizing the images with
histological slides proved prohibitively difficult. Although the expression of these
inflammatory markers is strongly correlated with global lactate-to-pyruvate, an even
stronger local relationship between anaerobic metabolism and inflammation may be
masked by a preponderance of non-injured lung regions.

5.6. Conclusion
In this sub-aim, we demonstrated the utility of hyperpolarized [1-13C] pyruvate
MRI for assessing the progression and resolution of pulmonary anaerobic metabolism in
an experimental model of aspiration pneumonitis; we showed that that PEEP contains
anaerobic metabolism and secondary inflammation during lung injury progression. In
contrast, in the absence of PEEP, we observed a substantial increase in anaerobic metabolic
activity associated with neutrophil recruitment and accumulation. Lastly, our findings
suggest a causal relationship between increased lactate-to-pyruvate ratio and the
progression of lung damage and inflammatory cascade during mechanical ventilation.
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Chapter 6: Impact of Hypoxia on Lung Metabolism

6.1. Introduction
Systemic hypoxemia is a clinical hallmark of lung injury which results from
impaired gas exchange1 and leads to increased anaerobic metabolism and overall lactate
levels in both blood and muscle tissue2,3. Hypoxia is also a prominent feature of
inflammatory pathology, as neutrophils’ increased metabolic demands reduce the
availability of metabolic substrates to the native cells4,5. In the case of the lung tissue,
however, several studies suggest that overall lung metabolism tolerates moderate
reductions of oxygen availability and continues to produce normal lactate levels6-9. Despite
this global tolerance, however, the local relationship between anaerobic metabolism and
regional hypoxia may be masked by a preponderance of well-aerated regions in the lungs.
In the previous chapter, we demonstrated hyperpolarized [1-13C] pyruvate
imaging’s ability to quantify in-vivo pyruvate-to-lactate metabolism in rat pulmonary tissue
with sufficient spatial resolution and SNR. We also showed the capacity of this novel
molecular imaging technology to monitor and highlight early metabolic changes in an
experimental rat model of aspiration pneumonitis followed by protective and nonprotective ventilation strategies: we observed a significant increase in pulmonary lactateto-pyruvate ratio during early lung injury progression, as well as contained anaerobic
metabolism in injured lungs subjected to protective ventilation using positive-end
expiratory pressure (PEEP).
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Further investigation revealed a strong correlation between increased lactate-topyruvate ratio and enhanced neutrophilic binding and activity in the lung tissue as
measured by the expression of intercellular adhesion molecule-1 (ICAM-1) and
myeloperoxidase activity (MPO) (Figure 5.4 and Table 5.2). While this finding suggests a
strong link between increased anaerobic activity and innate inflammatory cascade, it does
not definitively rule out the contribution of tissue hypoxia to this increased lactate-topyruvate ratio, as we observed a concomitant decrease in oxygen saturation during lung
injury progression.
In this study, we aimed to test our hypothesis that the previously-observed increase
in hyperpolarized lactate-to-pyruvate ratio in the lungs is predominantly due to the
presence and activity of inflammatory cells rather than hypoxia-induced metabolic shifts
in native cells during moderate hypoxia. We used hyperpolarized [1-13C] pyruvate MRI to
image rats ventilated with reduced oxygen (FiO2 <0.21) in order to induce moderate (SpO2
≈ 90%) and severe (SpO2 ≈ 75%) levels of hypoxia. Our imaging data showed a small
increase in the hyperpolarized lactate-to-pyruvate ratio in moderately hypoxic rat lungs,
while this ratio increased significantly in severely hypoxic rats. Histological analysis
revealed similarly low levels of alveolar infiltrates and damage to both control and sham
lungs. We also observed higher hyaline membrane deposition and edema in the hypoxic
lungs compared to healthy lungs, although this difference did not reach the level of
statistical significance. Lastly, we observed a significantly higher concentration of
systemic arterial lactate in severely hypoxic animals compared to both moderately hypoxic
and control animals.
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The imaging data obtained from the injured animals presented in the previous
chapter showed that animals with progressive lung injury were moderately hypoxic and
had similar levels of oxygen saturation to the non-injured, moderately hypoxic group
presented in this chapter. However, the hyperpolarized lactate-to-pyruvate ratio only
increased significantly in the lungs of injured animals. This study further elucidated the
source of increased hyperpolarized lactate-to-pyruvate ratio in the lungs during the
progression of acute lung injury, suggesting a causal relationship between the
inflammatory injury and the increased anaerobic glycolysis in the lungs.

6.2. Study Design and Methodology
A summary of the experiment is presented in Figure 6.1.

6.2.1. Animal Preparation, Imaging and Hypoxia Protocol
A total of twenty-six Sprague Dawley rats were used for this study. Animals were
prepared, administered [1-13C] pyruvate samples and imaged as described in Sections 4.3.1
and 4.3.2. An arterial line was placed into either the ventral or tail artery to collect arterial
blood samples (100µL per sample) for arterial blood gas (ABG) analysis using an EPOC
blood analysis device (Epocal Inc., Ottawa ON). We compared the arterial lactate
concentration in various groups to assess the systemic changes in overall glycolysis as a
consequence of hypoxemia.
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Figure 6.1. Summary of hyperpolarized 13C imaging studies. Arterial blood gases (ABG) were obtained first.
A healthy baseline 13C image was initially acquired. Fraction of inspired oxygen (FiO2) was reduced to 0.17
(N=8) and 0.1 (N=8) to induce moderate and severe hypoxia, respectively, throughout the rest of the
experiment. Follow-up 13C images were acquired after 1 hour, 2.5 and 4 hours.

After a baseline ABG and MRI, ten control rats remained ventilated with the same
parameters. We chose the timing of the [1-13C] pyruvate imaging and hypoxia based on the
lung injury study presented in chapter 5 such that hypoxia started immediately after the
baseline 13C hyperpolarized-MR images were acquired. We induced moderate hypoxia in
eight rats (Hyp90) by reducing the FiO2 to ~0.17 until a stable SpO2 ≈ 90% was achieved.
We chose the oxygen saturation level based on the average oxygen saturation measured
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chapter 5 ZEEP rats (Figure 5.3.C) in which injury progressed. In the remaining eight rats
(Hyp75), we induced severe hypoxia by reducing the FiO2 to ~0.1 until a stable SpO2 ≈ 75%
was achieved and performed follow-up hyperpolarized pyruvate MRI scans. After the final
scan, arterial blood gas was collected from 11 rats, ABG analysis was performed, and the
lungs were excised for immunohistochemistry as described in section 5.2.2. Statistical
analysis was done as described in section 5.2.3.

6.2.2. Comparison of Healthy, Hypoxic and Injured Rats
In order to further investigate the contribution of hypoxia to changes in pulmonary
lactate-to-pyruvate ratio during progressive inflammatory lung injury, we compared the
pulmonary hyperpolarized lactate-to-pyruvate ratios measured in hypoxic (Hyp90 and
Hyp75) and control animals presented in this chapter with those of the injured (ZEEP and
PEEP) and sham groups discussed in chapter 5. We also compared the hyperpolarized
lactate-to-pyruvate ratio over the heart among groups to assess whether the changes in the
pulmonary lactate-to-pyruvate ratio are local to the lungs. Data from an additional 6 rats (3
PEEP and 3 ZEEP) are included here that were obtained after data from chapter 5 was
published10. Table 6.1 summarizes number of rats (N=53 total) as well as their
physiological and ventilation parameters for each group.
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Table 6.1. Summary of experimental parameters for rat studies.
Cohort

Condition

Weight (g)
250-322

Tidal Volume(ml/kg)

PEEP(cmH2O)

SpO2(%)

Healthy

Number of Rats
10

Control

8-10

0-3

96-99

Sham

Healthy

7

6-10

0-7

97-99

PEEP

Injured

10

284-320
287-420

6-12

0-7

85-99

ZEEP

Injured

10

300-360

6-12

0-7

85-99

hyp90

Hypoxic

8

301-395

8-10

3

86-99

hyp75

Hypoxic

8

274-321

8-10

3

64-99

6.3. Results

6.3.1. Hypoxia Study
Figure 6.2 shows the representative anatomical proton scans as well as pyruvate
and lactate maps at the first and last time-points for all three groups. For display, the
pyruvate and lactate maps are normalized to their own maximum intensity for each map.
The pyruvate signal did not change significantly over time in any of the groups and was at
its most intense in the major vasculature close to the heart. Lactate signal intensity
remained stable over time in the control group (left columns), while the pulmonary lactate
signal increased by a small amount in the moderately hypoxic group (middle columns); we
observed a time-dependent global increase in lactate signal in the severely hypoxic rats
(right column).
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Figure 6.2. Representative pyruvate and lactate maps overlaid on their corresponding proton image acquired
at healthy baseline and 4 hours after start of systemic hypoxia. FiO2 was kept at 1.0 in the control group.
Lactate to pyruvate ratio and lactate signal remained unchanged over time in the control rats. While the lactate
signal did not change noticeably after 4 hours of moderate hypoxia, it increased dramatically after 4 hours of
severe hypoxia.

Figure 6.3.A shows the average lactate-to-pyruvate ratio as a function of time for
all groups. Initial ANOVA showed that the ratio was significantly different among groups
(F2,84=8.579, p=0.005) and pyruvate injections (F3,84=17.860, p<0.001). Post-hoc analysis,
reported in Table 6.1, suggests that the average lactate-to-pyruvate ratio was similar among
all groups at healthy baseline. In severely hypoxic animals (Hyp75), this ratio progressively
increased and was significantly higher than in both moderately hypoxic rats (Hyp90) and
control rats 1, 2.5 and 4 hours after the start of hypoxia. While the lactate-to-pyruvate ratio
did increase after 4 hours of moderate hypoxia, this increase did not reach the level of
significance compared to control animals.
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Figure 6.3. (A) Average lactate-to-pyruvate remained unchanged in the control group but increased in both
hypoxic groups over time. This ratio increased much more significantly in the severely hypoxic rats (Hyp75),
and was significantly higher than in both moderately hypoxic (Hyp90) and control rats 2.5 and 4 hours after
the start of hypoxia. The ratio was slightly higher in the moderately hypoxic rats than the control rats, but
this difference did not reach the level of statistical significance. (B) Pulmonary compliance (Cdyn) remained
unchanged in all rats. (C) Oxygen saturation (SpO2) remained unchanged in the control group but declined in
both moderately and severely hypoxic groups to around 90% and 75%, respectively (p<0.01 for all groupwise comparisons at any time except the first time point). (* p<0.05, ** p <0.01, *** p <0.001), (1Hyp75 vs.
control, 2Hyp75 vs Hyp90).

Pulmonary compliance remained unchanged over the course of the study, as shown
in Figure 6.3.B. Figure 6.3.C shows the SpO2 during each [1-13C] pyruvate injection: SpO2
was similar among all groups at healthy baseline, but declined significantly 1 hour after
the start of hypoxia, to ~90% and ~75% in moderately and severely and moderately
hypoxic groups respectively (c2(2) = 21.372, p<0.001). The average SpO2 for both groups
remained significantly lower than in control animals 2.5 (c2(2) = 19.373, p<0.001) hours
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and 4 hours (c2(2) = 15.053, p<0.001) after the start of hypoxia. Heart rate ranged between
350-400 beats-per-minute for all rats.
The arterial blood lactate level and its correlation with hyperpolarized lactate-topyruvate ratio in the lungs is shown in Figure 6.4. The initial ANOVA showed that overall
lactate concentration was significantly different among cohorts (F2,20 = 4.133, p=0.031)
and time points (F1,20 = 64.460, p<0.001). The arterial lactate concentration was similar
among animals before the start of imaging (F2,11=0.881, p=0.442) and increased in all
groups after imaging. However, there was significant inter-group difference at this time
point (F2,7=21.41, p=0.001). The post-hoc analysis showed that, similar to the pulmonary
hyperpolarized lactate-to-pyruvate ratio, the arterial lactate concentration of the Hyp75 rats
was significantly higher than that of both control (p=0.001) and Hyp90 (p=0.006) groups.
There was also a strong correlation between the hyperpolarized lactate-to-pyruvate ratio in
the lungs and the arterial lactate concentration (r=0.668, p<0.001).

Figure 6.4. (A) Arterial lactate concentration measured from arterial blood samples in control (N=3), Hyp90
(N=3) and Hyp75 (N=5) groups before and after imaging. Post-imaging arterial blood lactate was
significantly higher in the Hyp75 group than in both Hyp90 and control groups. (B) Pulmonary
hyperpolarized lactate-to-pyruvate ratio is strongly correlated with arterial blood lactate concentration (**
p<0.01, *** p<0.005).
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6.3.2. Comparison of Imaging Data from Hypoxia and Injury Studies
Figure 6.5.A-C compares the average pulmonary and cardiac lactate-to-pyruvate
ratio and oxygen saturation in all groups 4 hours after intervention (acid instillation or the
start of hypoxemia). The initial two-way ANOVA of the average pulmonary and cardiac
lactate-to-pyruvate ratios showed discrimination among all groups (F5,180=10.230, p<0.001
and F5,178=2.256, p=0.034) and pyruvate injections (F3,180=17.240, p<0.001 and
F3,180=9.956, p<0.001). Post-hoc analyses of both pulmonary and cardiac lactate-topyruvate ratios are reported in Table 6.2. The average pulmonary and cardiac lactate-topyruvate ratios were similar among all groups at both healthy baseline and 1 hour after
acid/saline instillation, but was significantly different both 2.5 hours and 4 hours after
intervention. 2.5 hours post-intervention (not shown in Figure 6.5), the pulmonary lactateto-pyruvate ratio was significantly higher in the Hyp75 group than in all others except the
ZEEP group. This ratio in the ZEEP group was only significantly higher than the control
and Hyp90 groups. 4 hours post-intervention, ZEEP and Hyp75 groups displayed similar
pulmonary lactate-to-pyruvate ratios, which were significantly higher than in the other
groups. On the other hand, the cardiac lactate-to-pyruvate ratio of the Hyp75 group was
higher than that of the ZEEP group, although this difference did not reach the level of
statistical significance. Compared to the other groups, however, the cardiac lactate-topyruvate ratio was significantly higher in the Hyp75 group.
Figure 6.5.D shows the average pulmonary and cardiac lactate-to-pyruvate ratios
vs. oxygen saturation in all animals at individual time points. At baseline, the average
lactate-to-pyruvate ratio is consistently low and all animals are well oxygenated (SpO2 >
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95%, green area). After intervention, oxygen saturation declines in both hypoxic groups
due to reduced fraction of inspired oxygen (yellow and red areas), and the lactate-topyruvate ratio increases in several Hyp75 animals. This ratio continues to increase 2.5 and
4 hours after intervention in all Hyp75 rats. A similar increase in lactate to pyruvate ratio
was observed in ZEEP animals (labeled by the dark gray zone); however, the oxygen
saturation in these animals remained similar to that of the moderately hypoxic animals in
this study, in which the lactate-to-pyruvate ratio did not markedly increase. The remaining
animals in other groups remained in the normal zone, as both their oxygenation and
pulmonary lactate-to-pyruvate ratio did not change over time.
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Figure 6.5. Average lactate-to-pyruvate ratios in all groups for different injections in the (A) lungs and (B)
heart; (C) oxygen saturation 4 hours after the start of injury or hypoxia. Post-hoc analysis results are included
in Table 6.2. The error bars represent the standard error for each measurement. (D) The pulmonary
hyperpolarized lactate-to-pyruvate ratio vs. oxygen saturation at individual timepoints shows the overall
trend of each cohort during the course of the experiment. The lactate-to-pyruvate ratio significantly increases
in injured rats (dark gray box) 2.5 hours after acid instillation, while oxygen saturation declines to ~90%. In
moderately hypoxic rats, the lactate-to-pyruvate does not increase despite oxygen saturation decreasing to
90%, suggesting that the source of increased lactate-to-pyruvate ratio is not hypoxia but severe inflammatory
response. The lactate-to-pyruvate ratio increases 1 hour after the start of severe hypoxia, consistent with other
findings suggesting that the lung tissue produces high concentrations of lactate if exposed to severe but not
moderate hypoxia. (Note that intervention for ZEEP and PEEP groups is acid instillation, for Sham group is
saline instillation, and for Hyp75 and Hyp90 groups is reducing the fraction of inspired oxygen) (* above a
bar indicates that data is significantly different from all other groups. Groups with letters “a” or “b” on top
are statistically different from groups with “a*” or “b*” on top, respectively. Finally, “ab” on top of a bar
indicates statistical difference from both groups with “a*” and “b*” on top.).
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Table 6.2. Summary of post-hoc analysis of both pulmonary and cardiac lactate-to-pyruvate ratios in all
groups. Analysis was performed using the Tukey honest significant difference test, performed when the
results of the one-way ANOVA test (with Bonferroni adjustment for four time points aadj.=0.05/4 = 0.0125)
for each time point was significant. Initial two-way ANOVA of the average pulmonary and cardiac lactateto-pyruvate ratios showed discrimination among groups (F5,180=10.230, p<0.001 and F5,178=2.256, p=0.034)
and pyruvate injections (F3,180=17.240, p<0.001 and F3,180=9.956, p<0.001). Both pulmonary and cardiac
lactate-to-pyruvate ratios were similar among groups at healthy baseline (F5,47=1.212, p=0.318 and
F5,47=1.893, p=0.113) and 1 hour after intervention (F5,46=2.201, p=0.070 and F5,45=0.518, p=0.761), while
pulmonary lactate-to-pyruvate ratio alone was different among groups 2.5 hours after the intervention
(F3,37=9.657, p<0.001, F5,38=3.237, p=0.0157). There was discrimination for both ratios among groups 4
hours (F5,35=20.290, p<0.001 and F5,33=4.986, p=0.001) after intervention.
Lung Lactate-to-Pyruvate Ratio
2.5 Hrs (Injection 3)
Group Comparisons

Hyp75 vs.

Heart Lactate-to-Pyruvate Ratio

4 Hrs (Injection 4)

4 Hrs (Injection 4)

Δmean

95% C.I.

p-value

Δmean

95% C.I.

p-value

Δmean

95% C.I.

p-value

Control

0.201

0.106, 0.296

<0.001*

0.244

0.129, 0.358

<0.001*

0.325

0.106, 0.544

0.026*

Hyp90

0.184

0.070, 0.299

<0.001*

0.185

0.076, 0.294

<0.001*

0.287

0.089, 0.485

0.026*

Sham

0.154

0.051, 0.258

0.0132*

0.227

0.122, 0.333

<0.001*

0.357

-0.166, 0.548

0.001*

PEEP

0.176

0.076, 0.277

<0.001*

0.219

0.118, 0.320

<0.001*

0.333

0.152, 0.515

0.002*

ZEEP

0.080

0.034, 0.194

0.783

0.049

-0.051, 0.150

0.893

0.254

0.068, 0.439

0.063

Control

0.121

0.011, 0.231

0.006*

0.194

0.093, 0.295

<0.001*

0.071

-0.128, 0.271

0.946

Hyp90

0.105

-0.022, 0.231

0.041*

0.135

0.041, 0.231

0.001*

0.033

-0.142, 0.209

0.989

Sham

0.074

-0.043, 0.192

0.442

0.178

0.087, 0.269

<0.001*

0.103

-0.065, 0.272

0.431

PEEP

0.096

-0.018, 0.211

0.079

0.169

0.085, 0.255

<0.001*

0.079

-0.078, 0.238

0.667

Control

0.017

-0.093, 0.126

0.999

0.058

-0.051, 0.168

0.268

0.038

-0.172, 0.248

0.999

Sham

-0.030

-0.147, 0.087

0.685

0.042

-0.058, 0.142

0.698

0.069

-0.111, 0.251

0.851

PEEP

-0.008

-0.122, 0.106

0.989

0.034

-0.061, 0.129

0.855

0.046

-0.125, 0.218

0.972

Control

0.025

-0.070, 0.120

0.909

0.024

-0.076, 0.125

0.789

-0.008

-0.204, 0.187

0.999

Sham

-0.022

- 0.125, 0.081

0.920

0.008

-0.083, 0.099

0.998

0.023

-0.141, 0.187

0.996

Control

0.047

-0.052, 0.146

0.256

0.016

-0.089, 0.122

0.946

-0.031

-0.236, 0.173

0.092

ZEEP vs.

Hyp90 vs.

PEEP vs.

Sham vs.
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6.3.3. Histological Analysis of the Lung Sections
The hypoxic lungs displayed evidence of mild lung injury, including edema and
hyaline membrane on the alveolar wall. Similar to both sham and control groups, however,
hypoxic lungs presented alveoli that were lined with flattened healthy epithelial cells, and
minimal inflammatory cells were present (Figure 6.6). On the other hand, PEEP and ZEEP
lungs presented high levels of alveolar infiltrates and damage, as discussed in the previous
chapter.
ANOVA showed a significant difference among groups (infiltration: F5,32=12.59,
p<0.001, alveolar damage: F5,32= 9.689, p<0.001, hyaline membrane deposition: c2(2)=
21.157, p<0.001, and edema: c2(2)= 20.576, p<0.001). Infiltration score (Figure 6.7.A)
was significantly higher in both ZEEP and PEEP groups compared to all others (p<0.05).
Alveolar damage score (Figure 6.7.B) was significantly higher in both ZEEP and PEEP
groups compared to controls; however, only the ZEEP group had significantly higher
scores than both hypoxic (Hyp75 and Hyp90) and sham groups. Hyaline membrane
deposition (Figure 6.7.C) and edema severity (Figure 6.7.D) were both significantly higher
in the ZEEP group compared to both control and sham groups (p<0.05). However, neither
were statistically different from hypoxic and PEEP groups, although hypoxic animals
presented higher levels of hyaline membrane deposition and similar levels of edema
compared to the PEEP group.
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Figure 6.6. (Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each group.
Representative images shown are at 10´. The scale bar is 100 µm. Average injury scores for various
morphological features for different groups assessed from H&E stained lung sections. (Groups with letters
“a” or “b” on top are statistically different from groups with “a*” or “b*” on top, respectively; “ab” on top
of a bar indicates statistical difference from both groups with “a*” and “b*” on top.)

7.4. Discussion
Lungs are among the best oxygenated organs, as they receive oxygen from three
independent sources: 1) oxygenated blood from the bronchial arteries, 2) partially
deoxygenated blood from the pulmonary artery, and 3) inhaled air11. Despite this
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heightened oxygenation, lung function is usually compromised in patients with acute lung
injury and ARDS due to severe alveolar injury and the presence of edema in the airspace
resulting in systemic hypoxemia12-14. Reduced oxygen availability in the tissue generally
leads to a metabolic shift from oxidative phosphorylation to glycolysis, which results in
elevated lactate production and endogenous lactate-to-pyruvate ratio in the tissue2,3. Yet
pulmonary metabolism has proven capable of producing normal lactate levels even in the
presence of moderate reductions in oxygen availability6-9. On the other hand other, studies
report elevated lactate production by the native lung cells due to increased lactate
dehydrogenase (LDH) activity under severe hypoxic conditions15.
Our findings in this sub-aim are consistent with both of these reported findings, as
evidenced by our measurement of the hyperpolarized pulmonary lactate-to-pyruvate ratio
in both moderately and severely hypoxic rats under mechanical ventilation. Our imaging
data showed a minimal increase in the pulmonary hyperpolarized lactate-to-pyruvate ratio
in moderately hypoxic rats (Hyp90 group). In contrast, we observed a rapid and progressive
increase in pulmonary hyperpolarized lactate-to-pyruvate ratio in rats with severe
hypoxemia (Hyp75 group) (Figures 6.2, 6.3.A and Table 6.2). Ex-vivo histological analysis
showed the presence of edema and hyaline membrane but an absence of inflammatory
injury to the lung, and arterial blood samples showed increased lactate levels caused by
systemic hypoxemia.
Pulmonary compliance remained unchanged over time (Figure 6.3.B), while H&E
staining showed similar levels of alveolar infiltrates and damage across control and both
hypoxic groups, suggesting the absence or minimal presence of inflammatory infiltrates in
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the lungs. However, the staining did show higher levels of edema and hyaline membrane
formation in both hypoxic groups compared to controls (Figure 6.6), likely due to increased
capillary permeability in hypoxic lung tissue16. While the mechanism by which this occurs
under hypoxic conditions is not well-understood, it is thought to be a result of pulmonary
vasoconstriction as well as elevated HIF-1a expression, which can lead to disruption of the
alveolar endothelial layer resulting in vascular leakage and edema in the lung tissue16,17.
Nevertheless, it is unlikely that the increased edema and hyaline membrane formation are
responsible for the elevated lactate-to-pyruvate ratio observed in the Hyp75 rats, since both
hypoxic groups presented similar histological features while the lactate-to-pyruvate ratio
only increased in the Hyp75 group. Additionally, the progressive increase in lactate-topyruvate ratio as early as 1 hour after the start of hypoxia (Figure 6.3.A) is consistent with
other studies that suggest a rapid shift to anaerobic glycolysis within several minutes of
severe hypoxia3. Severe systemic hypoxemia is therefore the most likely source of
increased hyperpolarized lactate-to-pyruvate ratio in Hyp75 rats.
To investigate the impact of systemic hypoxemia, we collected arterial blood
samples and measured the lactate concentration before and after imaging (Figure 6.5.A).
The lactate concentration increased over time in all groups, but was higher in both hypoxic
groups compared to controls after imaging. This difference is expected due to the former
rats’ exposure to systemic and persistent hypoxemia for 4 hours, although it only reached
statistical significance compared to controls in the Hyp75 group. Lastly, the strong
correlation observed between the systemic lactate concentration and pulmonary
hyperpolarized lactate-to-pyruvate ratio (Figure 6.5.B) validates our hyperpolarized
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MRI-derived measurement. However, while the blood lactate concentration is a global
measure, hyperpolarized [1-13C] pyruvate MRI is capable of measuring lactate levels
regionally in the pulmonary tissue.
Our findings in this study of hypoxemia and its impact on lung pyruvate metabolism
in the absence of inflammation helps to further confirm our hypothesis in aim II.A: that
elevated lactate-to-pyruvate ratio in rats with progressive lung injury (ZEEP group) is
caused by the presence of inflammatory lung injury rather than systemic hypoxemia. As
evident from their oxygen saturation levels, Hyp90 rats were exposed to similar levels of
systemic hypoxemia to ZEEP rats the (Figures 6.5.C and 6.5.D). Yet the pulmonary lactateto-pyruvate ratio was significantly higher in the ZEEP group than the Hyp90 group. In
contrast, the ZEEP and Hyp75 rats had similar pulmonary lactate-to-pyruvate ratios at the
end of their respective studies (Figures 6.5.A and 6.5.D), suggesting that severely hypoxic
regions of lung tissue can also produce high levels of lactate. These areas generally
coincide with areas of severe inflammatory activity in injured lungs5,11, however, as the
presence of metabolically demanding activated neutrophils reduces the availability of
oxygen for oxidative phosphorylation in the native cells5.
Lastly, we investigated the regionality of pulmonary lactate-to-pyruvate as a
surrogate for lactate production in the lungs by comparing the cardiac lactate-to-pyruvate
ratio among all groups 4 hours after the start of hypoxia/injury. Despite the significantly
elevated lactate-to-pyruvate ratio in the lungs of both Hyp75 and ZEEP groups, the cardiac
lactate-to-pyruvate ratio only increased significantly in the Hyp75 group. This suggests
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that anaerobic glycolysis is elevated systemically as a result of global hypoxemia in the
Hyp75 rats, whereas it only increases locally in the ZEEP rats as a result of injury.

6.5. Limitations
Our study has a number of limitations. First, exposure to either moderate or severe
systemic hypoxemia may not accurately represent regional inflammatory-induced hypoxia
in the lung tissue. Nevertheless, this approach enabled us to support our hypothesis in aim
II of this thesis. Second, the presence of severe hypoxemia can significantly alter blood
flow in the lungs due to pulmonary vasoconstriction18, which may in turn alter the
dynamics of the hyperpolarized signal. However, it is possible to address this potential
source of error by obtaining multiple images of the lungs in order to capture the dynamics
of the pyruvate signal and its conversion to lactate; this will be further discussed in chapter
8, where we develop a platform for a high resolution dynamic metabolic imaging of the
lungs. Another potential solution is to conduct isolated perfused lung studies in which the
lungs are harvested from the animals and connected to a perfusion system to keep them
physiologically viable19,20; the advantage of this method is that both blood flow and
oxygenation level can be tightly controlled, thereby reducing physiological variabilities in
the study.
The third limitation of our study is that our measurement of the lactate-to-pyruvate
ratio in the lung tissue may be biased from the contribution of the hyperpolarized lactate
signal in the blood pool. The risk of bias is particularly high in the case of severely hypoxic
rats, in which the blood lactate concentration is significantly increased from its baseline.
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One solution to this problem is to selectively saturate the lactate signal before it arrives in
the lungs21: e.g., in the liver. The use of perfused lung studies can address this issue as well.
Finally, limitations with the experimental setup meant that we did not measure arterial
blood lactate levels in the injured animals. However, in a separate study of lung injury
using a similar lung injury model, we observed a significantly smaller increase in the
arterial blood lactate level of moderately hypoxic animals with progressive lung injury22.

6.6. Conclusion
In this sub-aim, we used hyperpolarized [1-13C] pyruvate MRI to assess the impact
of hypoxia on pulmonary anaerobic metabolism, demonstrating that the lung shifts to
anaerobic metabolism in the presence of severe hypoxia but can tolerate moderate
reductions in oxygen availability. Furthermore, our findings in this study confirmed the
previously generated hypothesis that the increased pulmonary lactate-to-pyruvate observed
in rats with progressive lung injury is predominately due to inflammatory injury. However,
severely hypoxic regions in the injured lung tissue may also be responsible for elevated
lactate-to-pyruvate.

157

6.7. References
1.

Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA 307, 2526–2533 (2012).

2.

Mizock, B. A. Alterations in carbohydrate metabolism during stress: A review of the literature. The
American Journal of Medicine 98, 75–84 (1995).

3.

Zoremba, N., Homola, A., Rossaint, R. & Syková, E. Interstitial lactate, lactate/pyruvate and glucose
in rat muscle before, during and in the recovery from global hypoxia. Acta Vet Scand 56, 1–5 (2014).

4.

Scholz, C. C. et al. Regulation of IL-1β–induced NF-κB by hydroxylases links key hypoxic and
inflammatory signaling pathways. Proc. Natl. Acad. Sci. USA 110, 18490–18495 (2013).

5.

Fagenholz, P. J. & Harris, N. S. Hypoxia and Inflammation. N Engl J Med 364, 1976–1976 (2011).

6.

Routsi, C. & Bardouniotou, H. Pulmonary lactate release in patients with acute lung injury is not
attributable to lung tissue hypoxia. Critical Care 2014 18:5 (1999).

7.

Johnson, M. L., Hussien, R., Horning, M. A. & Brooks, G. A. Transpulmonary pyruvate kinetics.
AJP: Regulatory, Integrative and Comparative Physiology 301, R769–R774 (2011).

8.

Iscra, F., Gullo, A. & Biolo, G. Bench-to-bedside review: Lactate and the lung. Crit Care 6, 327–
329 (2002).

9.

Fisher, A. B. Intermediary metabolism of the lung. Environmental Health Perspectives 55, 149
(1984).

10.

Pourfathi, M., Cereda, M., Chatterjee, S., reports, Y. X. S.2018. Lung Metabolism and Inflammation
during Mechanical Ventilation; An Imaging Approach. nature.com, 8, 280 (2018).

11.

Vohwinkel, C. U., Hoegl, S. & Eltzschig, H. K. Hypoxia 2015: Hypoxia signaling during acute lung
injury. Journal of Applied Physiology 119, 1157–1163 (2015).

12.

Thompson, B. T., of, R. C. N. E. J.2017. Acute respiratory distress syndrome. Mass Medical Soc
377, 562–572 (2017).

13.

Force, T. A. D. T. Acute Respiratory Distress Syndrome: The Berlin Definition of ARDS. JAMA
307, 2526–2533 (2012).

14.

Johnson, E. R. & Matthay, M. A. Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment.
Journal of Aerosol Medicine and Pulmonary Drug Delivery 23, 243–252 (2010).

15.

Zhang, S. X. L. et al. Type I epithelial cells are the main target of whole-body hypoxic
preconditioning in the lung. - PubMed - NCBI. American Journal of Respiratory Cell and Molecular
Biology 40, 332–339 (2009).

16.

Dehler, M. Hypoxia causes permeability oedema in the constant-pressure perfused rat lung.
European Respiratory Journal 27, 600–606 (2006).

17.

Bowser, J. L., Lee, J. W., Yuan, X. & Eltzschig, H. K. The hypoxia-adenosine link during
inflammation. J. Appl. Physiol. 123, 1303–1320 (2017).

18.

Schumacker, P. T. Lung Cell Hypoxia: Role of Mitochondrial Reactive Oxygen Species Signaling
in Triggering Responses. Proceedings of the American Thoracic Society 8, 477–484 (2011).

158

19.

Shaghaghi, H. et al. Ascorbic acid prolongs the viability and stability of isolated perfused lungs: A
mechanistic study using (31)P and hyperpolarized (13)C nuclear magnetic resonance. Free Radical
Biology and Medicine 89, 62–71 (2015).

20.

Shaghaghi, H. et al. Metabolic spectroscopy of inflammation in a bleomycin‐induced lung injury
model using hyperpolarized 1‐13C pyruvate. NMR Biomed. 27, 939–947 (2014).

21.

Wespi, P., Steinhauser, J., Kwiatkowski, G. & Kozerke, S. Overestimation of cardiac lactate
production caused by liver metabolism of hyperpolarized [1‐13C]pyruvate. Magn. Reson. Med. 100,
10158 (2018).

22.

Xin, Y. et al. Unstable Inflation Causing Injury: Insight from Prone Position and Paired CT Scans.
Am J Respir Crit Care Med rccm.201708–1728OC (2018). doi:10.1164/rccm.201708-1728OC

159

Chapter 7: Translation of Hyperpolarized 13C Pulmonary Imaging to Larger Species

7.1. Introduction
Previous chapters demonstrated the use of hyperpolarized 13C MRI for metabolic
imaging of rat lungs, showing that this technology is capable of detecting increased
pulmonary pyruvate to lactate conversion as a result of inflammatory lung injury. Our data
suggested that hyperpolarized lactate-to-pyruvate ratio in the lungs is strongly correlated
with the severity of lung injury as well as neutrophilic infiltration and activation in lung
epithelium, but may also indicate the presence of severe hypoxia in the lung tissue.
Increased lactate release by the lungs is also strongly correlated with increased mortality
rate in ARDS patients1,2. Since hyperpolarized 13C MRI is capable of providing a map of
lactate in the lung tissue, its translation to larger species and human subjects can serve as a
clinical tool for measuring regional changes in lung metabolism, as a marker of injury
severity, and to monitor therapeutic response in patients.
In this chapter, we sought to demonstrate the translational potential of this
technology for pulmonary imaging in human patients. In light of their similar lung
physiology to humans, we performed imaging in a pig model using a setup similar to what
would be used clinically. First, we assessed the feasibility of imaging the conversion of
pyruvate to lactate in healthy pigs. Next, using intratracheal acid instillation to establish a
porcine lung injury model similar to the one we have previously used in rats, we
demonstrated hyperpolarized 13C MRI’s capacity to detect changes in pulmonary anaerobic
metabolism after injury.
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7.2. Materials and Methods
All animal procedures were approved by the Institutional Animal Care and Use
Committee (IUCAC) of the University of Pennsylvania (Philadelphia, PA). Seven
Yorkshire pigs were used for this study. A summary of the studies and ventilation
parameters during imaging is presented in Table 7.1.

7.2.1. Study Design and Injury Protocol
Pigs were anesthetized with an intramuscular injection of ketamine (20–25 mg·kg1

) and xylazine (2 mg·kg-1); anesthesia was maintained by continuous intravenous infusion

of ketamine (7–11 mg·kg-1·h-1) and midazolam (0.2–0.7 mg·kg-1·h-1) through a peripheral
catheter. The femoral artery was catheterized for blood pressure and arterial blood gas
monitoring. Pigs were intubated with a 6.5 mm cuffed endotracheal tube (Teleflex
Medical–Rusch, Research Triangle Park, NC, USA). SpO2, heart rate (Phillips North
America, Andover, MA, USA), and body temperature were monitored. All animals
received intravenous hydration with normal saline (10 mg·kg-1 bolus and 1 mg·kg-1·h-1
infusion). During preparation and acid instillation, pigs were ventilated in supine position
using either a custom-made ventilator, a Nellcor Puritan Bennett 849 or a Puritan Bennett
7200 clinical ventilator. PEEP was set to 0-3 cmH2O for all animals. All animals were
ventilated using the home-made ventilator during imaging, and PEEP was set to 0 cmH2O.
Hydrochloric acid (HCl, pH 1.0) was instilled in four pigs (pigs 4-7). Pig 4 was imaged
once before acid instillation as well as twice—125 and 140 minutes—after acid instillation
to assess the reproducibility of the measured lactate-to-pyruvate ratio. Due to limitations
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on the availability of the clinical scanner MRI system in our institution for animal use, we
did not obtain baseline images of pigs 5-7. In pigs 4 and 5, the acid was delivered using a
syringe into the endotracheal tube; in pigs 6 and 7, the acid was delivered to the base of the
right lung using a bronchoscope (Ambu aView, Columbia MD) to achieve a more local
injury. Pig 6 coughed slightly during the procedure, however, likely causing a small
amount of acid to spread to the left lung as evidenced by the presence of injury in that
location. Animals’ temperature was kept between 36.5-38.5°C during the study using a
blanket that circulates heated water. Arterial blood samples were collected in Pigs 4-7 from
a catheter line placed in the femoral artery for arterial blood gas (ABG) analysis as
described in section 6.2.1.

Table 7.1. Summary of pig studies, with conditions and ventilation parameters at the time of imaging.
Animal

Acid Instillation and Injury

Weight
Pig

Duration

Dose

TV

Condition
(Kg)

Ventilation

(min)

(ml/kg)

PIP
f (s-1)

Type

FiO2

(ml/kg)

(cmH2O)

1

30

Healthy

NA

NA

NA

8

15

0.5

14

2

24

Healthy

NA

NA

NA

8

15

0.6

15

3

27

Healthy

NA

NA

NA

8

15

0.6

14

4

25

Healthy

NA

NA

NA

12

20

1

15

4

25

Injured

140

2

Bilateral

12

20

1

21

5

28

Injured

420

4

Bilateral

8

25

1

24

6

27

Injured

580

1

Bilateral

12

20

1

34

7

45

Injured

440

1

Unilateral

12

20

1

33
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7.2.2. Hyperpolarization Protocol
Pyruvate samples were prepared by mixing 14 M [1-13C] pyruvate (Cambridge
Isotopes) with 15 mM AH111501 radical (GE Healthcare). 650 mg of this mixture was
polarized using a commercial SpinLab clinical DNP polarizer (GE Healthcare) for
approximately three to five hours at a temperature of 0.8K and 5T field-strength. Samples
were melted with 25 mL of a dissolution buffer (0.1 g/L disodium EDTA) at 25-bar
pressure and 200 °C, and were subsequently mixed with 7.3mg of a neutralization buffer
(0.72 M NaOH, 0.4M Trizma base and 0.1 g/L disodium EDTA) to yield a neutralized
isotonic solution of 250mM hyperpolarized [1-13C] pyruvate at 37 °C. Solid-state
polarization was estimated to be 45±5% based on the solid-state build-up curve and
separate measurements. Samples were transferred to a 60ml syringe, and 1ml/kg of the
sample was administered over 30 seconds via an ear vein catheter, followed by a 5ml saline
bolus over 5 seconds to flush the pyruvate from the catheter’s dead volume. Depending on
the study, each pig received 1-3 hyperpolarized samples within 2 hours.

7.2.3. 1H and 13C Imaging Protocols
All pigs were placed in supine position in a Siemens 3T Trio clinical MRI system
equipped with a multi-nuclear amplifier. An 8-channel flexible receive coil along with a
single-channel 13C flexible transmit RF coil (Clinical MR Solutions) were then used for
13

C data acquisition. Two small bottles containing 15M solution of

13

C-urea and 4M

solution of [1-13C] sodium lactate doped with 5mM gadolinium (Omniscan, GE
Healthcare) were placed on top of the pig to adjust the scanner’s frequency to the 13C at
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the center of the urea and lactate peaks (~174 ppm). RF power calibration of the 13C channel
was performed using a 4L bottle of 99% Ethelyn glycol prior to placing the pig in the
magnet.
After positioning the animal’s chest at the scanner’s isocenter, axial and coronal
T2-weighted proton images were acquired as anatomical references with the MRI system’s
built-in body coil using a multi-slice half-Fourier acquisition single-shot turbo spin-echo
(HASTE) pulse sequence. Imaging parameters were TR/TE=3000/87ms, 120° refocusing
flip angle, 320×320 matrix size, 250×250mm2 in-plane field of view (FOV), 250 kHz
readout bandwidth and 4 averages. A total of thirty 7 mm-thick slices were acquired to
cover the lungs. Global shimming was carried out by the system’s built-in automatic
shimming routine.
In pigs 1-2, the first hyperpolarized sample was used to perform slice selective
spectroscopy over the lungs to find the optimum imaging window. The axial slice was
positioned over the chest above the diaphragm; spectral acquisition was started
immediately after the start of injection and lasted for approximately 4 minutes using the
following parameters: TR = 2s, 15° flip angle, 50mm slice thickness, 2560 Hz spectral
bandwidth, 128 spectral points, total acquisition time of 4 minutes.
Two-dimensional chemical shift images were acquired from all pigs using the
modified FID-CSI pulse sequence described in section 4.2. The parameters were adjusted
for imaging the pig at a lower field-strength. Unless otherwise stated, imaging started 45
seconds after the start of pyruvate administration using the following parameters: TR/TE
= 52/0.87ms, 500µs sinc-shaped excitation RF pulse, 6° flip angle, 2560 Hz spectral
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bandwidth, 128 spectral points, 16×16 matrix size, 200×200 mm2 in-plane FOV and 50
mm slice thickness with a total scan time of approximately 13 seconds. This yielded a
nominal in-plane spatial resolution of 12.5×12.5mm2. To minimize respiratory motion
during data acquisition, a 15-second breath-hold was applied using the ventilator; data
acquisition was initiated 45 seconds after the start of injection. Three pigs were imaged
with slightly different parameters; the matrix size for pig 3 was set to 24×24, but resulted
in a poor SNR and a very long scan time (approximately 30s). The in-plane FOV for pigs
1 and 7 was set to 300×300mm2 and 250×250 mm2, respectively.

7.2.4. MRI Data Processing
All data were processed using custom routines programmed in MATLAB 2015b
(MathWorks, Inc.). Data from individual channels were processed independently and were
combined by taking the square root of the sum of the squares of the data from individual
channels. Slice-selective spectroscopy data obtained from each channel was reconstructed
by applying a one-dimensional Fourier transform on each FID. Baseline-correction was
performed using a 4th order polynomial function, followed by manual first-order and
automatic zero-order phase correction of the real part of the spectrum. The time-course of
each metabolite was obtained from the area under the corresponding peak (pyruvate,
lactate, alanine and bicarbonate).
Imaging data for each channel was reconstructed using a three-dimensional Fourier
transform as described in section 4.3.5. The lactate and pyruvate signals and the lactate-topyruvate ratios across the entire lung were obtained from the combined spectroscopic maps
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as described in section 4.3.5. We further investigated regional changes in the lactate-topyruvate ratio and the NMR linewidth of the injured pigs, assessing the spectroscopic data
averaged over the anterior and posterior regions of the lungs.

7.3. Results
Figure 7.1.A shows a representative proton image of a healthy pig (pig 2) and the
location of the eight receive channels wrapped around the animal.

7.3.1. 13C Spectroscopy
Figure 7.1.B shows the time-course of pyruvate, lactate and bicarbonate peaks for
each coil. The inset for each channel shows the spectrum obtained 50 seconds after the start
of the injection. Channels 2 and 3 have the maximum pyruvate signal intensity due to their
proximity to the heart; they also have the largest bicarbonate signal, since the latter is
produced by the heart in high quantities3. Figure 7.1.C shows the time-course of the
metabolites obtained from the combined signal from all channels; the inset shows the
combined spectrum 50 seconds after the start of injection. The vertical dashed line shows
the time at which the lactate signal is at its maximum, 45 seconds after the start of injection.
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Figure 7.1. (A) Representative axial T2-weighted image obtained over the lungs and the location of the
receive channels of the 13C RF coil around the pig. Time-course of each metabolite obtained by (B) individual
channels and (C) the combined channels shows that the maximum lactate signal in an axial slice over the
lungs is attained 45 seconds after the start of injection. The inset shows the spectrum obtained 50 seconds
after the start of injection.
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7.3.2. 13C Chemical Shift Imaging
Figure 7.2.A. shows representative axial magnetic resonance spectroscopic images
(MRSI) obtained from individual receive channels overlaid on the corresponding T2weighted proton scan. For each channel, the signal in the image is visibly higher near the
corresponding receive coil. Figure 7.2.B shows the combined MRSI overlaid on the T2weighted proton image. Two spectra are shown from two voxels outlined with white
squares over the vessel (V) and the left lung (L). The signal in the vessel is significantly
larger than the signal in the lungs. The linewidth of the peaks are also narrower in the voxel
over the vessel due short the T2* relaxation time constant in the lung tissue. Lastly, figure
7.2.C shows the maps of the individual metabolites overlaid on the T2-weighted image. In
this pig, we observed high lactate and alanine signals in the muscle tissue, while
bicarbonate signal was localized to the heart. The pyruvate signal in the lungs was localized
predominantly in the posterior region.
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Figure 7.2. 13C MRSI acquired by (A) individual channels and (B) all channels combined together, overlaid
on the corresponding T2-weighted proton image. The spectra are from two voxels outlined with white boxes
over the vessel and the left lung, labeled with V and L. (C) Metabolite maps obtained from the area under
their corresponding peaks.

Figures 7.3 and 7.4 show pyruvate and lactate maps overlaid on the T2-weighted
images of all non-injured and injured pigs, respectively. Note that pig 4 was imaged before
and after short-term injury (125 minutes after acid instillation). Although we observed a
large lactate signal in the muscles of pigs 1 and 2, the dominant source of both pyruvate
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and lactate signals in all non-injured pigs was the heart. We observed a similar pattern in
pig 4 after injury. In contrast, in pigs imaged 7-9 hours after acid instillation (pigs 5-7), we
observed comparable pyruvate and lactate signals in both the heart and injured regions of
the lung. The injury in pig 5 was bilateral and was the most severe among all animals,
likely due to the fact that it received the largest dose of HCl. The lactate signal was equally
high in posterior regions of both lungs. In pig 6, the injury was primarily localized to the
right posterior lung, although some injury spread to the left posterior lung was also
observed. Both pyruvate and lactate maps showed increased signal intensity over the entire
lungs; however, the lactate signal was higher in the right posterior lung where the proton
image appears to identify more severe injury. Lastly, the injury in pig 7 was unilateral and
localized to the entire right lung, where the lactate map also showed increased intensity.
On the other hand, pyruvate signal appears visually similar in both lungs.
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Figure 7.3. T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C] lactate maps of the
non-injured pigs (pigs 1-4).
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Figure 7.4. T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C] lactate maps of the
injured pigs (pigs 4-7). Pig 4 was imaged 140 minutes after acid instillation, while Pigs 5-7 were imaged
approximately 8 hours after acid instillation. White arrows show the areas in the lungs with visible injury and
edema.
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Table 7.2 summarizes average pulmonary lactate-to-pyruvate ratio, average signalto-noise ratio (SNR) of both pyruvate and lactate images over the lungs, as well as the
animal’s oxygen saturation and heart rate during

13

C imaging. Overall, the SNR of the

lactate signal was higher in injured animals compared to healthy, although the lactate SNR
in (healthy) pig 2 was high as well. The SNR of both pyruvate and lactate images in pig 5
were poor, likely due to low polarization level of the sample. The average lactate-topyruvate in the lungs of the injured animals appeared higher overall; however, there is
significant variability among the animals—e.g., pig 2, in particular, presented a high
lactate-to-pyruvate ratio.

Table 7.2. Summary of the average lactate-to-pyruvate ratio, lactate and pyruvate signal-to-noise ratios,
heart-rate and oxygen saturation recorded at the time of 13C injection.
Animal

Vitals

Imaging Results

Pig

Condition

SpO2 (%)

Heart Rate (bpm)

Lac/Pyr

Pyr SNR

Lac SNR

1

Healthy

95

71

0.036

2477.4

93.1

2

Healthy

99

80

0.111

1967.5

245.65

3

Healthy

100

60

0.008

3742.1

29.8

4

Healthy

100

65

0.039

2861.8

104.9

4

Injured

100

60

0.061

5090.2

233.1

5

Injured

99

45

0.086

896.9

43.4

6

Injured

95

160

0.241

1577.3

346.8

7

Injured

99

95

0.112

3712.1

341.4

Figure 7.5 compares the shape of the spectra and the lactate-to-pyruvate ratios in
the anterior and posterior regions of the lungs in pig 4 before and after acid instillation. The
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lactate-to-pyruvate ratio in the posterior lung (outlined by the red box) increased by
approximately 50% from 0.040 to 0.061, while the linewidth of the peaks in became
narrower. The lactate-to-pyruvate ratio was lower in the anterior than the posterior lung
(outlined by the blue box) before acid instillation (0.023), and only slightly higher postinjury (0.028). Lastly, we compared the signal in the posterior region from two images
obtained from two separate pyruvate injections performed 125 and 140 minutes after acid
instillation in pig 4 (Figure 7.5-right panel): the average spectra from these two injections
overlaid on each other show only 10% difference in the lactate signal.

Figure 7.5. (Left) The

13

C MRSI overlaid on the axial T2-weighted image obtained 2 hours after acid

instillation in pig 4. The average spectra in the posterior (red) and middle (blue) sections of the lung before
and after acid instillation show a ~20% and ~50% increase in the lactate-to-pyruvate ratio in these areas,
respectively; the linewidth became narrower in the posterior region due to the presence of edema. (Right)
Two images were obtained within 15 minutes of injury induction. Spectra in the posterior lungs shows an
approximately 10% difference in lactate signal between the repeated scans.

Figure 7.6 shows the MRSI overlaid on the T2 proton scans as well as the

13

C spectra

averaged over four different regions of the lung in pigs 5-7, imaged over 7 hours after acid
instillation. The overall SNR of pig 5 was poor (Table 7.2), which makes the quantifying
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the lactate-to-pyruvate ratio unfeasible in the anterior regions of the lungs. However, this
ratio was equal in both sides of the lung and was higher than in healthy pigs. Overall lactateto-pyruvate ratio was significantly higher in pig 6 than in healthy pigs, and was at its
highest in the posterior regions of the lungs where more injury present seemed to be
present. The peaks are narrower in the posterior regions than in the anterior regions.
Similarly, we observed a higher global lactate-to-pyruvate ratio in pig 7 compared to
healthy pigs, but this time in both anterior and posterior regions of the right lung. The
linewidth of the peaks was narrower overall in the right lung than in the left.
Lastly, Table 7.3 summarizes the arterial blood gas analysis before acid instillation
and after 13C imaging in injured animals (pigs 4-7) during ventilation with 100% oxygen
(as listed in Table 7.1). Partial oxygen pressure (PO2) declined dramatically in pigs 5 and
6 at the end of the study but remained unchanged in pigs 4 and 7. The arterial lactate
concentration increased in pigs 4-6 at the end of the study but remained unchanged in pig
7.
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Figure 7.6. 13C MRSI overlaid on the T2-weighted image of pigs with long-term injury (pigs 5-7). On the
right, spectra obtained by averaging the signal over four voxels positioned in the anterior right (AR), anterior
left (AL), posterior right (PR) and posterior left (PL) regions of the lungs are shown. The linewidth of the
NMR peaks is significantly narrower in bright regions in the T2-weighted images, suggesting the presence of
edema. Although the lactate-to-pyruvate ratio is higher than in an average healthy pig across the entire the
lung, this ratio is highest in the injured right lung.
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Table 7.3. Summary of arterial blood gas results at baseline (pre) and after imaging (post) in injured animals.
Pig 4

Pig 5

Pig 6

Pig 7

Pre

Post

Pre

Post

Pre

Post

Pre

Post

pH

7.557

7.535

7.617

7.432

7.504

7.42

7.564

7.53

PCO2 (mmHg)

41.7

41.1

27.8

42.5

38.8

44.8

35.8

39

PO2 (mmHg)

558.7

568.3

621.1

125.4

501.2

104.9

498.1

491

cHCO3 (mM)

37.1

34.7

28.4

28.4

30.5

29

32.4

32.6

SpO2 (%)

100

100

100

98.9

100

98.1

100

100

Glu (mg/dL)

91

55

102

104

76

103

112

112

Lac (mM)

0.72

1.25

0.63

1.81

1.56

2.04

1.03

0.88

Crea (mg/dL)

1.59

1.72

1.17

1.49

1.15

2.06

1.23

1.36

Hct (%)

27

25

25

29

30

32

27

25

cHgb (g/dL)

9.2

8.6

8.5

9.9

10.3

10.8

9.1

8.5

7.4. Discussion
In this sub-aim, we demonstrated the scalability of hyperpolarized

13

C MRI

technology as a metabolic imaging tool to probe pulmonary pyruvate to lactate conversion
in large species. First, we implemented the modified FID-CSI pulse sequence developed
in chapter 4 on a clinical MRI scanner and obtained pyruvate and lactate images in healthy
pigs. We then implemented an acid instillation lung injury model in additional pigs. Despite
variability in dosage, instillation method and injury progression, we showed that, similar
to our small animal studies, pulmonary lactate-to-pyruvate ratio is higher in injured
animals.
In previous chapters, we demonstrated that the elevated pulmonary lactate-topyruvate ratio in small animals with progressive lung injury can be attributed primarily to
increased neutrophil activity and recruitment in the lung tissue, but that elevated pulmonary
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lactate-to-pyruvate can also be caused by severe hypoxemia. Although overall oxygenation
declined in two of the injured pigs (Table 7.3), none were exposed to severe hypoxemia in
this study (Tables 7.2 and 7.3). We therefore postulate that, similar to our small animal
studies, the increased lactate-to-pyruvate ratio observed in the injured animals (pigs 4-7)
was caused by inflammation. While we did not assess lung tissue histologically in this
study, our hypothesis is consistent with other large animal studies of lung injury using 18FFDG PET that suggest a significant increase in neutrophilic burden and metabolic activity
in the lungs as early as 6 hours post-injury4.
In images acquired 125 and 140 minutes after post-injury in pig 4, we only observed
a small and consistent increase in the anaerobic metabolic activity in the posterior region
of the lungs. First, the fact that both scans measured both the overall signal intensity and
the lactate-to-pyruvate ratio within a 10% error margin suggests good reproducibility for
our measurement (Figure 7.5-right panel). Second, this small increase in the lactate-topyruvate ratio may be attributed to the onset of inflammatory activity, as the injury is likely
to have fully recruited and activated the inflammatory infiltrates in the lung tissue within
2 hours of acid instillation.
Regional analysis of the spectroscopic data and the lactate-to-pyruvate ratio in the
injured animals showed that while the lactate-to-pyruvate ratio increases globally, there is
a measurably greater increase in the areas that show injury and edema on the anatomical
scans (Figures 7.5 and 7.6). We also observed that the linewidths in the spectra over the
injured regions notably decrease due to the presence of edema, as this improves field
homogeneity and therefore increases the T2* relaxation time constant in these regions.
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While the overall trend of our results in this large animal study is similar to what
we observed in small animals, there are a number of key differences which are critical in
considering the use of hyperpolarized pulmonary lactate-to-pyruvate ratio as a reliable
measure of lung lactate production. First, because the blood circulation time in large
species is much longer than in small animals, it therefore takes longer for the pyruvate to
distribute systemically after injection. Consequently, as we observed in Figure 7.1, the time
to peak for the lactate signal is considerably longer in pigs than in rats, which delays the
optimum imaging window. It is therefore critical to compensate for the extra signal loss
due to irreversible T1 relaxation mechanisms. The first solution is to improve the overall
hyperpolarization level: the Spinlab clinical DNP polarizer operates at a higher filed
strength (5T) and a lower temperature (0.8K) than the Hypersense system, and can
therefore provide higher polarization levels than were achieved in small animal studies.
The second solution is to use more sophisticated and sensitive RF coils. In this study, we
used a flexible 8-channel receive array which significantly improves the RF reception
sensitivity near each coil. However, it must be noted that, as the sensitivity of each receive
coil in the array drops rapidly as we move away from the coil, the SNR in the deeper
regions of the lung tissue located farther from the coils may suffer. For instance, we were
unable to quantify the lactate signal in the anterior lungs in pig 5 due poor SNR (Figure
7.6).
Second, we generally observed that in larger species, unlike in rats, pulmonary
pyruvate and lactate signals were predominantly localized in the posterior lung, possibly
due to the more pronounced gravitational gradient of perfusion (Figures 7.3 and 7.4) 5. This
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also suggests that regional changes in pulmonary blood flow and volume may be more
pronounced in large species compared to rats—a critical consideration when using
hyperpolarized lactate-to-pyruvate ratio as a surrogate for pulmonary lactate production
that has the potential to be especially limiting of attempts to quantify the lactate-to-pyruvate
ratio in severely injured regions of the lungs where blood is generally increased. We
observed a similar, global limitation in our small animal studies in chapter 4, where, despite
the overall increase in pulmonary lactate signal in rats after injury with a large dose of HCl,
the global lactate-to-pyruvate ratio decreased due to increased pulmonary blood volume in
the lungs.
Moving forward, we believe that the translation of 13C technology to larger species,
and ultimately human subjects, requires the development of MRI pulse sequences that can
improve the spatial and temporal resolution of images without comprising the SNR.
Improved spatial resolution will facilitate more effective regional assessment of individual
metabolites, while improved temporal resolution will enable the acquisition of multiple
scans to capture the time course of individual metabolites. These improvements are crucial
for two reasons: first, the optimum imaging window likely differs among subjects due to
variability of the heart, as we observed in this study (Table 7.2); second, being able to
capture the time course of each metabolite enables the measurement of the metabolic flux,
which in turn allows for the more accurate quantification of pyruvate’s conversion to
lactate.
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7.5. Conclusion
Our study demonstrates the feasibility of pulmonary metabolic imaging using
hyperpolarized

13

C MRSI technology in larger species. Despite the limited number of

animals in this study, we consistently observed elevated lactate-to-pyruvate ratio in the
injured regions of the lungs as early as 2 hours after acid instillation. This increase was
significantly higher in animals imaged 7-9 hours after the acid instillation, possibly due to
recruitment and activation of lung inflammatory infiltrates. Because pulmonary lactate
production significantly increases during inflammatory injury2,6-8, visualizing the regional
distribution of pulmonary lactate may provide useful information for both early detection
and clinical management.
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Chapter 8: Development of a Platform for High-Resolution Pulmonary Metabolic
Imaging Using Hyperpolarized 13C MRI

8.1. Introduction
Previous chapters demonstrated the use of a modified FID-CSI pulse sequence for
pulmonary metabolic imaging, showing that our method is capable of visualizing and
quantifying abnormalities in pulmonary metabolism during progressive lung injury in
small and large species. However, the FID-CSI pulse sequence is inherently slow and
inefficient, as it requires a large number of excitations to produce spectroscopic images:
e.g., increasing the spatial resolution by a factor of 2 in both dimensions increases the scan
time 4-fold. Consequently, the FID-CSI sequence can offer only limited spatial resolution
for 13C MRI. What is more, its long scan time makes imaging with it more susceptible to
artifacts caused by cardiac motion and blood flow.
While the FID decays with the short T2* relaxation time constant in the lungs,
studies report that NMR signal in the lungs actually has a substantially longer T2 relaxation
time constant 1, potentially creating an opportunity to develop strategies for rapid and highresolution pulmonary 13C MRI. In this chapter, we first demonstrate that the half-Fourier
single-shot turbo spin-echo (HASTE) pulse sequence can serve as a platform for highresolution pulmonary imaging in small species; we then show that a similar method can be
used on a clinical scanner to image larger species. Finally, we propose a number of
strategies to modify the HASTE pulse sequence for spectroscopic and metabolic imaging
using 13C MRI.
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8.2. Materials and Methods
Figure 8.1. shows the use of a train of refocusing pulses to take advantage of the
long T2 relaxation time constant in the lungs for imaging. The FID generated after RF
excitation with a 90° flip angle decays with a short T2* relaxation time constant. However,
the de-phased signal can be partially re-phased multiple times using a train of refocusing
pulses (180° flip angle) to form spin-echoes that decay with the longer T2 time constant.
The signal generated by each spin-echo can then be spatially encoded.

Figure 8.1. Excitation with a 90° RF pulse followed by a series of 180o refocusing pulses forms a spin-echo
train. The transverse magnetization initially generated after the excitation decays with a T2* relaxation time
constant. Each refocusing pulse recovers the part of transverse magnetization lost due to magnetic field
inhomogeneity. The signal generated via the spin-echo train therefore decays with T2 relaxation time
constant. Since T2 >> T2* in the lung tissue, the spin-echo formation can recover a major fraction of the
transverse magnetization that is otherwise de-phased due to field inhomogeneity. Note that while the
refocusing can occur with any flip angle, it is most efficient with 180o RF pulses.

8.2.1. Animal Preparation
A total of twelve BLAB/c mice (27±2 g) and two pigs (pigs 2 and 6 from chapter
7) were used for this study. All animal procedures were approved by the Institutional
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Animal Care and Use Committee (IUCAC) of the University of Pennsylvania
(Philadelphia, PA). Mice and pigs were prepared as described in sections 4.6.1 and 7.2.1,
respectively.

8.2.2. 1H and 13C Imaging
Mice were scanned using a 9.4T Avance III vertical-bore (89 mm) micro-imaging
system (Bruker Biospin, Rheinstetten, Germany), and T2-weighted anatomical images
were acquired as described in section 4.6.1. First and second order shimming was
performed using the system’s automatic field-map shimming over the chest. 44µl of [113

C] pyruvate sample was polarized using a commercial Hypersense DNP polarizer as

described in section 4.3.2. A 250µL aliquot containing 160mM of hyperpolarized [1-13C]
pyruvate was administered via the tail vein over 30 seconds.
13

C imaging began 15 seconds after the start of injection using a respiratory-gated

single-slice HASTE (partial Fourier = 1.68) with an outward centric phase-encoding order
(Figure 8.2). RF excitation was performed using a 1ms second-order Shinar-Le Roux RF
pulse with a 90° flip angle; refocusing was performed using an 0.5ms adiabatic refocusing
pulse with a 180° flip angle. Eight mice were imaged using the single-echo imaging
configuration of the sequence, in which only the first readout loop (Figure 8.2) was used
to acquire one image per excitation. The imaging parameters were TE = 2.3ms, 48×48
matrix size, 40 kHz bandwidth, 25×25 mm2 in-plane FOV, 5 mm slice thickness, and total
ETL = 29. The rest of the mice were imaged using the dual-echo imaging configuration of
the sequence, in which both readout loops were used acquire two images with different
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effective echo times (TE1/TE2 = 2.98/50.66ms) in order to calculate T2 maps of [1-13C]
pyruvate. The dual-echo imaging parameters were 32×32 matrix size, 20 kHz bandwidth,
25×25 mm2 in-plane FOV, 10mm slice thickness, and echo-train length (ETL) = 19 per
loop (total of 38). The single-echo configuration yielded images with higher spatial
resolution (0.52×0.52×5 mm3) than the dual-echo configuration (0.78×0.78×10 mm3).
Each repetition of the sequence with both configurations ended with a flip-back module
consisting of additional refocusing and excitation pulses to preserve the remainder of the
transfer magnetization decayed with the T2 time constant as longitudinal magnetization for
the next repetition. This acquisition was repeated six times every 5 seconds for each study.

Figure 8.2. The HASTE pulse sequence used for hyperpolarized 13C imaging in mice. Each readout loop
forms an echo train, followed by the flip-back module that used an additional refocusing and excitation pulses
to transfer the leftover transverse magnetization to longitudinal magnetization. Higher resolution imaging
(48×48 matrix size) was performed using the single-echo imaging confirmation, where only the first readout
loop was used. T2 maps were calculated from the two lower resolution images (32×32 matrix size) acquired
using the dual-echo imaging configuration of the sequence, where both readout loops were used to generated
two images per excitation.
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The frequency of the 13C channel was automatically calibrated by the scanner at the
beginning of each animal study: a chemical shift of 3.5ppm was assigned to the water peak
and the frequency was scaled down based on the difference between the gyromagnetic
ratios of 1H and 13C nuclei to find the frequency of the 13C channel at 0ppm. The frequency
was then manually set to the position of the pyruvate peak (171ppm) in the NMR spectrum.
The accuracy of this method of frequency calibration was verified in separate studies. The
flip angle calibration was performed prior to the animal study using a phantom containing
5ml of a 5M solution of [1-13C] sodium propionate in a sealed 20ml syringe.
For the pig studies, [1-13C] pyruvate samples were polarized using a SpinLab
commercial DNP polarizer and MRI scans were performed as described in sections 7.2.2
and 7.2.3, respectively.

13

C images were acquired using a TrueFISP with the following

parameters: TR/TE=4.57/2.11ms, 45° excitation flip angle and 90° refocusing flip angle,
52kHz acquisition bandwidth, 48×48 matrix size, and five 2cm-thick slices covering the
lung. In-plane FOV was set to either 50×50 cm2 or 25×25 cm2 for pigs 2 and 6, respectively,
yielding respective in-plane spatial resolutions of 1.04×1.04 cm2 and 0.52×0.52 cm2. A 15s
breath-hold was applied 10s after the start of injection to minimize motion artifacts, and
one set of multi-slice images was acquired 15 seconds after the start of injection. Our
refocusing flip angle was set to 90°, as the RF amplifier was unable to generate enough
power for a 180° flip angle with our 8-channel coil. Nevertheless, the TrueFISP sequence
with the large flip angle used in our study generates a train of spin-echoes similar to the
HASTE sequence 2,3.
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8.2.3. MRI Data Processing
Proton and

13

C DICOM images were exported to OsiriX 8.0 (Pixmeo SARL,

Switzerland) to generate the carbon/proton image overlays. Mean and standard deviation
of the noise in each image were calculated from mean and standard deviation of the voxel
intensities within a region-of-interest (ROI) in the upper left corner of the image. Bias
correction was performed by subtracting the mean of the noise from the overall image
intensity. Two ROIs were selected over the left and right lung in the bias-corrected image,
and the signal-to-noise ratio (SNR) in the lung tissue was calculated by dividing the
average voxel intensities within the latter ROIs over the standard deviation of the noise. T2
maps were generated from the dual-echo HASTE data using custom routines programmed
in MATLAB 2015b (Mathworks, Inc.) from equation 8.1:
𝑇K (𝑥, 𝑦) =

𝑇𝐸K − 𝑇𝐸›
𝑙𝑛o𝐼K (𝑥, 𝑦)p − 𝑙𝑛o𝐼› (𝑥, 𝑦)p

[8.1]

where I1(x,y) and I2(x,y) are the first and second echo images obtained with echo times
TE1 and TE2. Average T2 in each lung was calculated from the previously drawn ROIs over
the lungs.

8.3. Results
Figure 8.3 shows the representative higher-resolution image (48×48 matrix size)
hyperpolarized

13

C axial image in a mouse overlaid on its corresponding T2-weighted

image. The image shows a clear delineation of the cardiac chambers and the lung
parenchyma. The signal in the right ventricle appears to be stronger than in the left
ventricle. Average SNR in the higher- and lower-resolution (32×32 matrix size) images
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obtained using the single-echo and dual-echo configurations over the lungs were 61.7
(11.9, 244.7) and 28.7 (14.8, 77.1), respectively (the numbers in parenthesis show the
range).

Figure 8.3. (A) T2-weighted proton image, (B) representative high resolution hyperpolarized

13

C image

overlaid on the T2 image, and (C) the grey scale 13C image of the lungs.

Figure 8.4 shows the dynamic 13C imaging capability of the HASTE sequence, in
which imaging started 15 seconds after the end of the pyruvate injection (t=0s). The
pulmonary signal lasted for approximately 25 seconds after the start of imaging. 30 seconds
after the start of imaging (the sixth image), the signal in the lung had considerably decayed
and only the right ventricle was visible.
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Figure 8.4. Dynamic high resolution hyperpolarized 13C imaging of the lungs; t=0s is the moment from the
first image acquisition.

Figure 8.5 shows two lower-resolution

13

C images acquired using the dual-echo

configuration of the sequence. Similar to Figure 8.3, the cardiac chambers and the
parenchyma are clearly visible in the both echo images, although the parenchymal signal
in the second image has drastically decayed. The masked T2 map calculated using equation
8.1 overlaid on the anatomical scan shows a considerably longer T2 measured in the heart
than in the lungs. The image was masked to discard regions where the pyruvate signal in
the first echo was below 10% of the maximum image intensity. A summary of the T2
measurements in all mice is shown in Table 8.1. There was no in the T2 relaxation time
constant between the left and right lungs.
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Figure 8.5. First (left) and second (middle) echo images obtained from a mouse lung after injection of
hyperpolarized [1-13C] pyruvate. Images were obtained using the dual-echo version of the sequence with
32×32 matrix size. The effective echo times were TE1 = 2.98ms and TE2 = 50.66ms. An estimated masked
T2 map of [1-13C]-pyruvate in the lungs (right) is also shown.

Table 8.1. Summary of the estimated T2 measured in the lungs after injection of hyperpolarized [1-13C]
pyruvate (numbers are reported as Mean ± SD).
Estimated T2 (ms)
Mouse

Left Lung

Right Lung

1

119 ± 42

133 ± 28

2

74 ± 22

91 ± 47

3

82 ± 37

71 ± 40

4

138 ± 61

147 ± 60

Mean

106

111

SD

34

36

Figure 8.6 shows 13C images using the TrueFISP sequence in both a healthy (pig 2)
and an injured pig (pig 6). The signal intensity was approximately 20% higher in posterior
lungs of the healthy pig than in the anterior regions, consistent with our earlier observations
in chapter 7. In pig 6, however, the signal intensity was approximately 3× higher in the
posterior regions of the injured lung than in the anterior areas. The average SNR in the
lungs for pigs 2 and 6 was 258±52 and 34±16, respectively.
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Figure 8.6. 13C Imaging using a multi-slice TrueFISP sequence in one healthy (pig 2) and one injured pig
(pig 6). The signal intensity in the injured areas of the posterior lung (pig 6; outlined areas) was 3×higher
than in the anterior lung. The white arrow shows the signal in the descending thoracic aorta.

8.4. Discussion
In this sub-aim, we showed that a HASTE pulse sequence can be used for rapid
high-resolution 13C MRI of the lungs in mice. The sequence takes advantage of the long T2
relaxation time constant of

13

C pyruvate in the lungs, as well as the complex conjugate

symmetry property of the k-space data4, to offer a 3-fold improvement in spatial resolution
and an over 20-fold reduction in the total scan time compared to the FID-CSI pulse
sequence. Our data also showed that, despite such dramatic improvement, the SNR of the
acquired images is sufficient for quantitative imaging. We then showed the use of a
modified TrueFISP pulse sequence that, similar to the HASTE sequence, generates a spinecho train to acquire rapid high resolution 13C MRI in the pigs with similar gains in spatial
resolution and imaging time. Additionally, we were able to improve the spatial coverage
of our imaging by acquiring multiple slices over the lungs. Lastly, T2 measurements in the
lungs showed that, much like protons in the lungs, the T2 relaxation time of the 13C species
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in the lungs is considerably longer than the T2* relaxation times, the latter of which are
estimated to be ~2ms from the NMR linewidths of the FID-CSI images.
Although we used rats for the small animal studies discussed in previous chapters,
we chose to use mice in this section for two reasons: first, we had access to more advanced
pulse sequence programming capabilities on the 9.4T micro-imaging system, which was
only capable of imaging mice; second, the development of higher resolution imaging
sequences for mice facilitates the study of a much broader range of pulmonary disorders
using hyperpolarized 13C MRI, as there is a broader range of disease and genetic models
available in mice.
The FID-CSI pulse sequence enabled us to effectively study alterations in lung
metabolism due to lung injury, hypoxemia and lung cancer in chapters 4-6. We also showed
that this sequence has potential for pulmonary imaging in larger species, and potentially
human patients (chapter 7). However, improving the spatial and temporal resolution of our
imaging method is critical for making more effective use of this molecular imaging tool
for preclinical and clinical pulmonary imaging. Higher spatial resolution can better localize
areas with abnormal metabolism, and can provide a diagnostically useful assessment of
metabolic alterations in focal injuries. Higher temporal resolution enables the acquisition
of multiple images of pyruvate and lactate, enabling a more accurate quantification of the
flux through LDH by allowing us to visualize their time-courses regionally 5,6.
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8.5. Lung Metabolic Imaging Strategies using the HASTE Pulse Sequence
Because the HASTE pulse sequence is not capable of resolving the separate
contributions of the pyruvate and lactate peaks to the overall 13C image, strategies must be
implemented in order to use HASTE as a spectroscopic imaging pulse sequence. Our first
proposed approach is to use interleaved, spatial-spectral (SPSP) excitation pulses which
excite and image pyruvate and lactate peaks separately in an alternating fashion (Figure
8.7). As discussed in section 2.8.3, this excitation scheme has been used extensively for
hyperpolarized

13

C MRI of various tissues5,7. However, given the 12ppm separation

between pyruvate and lactate peaks, such SPSP RF pulses are often 10-20ms long 8, which
is significantly longer that the T2* of 13C species in the lung tissue. Although limiting, it
may be possible to take this into account when designing the appropriate SPSP RF pulses
to minimize signal decay during the excitation period.

Figure 8.7. Proposed HASTE pulse sequence implementation with SPSP excitation and flip-back RF pulses.
The SPSP pulse individually excites pyruvate and lactate peaks.
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The second proposed approach is to use the IDEAL method described in section
2.8.2 to take advantage of the ~12ppm frequency separation between the pyruvate and
lactate peaks in order to acquire multiple gradient echoes after each refocusing pulse. Since
we are not interested in quantifying alanine and pyruvate-hydrate in the lungs, we can
suppress their contribution to the overall signal using a selective saturation RF pulse before
excitation (Figure 8.8). The echo spacing must be selected such that the pyruvate and
lactate peaks are in and out of phase in the first and second gradient echoes, respectively.
While it is theoretically possible to perform the IDEAL reconstruction from two gradient
echoes, we suggest acquiring a third gradient echo to improve the performance of the
reconstruction algorithm9. Another consideration is that, since signal decays with T2*
between refocusing pulses, the total data acquisition time over the multi-echo readout
cannot be significantly longer than the T2* in order to ensure sufficient SNR over each
gradient echo. The IDEAL methodology is also limited in that its reconstruction is
susceptible to B0 inhomogeneities. However, this may be resolved by acquiring B0-maps
over the FOV using proton imaging and incorporating them into the reconstruction
algorithm.
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Figure 8.8. Proposed HASTE pulse sequence implementation with a multi-echo readout for Dixon
reconstruction. The initial saturation pulse minimizes the contributions of the alanine and pyruvate hydrate
peaks, located between the pyruvate and lactate peaks, for more effective use of the IDEAL approach.

8.6. Conclusion
Our study demonstrates the feasibility of high-resolution dynamic imaging of the
lungs using 13C MRI in both small and large animal species using spin-echo based pulse
sequences (e.g. HASTE), yielding up to a 3-fold improvement in spatial resolution and an
over 20-fold reduction in scan time compared to the FID-CSI pulse sequence. Using this
technique, we have shown that we can obtain images with sufficiently high SNR for
quantitative imaging. While we did not resolve pyruvate and lactate images in this study,
we propose two potential strategies that can be implemented in the HASTE pulse sequence
in order to separate the contributions of pyruvate and lactate signals to a given image. The
first strategy is to alternately excite pyruvate and lactate peaks using SPSP excitation
pulses, while the second is to acquire multiple gradient-echoes per spin-echo in order to
separate pyruvate and lactate images using IDEAL reconstruction.
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Chapter 9: Conclusion and Future Work

9.1. Conclusion
This project began by demonstrating the utility of hyperpolarized [1-13C] pyruvate
MRI for quantifying pyruvate to lactate metabolism in pulmonary tissue with sufficient
spatial resolution and SNR in small animals using a modified FID-CSI pulse sequence. We
then showed this novel molecular imaging technology’s ability to monitor and highlight
early metabolic changes in an experimental aspiration pneumonitis model in rats, as
measured lactate metabolism correlates well with both tissue injury and neutrophilic
infiltration and activity assessed from histology and immunofluorescence staining. Having
also found a correlation between increased pyruvate to lactate conversion and hypoxemia
in injured rats, we further explored the contribution of systemic hypoxemia to anaerobic
metabolism in the lung by exposing non-injured rats to mild and severe hypoxemia. Our
results showed that pulmonary lactate-to-pyruvate only increased significantly in the
presence of severe, rather than moderate, hypoxemia. Since the injured rats in our earlier
study were moderately hypoxic, the findings of the second suggests that the elevated
pulmonary lactate-to-pyruvate ratio in rats with progressed lung injury is primarily the
result of inflammatory injury, although severe regional tissue hypoxia—which can also
occur in severely injured lungs—may cause increased anaerobic metabolism as well.
While our small animal studies demonstrated 13C hyperpolarized MRI’s capacity
for both molecular and metabolic lung imaging, translating this technology to the clinic
will require accounting for the considerable physiological differences between small
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animals and humans, as well as the pathophysiology differences between lung injury
models in rodents and ARDS/ALI patients. In order to help bridge this gap, we showed
that hyperpolarized 13C MRI can be effectively scaled to larger species as a step toward
clinical translation. We chose a pig model in order to take advantage of their similar lung
physiology to humans, and first assessed the feasibility of imaging lung metabolism in
healthy pigs using our modified FID-CSI pulse sequence. We then showed increased
pulmonary lactate signal intensity in a porcine model of aspiration pneumonitis: while the
lactate-to-pyruvate ratio increased globally in the injured lungs, this increase was more
significant in areas that co-localized with injury.
Finally, we explored the feasibility of using a HASTE pulse sequence as a platform
for 13C pulmonary MRI in mice and pigs, and showed its potential to image the lungs with
up to 2× improvement in spatial resolution compared the FID-CSI pulse sequence with an
approximately 20× reduction in scan time. By exploiting the long T2 relaxation time
constant in the lung tissue, the HASTE sequence is able to recover much of the transverse
magnetization coherency that is lost due to the short T2* relaxation time constant.

9.2. Future Work

9.2.1. Specifying the Source of Increased Lactate Production
Elevated pulmonary lactate production is common in patients suffering from
ARDS, and its extent has been shown to correlate strongly with the mortality rate. This
elevation is often attributed to the lung tissue’s increased metabolic demands upon
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infiltration and activation of neutrophils1,2. However, a number of studies have shown
elevated lactate production by pulmonary pneumocytes under conditions of stress as
well3,4. In chapters 4 and 5 we demonstrated that

13

C hyperpolarized MRI is capable of

visualizing regions in the lung tissue with elevated lactate production, and showed the
lactate-to-pyruvate ratio is strongly correlated with markers of lung injury, neutrophilic
infiltration and activation. One potential approach to further elucidate the contribution of
neutrophil activity to elevated lactate production in injured lungs is to induce acute
neutrophil depletion prior to the study similar what was presented in chapter 5. Acute
neutrophil depletion can be achieved by intravenous administration of a rabbit anti-rat
polymorphonuclear neutrophil antiserum 12-18 hour before the imaging study5,6.
The acid instillation model is characterized by formation of edema within the first
hour of injury followed by innate inflammatory cascade that peaks 4-6 hours after acid
instillation7. In our in-vivo studies, we did not detect any changes in the lactate-to-pyruvate
ratio within the first hour of injury. Moreover, were also unable to reliably detect and
quantify other downstream metabolites of pyruvate, such as bicarbonate, that has been
shown to change due to edema8. In our earlier isolated perfused rat lung studies, we have
shown that we can reliably quantify those metabolites that were otherwise not detectable
in our in-vivo studies, while allowing us to tightly regulate the conditions of the
experiment9,10. We propose to conduct similar ex-vivo studies in injured and non-injured
rats 1 hour and 4 hours after acid or saline instillation to mimic early edematous injury and
inflammatory injury caused acid instillation injury in separate cohorts (Figure 9.1). The
improved signal sensitivity we gain by performing ex-vivo studies may provide additional
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insight into lung’s metabolic alterations that are associated with edema, tissue damage or
inflammation.

Figure 9.1. Proposed study design to assess metabolic changes in injured and non-injured ex-vivo perfused
rat lungs.

9.2.2. Tandem Hyperpolarized 13C and 129Xe Imaging to Improve Specificity
We showed that hyperpolarized

13

C MRI is capable of detecting regions with

elevated lactate production in the lungs in-vivo due to injury. However, our findings also
demonstrated that hyperpolarized

13

C MRI is not capable of distinguishing between

hypoxic and injured tissues. Using hyperpolarized 129Xe MRI, we can assess structural and
functional alterations caused by inflammatory injury and local tissue hypoxia obtaining
local measurements of oxygen tension and specific ventilation11. Additionally, 129Xe in the
alveolar airspace have a large chemical shift difference from the xenon dissolved in the
blood or the tissue, which enables us to interrogate changes in gas uptake12. We can
improve the specificity for detection of inflammatory injury and hypoxia by using
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hyperpolarized 129Xe MRI in tandem with hyperpolarized 13C MR imaging. For example,
by co-localizing dissolved phase (gas uptake) maps attained with hyperpolarized
MRI and with lactate and pyruvate maps measured via hyperpolarized

13

129

Xe

C MRI (Figure

9.2), we may be able to sensitively distinguish between hypoxia and inflammatory response
and better quantify the spatial heterogeneity of lung injury and its progression.

Figure 9.2. Representative hyperpolarized 129Xe and hyperpolarized 13C MRI scans obtained 6 and 8 hours
after acid aspiration lung injury in an injured pig (pig 5, chapter 7). Lactate signal is elevated in posterior
region of both lungs, however, the
(white arrow). While

13

129

Xe scan shows low ventilation and gas uptake only in the right lung

C MRI highlight regions with abnormal metabolism,

129

Xe MRI can provide

additional information regarding gas uptake and ventilation, thereby differentiating hypoxic and inflamed
regions.

129

Xe and

13

C images were acquired using two different clinical scanners at 1.5T and 3T field-

strength respectively since RF coils were only available at those fields for each nucleus. However, both scans
can be performed in a single session within minutes of each other with RF coils designed for the same fieldstrength.

9.2.3. Assessment of Treatment TRPV4 Inhibition in Lung Injury Models using
Hyperpolarized MRI Technology
ARDS/ALI is a complex and heterogenous disorder for which the only currently
available, widely used treatment is supportive therapy using protective ventilation, and
more recently prone positioning{Thompson:2017di}. However, there are several novel
pharmacological therapies that are currently being investigated for treatment of
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ARDS/ALI13. A new potential treatment that has shown promise is inhibition of the TRPV4
channel14. Activation of TRPV4 channel after lung injury causes detachment of endothelial
cells from the basement membrane in the alveolar septa, disrupting this barrier and
allowing alveolar flooding that eventually leads to diffuse inflammation and gas change
impairment14. Using hyperpolarized

13

C MRI we can investigate the effects of this

treatment on cellular bioenergetics in order to assess the metabolic mechanisms underlying
this investigational pharmacological therapy for lung injury. We will then explore whether
the additional information obtained via hyperpolarized 13C and 129Xe MRI can be valuable
in predicting outcome of treatment in small animals.

9.2.4. Development of High-Resolution MRI Pulse Sequences For Metabolic Imaging
in Small and Large Species
Continued use of hyperpolarized

13

C MRI for preclinical pulmonary metabolic

imaging and its critical translation will require development of imaging pulse sequences
capable of obtaining metabolic images with higher spatial and temporal resolutions than
are currently produced. Higher spatial resolution is critical for better localization of areas
with abnormal metabolism; improved temporal resolution will enable the acquisition of
multiple images of pyruvate and lactate, as well as making it possible to quantify the flux
through LDH more accurately by visualizing their time-courses regionally. Working
towards this purpose, we demonstrated that the use of a HASTE pulse sequence to exploit
the long T2 relaxation time constant in the lung tissue for high resolution 13C pulmonary
MRI. Although, in our current studies, we did not resolve the respective contributions of
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pyruvate and lactate metabolites to the overall signal in these studies, in section 8.5, we
suggested two strategies that can be implemented in the HASTE sequence for
spectroscopic imaging: selective excitation of individual metabolites using SPSP RF pulse
excitation, and IDEAL-based reconstruction. We have currently implemented the IDEALbased sequence for imaging small and large species and are working towards optimizing
the parameters and image quality.

9.2.5. Explore the Use of 13C MRI to Study Other Pulmonary Disorders
Lastly, this project focused primarily on imaging an aspiration pneumonitis model
of acute lung injury model designed to mimic the pathophysiology of ARDS. Additionally,
we definitively demonstrated the utility of our developed imaging and quantification tools
for visualizing increased lactate production in a murine model of lung cancer. Increased
anaerobic metabolism in the lung tissue is not unique to lung injury and cancer, however,
but may occur in a much broader range of pulmonary disorders: e.g. pulmonary allograft
rejection and cystic fibrosis. Nevertheless, we believe that the tools and methodologies
developed in this project will be applicable to imaging a variety of pulmonary disorders in
human subjects for the dual purposes of diagnosis and monitoring treatment response.
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